<SEC-DOCUMENT>0001104659-23-124994.txt : 20231211
<SEC-HEADER>0001104659-23-124994.hdr.sgml : 20231211
<ACCEPTANCE-DATETIME>20231211160951
ACCESSION NUMBER:		0001104659-23-124994
CONFORMED SUBMISSION TYPE:	N-CSR
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230930
FILED AS OF DATE:		20231211
DATE AS OF CHANGE:		20231211
EFFECTIVENESS DATE:		20231211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			abrdn Healthcare Investors
		CENTRAL INDEX KEY:			0000805267
		IRS NUMBER:				046564285
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		N-CSR
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-04889
		FILM NUMBER:		231478222

	BUSINESS ADDRESS:	
		STREET 1:		1900 MARKET STREET
		STREET 2:		SUITE 200
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103
		BUSINESS PHONE:		6177728515

	MAIL ADDRESS:	
		STREET 1:		1900 MARKET STREET
		STREET 2:		SUITE 200
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TEKLA HEALTHCARE INVESTORS
		DATE OF NAME CHANGE:	20141015

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	H&Q HEALTHCARE INVESTORS
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-CSR
<SEQUENCE>1
<FILENAME>tm2325130d1_ncsr.htm
<DESCRIPTION>N-CSR
<TEXT>
<!-- Assembled by CompSci Transform  (tm) - http://www.compsciresources.com - version 1.2 -->
<!-- Created: Sat Dec 09 18:25:48 UTC 2023 -->
<html>
<head>
     <title></title>
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2325130d1_regcover.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2325130-1/tm2325130-1_ncsrseq1" -->
<p style="margin: 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#xa0;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="text-align: center">&#xa0;</td>
    <td style="border-right: Black 1pt solid; text-align: center">&#xa0;</td>
    <td colspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMB APPROVAL</font></td></tr>
<tr style="vertical-align: top">
    <td style="width: 24%; text-align: center">&#xa0;</td>
    <td style="width: 52%; border-right: Black 1pt solid; text-align: center">&#xa0;</td>
    <td style="width: 12%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OMB Number:</font></td>
    <td style="border-right: Black 1pt solid; white-space: nowrap; width: 12%; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3235-0570</font></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#xa0;</td>
    <td style="border-right: Black 1pt solid; text-align: center">&#xa0;</td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expires:</font></td>
    <td style="border-right: Black 1pt solid; white-space: nowrap; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
30, 2025</font></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center">&#xa0;</td>
    <td style="vertical-align: bottom; border-right: Black 1pt solid; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNITED STATES</font></td>
    <td colspan="2" style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    average burden hours per response. . . . . . . . . . . . . . .7.8</font></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center">&#xa0;</td>
    <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES AND EXCHANGE COMMISSION</font></td>
    <td colspan="2" style="text-align: center">&#xa0;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 2pt; text-align: center">&#xa0;</td>
    <td style="padding-top: 2pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington, D.C. 20549</font></td>
    <td colspan="2" style="padding-top: 2pt; text-align: center">&#xa0;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#xa0;N-CSR</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTIFIED SHAREHOLDER REPORT OF REGISTERED<br>
MANAGEMENT
INVESTMENT COMPANIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%">Investment Company Act file number</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 75%">811-04889</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-size: 14pt">abrdn
Healthcare Investors</font></p>

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(Exact name of registrant as specified in charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 80%">1900 Market Street, Suite&#xa0;200, Philadelphia</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 20%"> 13103</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif">(Address of principal executive offices)</td>
    <td style="text-align: center; font: 10pt Times New Roman, Times, Serif"> (Zip code)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Sharon Ferrari, abrdn Inc., 1900 Market Street,
Suite&#xa0;200, Philadelphia, PA 19103</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Name
and address of agent for service)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 203.25pt">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%">Registrant&#x2019;s telephone number, including area code:</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 66%">1-800-522-5465</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 17%">Date of fiscal year end:</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 83%"> September&#xa0;30</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">Date of reporting period:</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">October&#xa0;1, 2022 to September&#xa0;30, 2023</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#xa0;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#xa0;</p>

</div><div style="font: 10pt Times New Roman, Times, Serif"><div style="Page-Break-Before: Always"></div><!-- BannerFile="tm2325130d1_item1.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2325130-1/tm2325130-1_ncsrseq1" -->
<p style="margin: 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>ITEM 1. REPORTS TO STOCKHOLDER</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#xa0;</p>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#xa0;</p>



</div><div style="Page-Break-Before: Always"></div><!-- BannerFile="tm2325130d1_hqhar25130d2.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2325130-1/tm2325130-1_ncsrseq1" --><!-- Document name: 23-25130-2.aa-->
<p style="margin:12pt 0pt 12pt 0pt"><img src="tm2325130d1hqhar25130d2i001.jpg"></p>
<p style="margin:12pt 0pt 12pt 0pt"><img src="tm2325130d1hqhar25130d2i002.jpg"></p>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:16pt; font-family: Times New Roman, Times, serif;"><b>abrdn Healthcare Investors (HQH)</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:12pt; font-family: Times New Roman, Times, serif;"><b>(Formerly Tekla Healthcare Investors)</b></font></p>
<p style="margin:5.60001pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:12pt; font-family: Times New Roman, Times, serif;"><b>Annual Report<br></b>September 30, 2023</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:18pt; font-family: Times New Roman, Times, serif;"><b>abrdn.com</b></font></p>
</div>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=1,FOLIO='',FILE='23-25130-2.aa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><font style="font-size:19pt; font-family: Arial, Helvetica;">abrdn Healthcare Investors</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Distribution policy:</b> The Fund has implemented a managed distribution policy (the Policy) that provides for quarterly distributions at a rate set by the Board of Trustees. Under the current Policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund's net assets to shareholders of record. The Policy would result in a return of capital to shareholders, if the amount of the distribution exceeds the Fund's net investment income and realized capital gains. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund's investment performance and should not be confused with "yield" or "income."</font></p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The amounts and sources of distributions reported in the Fund's notices pursuant to Section 19(a) of the Investment Company Act of 1940 are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that tells you how to report distributions for federal income tax purposes.</font></p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">During the last fiscal year ended September 30, 2023, the Fund made quarterly distributions totaling $1.61 per share, which were characterized as $1.61 per share of net realized long-term capital gains. Final determination of the tax character of the distributions paid by the Fund in 2023 will be reported to shareholders in January 2024.</font></p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">You should not draw any conclusions about the Fund's investment performance from the amount of distributions pursuant to the Policy or from the terms of the Policy. The Policy has been established by the Trustees and may be changed or terminated by them without shareholder approval. The Trustees regularly review the Policy and the frequency and rate of distributions considering the purpose and effect of the Policy, the financial market environment, and the Fund's income, capital gains and capital available to pay distributions. The suspension or termination of the Policy could have the effect of creating a trading discount or widening an existing trading discount. At this time there are no reasonably foreseeable circumstances that might cause the Trustees to terminate the Policy.</font></p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Consider these risks before investing:</b> As with any investment company that invests in equity securities, the Fund is subject to market risk&#x2014;the possibility that the prices of equity securities will decline over short or extended periods of time. As a result, the value of an investment in the Fund's shares will fluctuate with the market generally and market sectors in particular. You could lose money over short or long periods of time. Political and economic news can influence market-wide trends and can cause disruptions in the U.S. or world financial markets. Other factors may be ignored by the market as a whole but may cause movements in the price of one company's stock or the stock of companies in one or more industries. All of these factors may have a greater impact on initial public offerings and emerging company shares. Different types of equity securities tend to shift into and out of favor with investors, depending on market and economic conditions. The performance of funds that invest in equity securities of healthcare companies may at times be better or worse than the performance of funds that focus on other types of securities or that have a broader investment style.</font></p>
</div>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=2,FOLIO='',FILE='23-25130-2.aa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><font style="font-size:19pt; font-family: Arial, Helvetica;">Welcome to abrdn</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Dear Shareholder,</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Effective close of regular business on October 27, 2023, abrdn, Inc. is your new investment adviser. abrdn Inc. assumed responsibility for the management of four former Tekla Capital Management, LLC closed-end funds: abrdn Healthcare Investors (Ticker: HQH), formerly Tekla Healthcare Investors, abrdn Life Sciences Investors (Ticker: HQL), formerly Tekla Life Sciences Investors, abrdn Healthcare Opportunities Fund (Ticker: THQ), formerly Tekla Healthcare Opportunities Fund and abrdn World Healthcare Fund (Ticker: THW), formerly Tekla World Healthcare Fund.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Two existing trustees of the Funds, Jeffrey Bailey and Kathleen Goetz, were joined by four newly elected trustees of the Funds, who were approved by shareholders of HQL on October 3, 2023, by shareholders of HQH on October 13, 2023, and by shareholders of THQ and THW on October 25, 2023, with each approval being contingent upon abrdn's appointment as adviser. The new trustees are Stephen Bird, Rose DiMartino, C. William Maher, and Todd Reit, who will serve as Chair of the Boards.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Upon the close of business on October 27, 2023, nearly all of the investment team responsible for the management of the Funds joined abrdn. The Funds will continue to be managed in accordance with their existing investment objectives and strategies by the same team of Boston-based investment professionals pursuing the same investment philosophy and employing the same investment process that has served the Funds well through the years. abrdn is one of the largest closed-end fund managers globally and is dedicated to creating long-term value for our clients.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">As of June 30, 2023, we managed over $602 billion in assets on behalf of institutional and retail clients worldwide. We believe that our global footprint ensures that we are always close to our clients and the challenges they face. Should you have any questions about the recent change in management of the funds, or our U.S. registered fund products, please don't hesitate to contact us. We look forward to serving you.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>An Introduction to abrdn</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">We invest to help our clients create more. More opportunity. More potential. More impact. We offer investment expertise across all key asset classes and markets so that our clients can capture investment potential wherever it arises. By combining market and economic insight with technology and diverse perspectives, we look for optimal ways to help investors navigate the future and reach their financial goals. As a leading global asset manager, abrdn is dedicated to creating long-term value for our clients. Closed-end funds have been a longstanding and important part of our firm's business, and we believe in their long-term value in helping to meet investors' needs. Visit our Investor Center to learn more about abrdn and our entire suite of 16 U.S. closed-end funds across a variety of asset classes.</font></p>
</div>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=3,FOLIO='',FILE='23-25130-2.aa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Shareholder Information</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">As part of abrdn's commitment to shareholders, we invite you to visit the Funds on the web at www.abrdnhqh.com, www.abrdnhql.com, www.abrdnthq.com and www.abrdnthw.com. Here, you can view monthly fact sheets, quarterly commentary, distribution and performance information, and other Fund literature.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Contact us:</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">&#x2022; Visit: https://www.abrdn.com/en-us/cefinvestorcenter</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">&#x2022; Email: Investor.Relations@abrdn.com; or</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">&#x2022; Call: 1-800-522-5465 (toll free in the U.S.).</font></p>
<p style="margin:9pt 0pt 6pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Yours sincerely,</font></p>
<p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><img src="tm2325130d1hqhar25130d2i003.jpg">
</p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Christian Pittard<br>President</font></p>
</div>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=4,FOLIO='',FILE='23-25130-2.aa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>

<!-- Document name: 23-25130-2.ba-->
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 6pt 0pt; text-align: center;"><font style="font-size:19pt; font-family: Arial, Helvetica;">Letter to Shareholders</font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> (Unaudited)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Dear Shareholders,</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Healthcare continues to be a unique and differentiated sector of the economy. The sector contains relatively non-cyclical defensive components, in the pharmaceutical and payor subsectors, for example. Healthcare also includes highly innovative, capital intensive subsectors like biotechnology that can perform in line with or in contrast to the more defensive market sectors. The overall consequence is that the healthcare sector, as a whole, can perform better or worse than the broad market, depending on a combination of fundamentals and macroeconomic conditions.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Healthcare materially outperformed the broad market in 2022 at a time when interest rates moved much higher quickly and there were heightened recession fears. Outperformance was presumably due to the defensive nature of such healthcare subsectors as Pharmaceuticals and Managed Care. So far in 2023, this trend has reversed. That is, the broad market has materially outperformed healthcare. Part of that outperformance was undoubtedly the result of the AI "craze" earlier in the year, but we believe that a lessening of inflation and a slowing in the rate of interest rate increase, conditions which can favor such sectors as tech, were at least as helpful to broad market advancement.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">It is important to note that our faith in the long-term future of healthcare remains strong. We continue to believe in the underlying demographics. The population is aging. People spend more on healthcare as they get older. And innovation moves ahead unbowed. We believe that the combination of these things will 1) continue to help us address unmet medical needs for patients, 2) reduce side effects and extend the lives of patients and 3) reward healthcare investors.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">There can be no better example of this than the recent development of the so-called GLP-1 class of incretin drugs being used to treat diabetes and obesity. Results in this area have been truly remarkable. Advancement in A1c control and weight loss for diabetics as well as profound weight loss for individuals battling obesity have been, in our experience, without precedent. Who would have thought, just a few years ago, that a weekly dose of a drug could, over just months, produce weight loss of 20% of body weight. And this class of drugs has the potential to have much broader impact. Initial studies suggest that, simultaneous with weight loss, incretin therapy could provide cardiovascular and renal benefit. Moreover, initial studies suggest that these agents could have potential impact in a wide array of diseases, including but not limited to obstructive sleep apnea, chronic obstructive pulmonary disease (COPD), cancer and CNS diseases like Alzheimer's. There are sure to be bumps in the road during clinical and other evaluation of GLP-1 drugs (which may or may not be represented in your Fund's portfolio at this or other times), but their potential is impressive. Some Wall Street analysts are projecting market size for this class of drugs in excess of $100B. Sales at this level would likely make this class of drugs among the most successful (and arguably the most effective) drugs of all time.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 1</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=5,FOLIO='1',FILE='23-25130-2.ba.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Separately, we note that Tekla has announced that its investment capabilities and management of your Fund have been acquired by abrdn Inc., a prominent U.K. based asset manager. We think this is a win-win-win situation. We believe that Tekla has a highly competent healthcare investment capability; the Company has managed your fund for more than twenty years. Nearly the entire Tekla team will be joining abrdn. This firm is one of the largest and most well-known closed-end fund (CEF) sponsors in the world and possesses premier CEF sponsor capabilities. We expect that with the addition of the Tekla Funds (which have been re-named as abrdn Funds), abrdn will become the third largest CEF sponsor worldwide. We look forward to working with abrdn and believe that the combination of the capabilities of these two fine firms will significantly benefit shareholders. I can tell you personally that it has been both a rewarding experience and a privilege to serve your Fund.</font></p>
<p style="margin:9pt 0pt 1pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Be well,</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="top" style="padding:0pt .7pt 0pt 0pt; width: 8px; text-align: left;">
<img src="tm2325130d1hqhar25130d2i004.jpg">
<img src="tm2325130d1hqhar25130d2i005.jpg">
</td>
<td colspan="1">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Daniel R. Omstead<br>Vice President and Portfolio Manager</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">2 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=6,FOLIO='2',FILE='23-25130-2.ba.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><font style="font-size:11pt; font-family: Arial, Helvetica;"><b>Fund Essentials</b></font><font style="font-size:11pt; font-family: Times New Roman, Times, serif;"><i> (Unaudited)</i></font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Objective of the Fund</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. In addition, the Fund seeks to provide regular distribution of realized capital gains.</font></p>
</div>
<div style="width:48%; float:left; margin-top:10pt; margin-right:3%">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Description of the Fund</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">abrdn Healthcare Investors ("HQH") is a non-diversified closed-end healthcare fund traded on the New York Stock Exchange under the ticker HQH. HQH primarily invests in healthcare industries and will emphasize both large established companies and smaller, emerging companies with a maximum of 40% of the Fund's assets in restricted securities of both public and private companies.</font></p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Investment Philosophy</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">The Investment Adviser to the Fund, believes that:</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2022;&#xa0;&#xa0;Aging demographics and adoption of new medical products and services can provide long-term tailwinds for healthcare companies</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2022;&#xa0;&#xa0;Late stage biotechnology product pipeline could lead to significant increases in biotechnology sales</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2022;&#xa0;&#xa0;Robust M&amp;A activity in healthcare may create additional investment opportunities</font></p>
</div>
<div style="width:48%; float:left; margin-top:10pt; margin-right:0%">
<p style="margin:0pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Fund Overview and Characteristics </b>as of 9/30/23</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 85px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Market Price<sup>1</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$15.55</b></font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 85px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">NAV<sup>2</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$18.84</b></font></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 85px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Premium/(Discount)</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>-17.46%</b></font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 85px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Average 30 Day Volume</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>98,912</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 85px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Net Assets</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$931,342,991</b></font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 85px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Ticker</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 99px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>HQH</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 85px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">NAV Ticker</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 99px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>XHQHX</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 85px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Commencement of<br>Operations Date</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 99px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>4/22/87</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 85px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Fiscal Year to Date <br>Distributions<br>Per Share</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$1.61</b></font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:4pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><i><sup>1</sup>&#x200b; The closing price at which the Fund's shares were traded on the exchange.</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><i><sup>2</sup>&#x200b; Per-share dollar value of the Fund, calculated by dividing the total value of all the securities in its portfolio, plus any other assets and less liabilities, by the number of Fund shares outstanding.</i></font></p>
</div>
<div style="clear:both"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Holdings of the Fund </b></font><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><i>(Data is based on net assets)</i></font></p>
</div>
<div style="width:48%; float:left; margin-top:10pt; margin-right:3%">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Asset Allocation as of 9/30/23</font></p>
<p style="margin:0pt 0pt 0pt 0pt"><img src="tm2325130d1hqhar25130d2i006.jpg">
</p>
</div>
<div style="width:48%; float:left; margin-top:10pt; margin-right:0%">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Sector Diversification as of 9/30/23</font></p>
<p style="margin:0pt 0pt 0pt 0pt"><img src="tm2325130d1hqhar25130d2i007.jpg">
</p>
</div>
<div style="clear:both"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><font style="font-size:7pt; font-family: Times New Roman, Times, serif;"><i>This data is subject to change on a daily basis.</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 3</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=7,FOLIO='3',FILE='23-25130-2.ba.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:11pt; font-family: Arial, Helvetica;"><b>Largest Holdings by Issuer </b></font><font style="font-size:11pt; font-family: Times New Roman, Times, serif;"><i>(Unaudited)</i></font></p>
<p style="margin:2pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:9pt; font-family: Arial, Helvetica;"><b>(Excludes Short-Term Investments)</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i>As of September 30, 2023</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:11pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 225px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Issuer</b></font><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Sector</i></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:11pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 78px; text-align: center;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>% of Net <br>Assets</b></font></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; background-color: #cceeff; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>Regeneron Pharmaceuticals, Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Biotechnology</i></font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">7.7</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>Amgen, Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Biotechnology</i></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">7.4</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; background-color: #cceeff; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>Vertex Pharmaceuticals, Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Biotechnology</i></font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">7.3</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>Gilead Sciences, Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Biotechnology</i></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">5.3</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; background-color: #cceeff; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>Biogen, Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Biotechnology</i></font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">3.7</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>AstraZeneca plc</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Pharmaceuticals</i></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">3.6</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; background-color: #cceeff; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>Alnylam Pharmaceuticals, Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Biotechnology</i></font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">2.4</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>Illumina, Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Life Sciences Tools &amp; Services</i></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">2.1</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; background-color: #cceeff; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>Moderna, Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Biotechnology</i></font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">2.0</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>AbbVie, Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Biotechnology</i></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">1.8</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; background-color: #cceeff; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>Johnson &amp; Johnson</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Pharmaceuticals</i></font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">1.6</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>BioMarin Pharmaceutical, Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Biotechnology</i></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">1.5</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; background-color: #cceeff; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>Thermo Fisher Scientific, Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Life Sciences Tools &amp; Services</i></font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">1.5</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>Sarepta Therapeutics, Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Biotechnology</i></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">1.5</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; background-color: #cceeff; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>argenx SE</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Biotechnology</i></font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">1.4</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>Exelixis, Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Biotechnology</i></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">1.4</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; background-color: #cceeff; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>Neurovance Milestone Interest</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Pharmaceuticals</i></font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">1.4</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>UnitedHealth Group, Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Health Care Providers &amp; Services</i></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">1.3</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; background-color: #cceeff; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>Immunovant, Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Biotechnology</i></font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">1.3</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;"><b>Merck &amp; Co., Inc.</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> &#x2013; Pharmaceuticals</i></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 47px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">1.3</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 23px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

<p style="margin:12pt 0pt 0pt 0pt; text-align: center;"><font style="font-size:11pt; font-family: Arial, Helvetica;"><b>Fund Performance</b></font><font style="font-size:11pt; font-family: Times New Roman, Times, serif;"><i> (Unaudited)</i></font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Fund and Benchmark Performance and Other Influencing Factors</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">HQH is a closed-end fund which invests predominantly in healthcare companies. Subject to regular consideration, the Trustees of HQH have instituted a policy of making quarterly distributions to shareholders. The Fund seeks to make such distributions in the form of long-term capital gains.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund considers investments in companies of all sizes and in all healthcare subsectors, including, but not limited to, biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare, healthcare technology and healthcare facilities. The Fund emphasizes innovation, investing both in public and pre-public venture companies. The Fund considers its venture investments to be a differentiating characteristic. Among the various healthcare subsectors, HQH has considered the biotechnology subsector, including both pre-public and public companies, to be a key contributor to the healthcare sector. The Fund holds biotech assets, including both public and pre-public, often representing 50-65% of net assets.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">4 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=8,FOLIO='4',FILE='23-25130-2.ba.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">There is no commonly published index which matches the investment strategy of HQH. The S&amp;P Composite 1500<sup>&#xae;</sup>&#x200b; Health Care Index* (S15HLTH) consists of approximately 170 companies representing most or all of the healthcare subsectors in which HQH typically invests; biotechnology often represents 15-20% of this index. By contrast, the NASDAQ Biotechnology Index<sup>&#xae;</sup>&#x200b;* (NBI), which contains approximately 260 constituents, is much more narrowly constructed. The vast majority of this index is comprised of biotechnology, pharmaceutical and life science tools companies. In recent years, biotechnology has often represented 72-82% of the NBI. Neither the S15HLTH nor NBI indices contain any material amount of pre-public company assets.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Given the circumstances, we present both NAV and stock price returns for the Fund in comparison to several commonly published indices. One index, the S&amp;P 500<sup>&#xae;</sup>&#x200b; Index* (SPX), is a commonly considered broad based index; this index is comprised of companies in many areas of the economy, including, but not limited to, healthcare. As described above, the NBI is a healthcare index mostly focused in three healthcare sectors with a high level of biotechnology by comparison. The S15HLTH contains a wider representation of healthcare subsectors, but typically contains a much lower biotechnology composition.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">HQH generally invests in a combination of large-cap growth-oriented and earlier stage innovative healthcare companies with a focus on the biotechnology sector. Generally, HQH targets biotechnology exposure below that of the NBI and a higher biotechnology exposure than that of the S15HLTH. We note that, in recent periods, biotechnology has been a significant contributor to returns (both positive and negative) associated with those indices. We believe this sector continues to have significant potential for growth in the future.</font></p>
<p style="margin:12pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Fund Performance for the Period Ended September 30, 2023</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">For the 12-month period ended September 30, 2023, the return on the Fund's net asset value was up 6.8% and market value was down 1.2%, including reinvestment of dividends and distributions. Over the same period the NBI was up 5.8% and the S15HLTH was up 7.4%, including reinvestment of dividends.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 43px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Period</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 71px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>HQH NAV %</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 72px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>HQH MKT %</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 51px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>NBI %</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 68px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>S15HLTH %</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 52px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>SPX %</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 43px; background-color: #cceeff; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;">6 month</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 55px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">-2.39</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 56px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">-7.57</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">-3.75</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">-0.29</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 36px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">5.18</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 43px; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;">1 year</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 55px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">6.80</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 56px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">-1.24</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">5.79</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">7.38</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 36px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">21.59</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 43px; background-color: #cceeff; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;">5 year</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 55px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">2.97</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 56px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">1.13</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">1.31</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">7.65</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 36px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">9.90</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 43px; text-align: left;">
<font style="font-size:9pt; font-family: Arial, Helvetica;">10 year</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 55px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">6.32</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 56px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">4.70</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">6.66</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">11.69</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 36px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:9pt; font-family: Arial, Helvetica;">11.90</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 9pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><img src="tm2325130d1hqhar25130d2i008.jpg">
</p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 5</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=9,FOLIO='5',FILE='23-25130-2.ba.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Change in the value of a $10,000 investment</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Cumulative total return from 9/30/2013 to 9/30/2023</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><img src="tm2325130d1hqhar25130d2i009.jpg">
</p>
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><i>All performance over one-year has been annualized. Performance data quoted represents past performance, which is no guarantee of future results, and current performance may be lower or higher than the figures shown. The NAV total return takes into account the Fund's total annual expenses and does not reflect transaction charges. If transaction charges were reflected, NAV total return would be reduced. All distributions are assumed to be reinvested either in accordance with the dividend reinvestment plan (DRIP) for market price returns or NAV for NAV returns. Until the DRIP price is available from the Plan Agent, the market price returns reflect the reinvestment at the closing market price on the last business day of the month. Once the DRIP is available around mid-month, the market price returns are updated to reflect reinvestment at the DRIP price. The graph and table do not reflect the deduction of taxes a shareholder would pay on fund distributions or the sale of fund shares.</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><i>Risk Adjusted NASDAQ Biotechnology Index<sup>&#xae;</sup>&#x200b; computed by the Adviser using Bloomberg data for the NBI and applying the Fund's computed 0.90 beta to NBI performance to reflect the Fund's lower historical risk.</i></font></p>
<p style="margin:12pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:11pt; font-family: Arial, Helvetica;"><b>Portfolio Management Commentary</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">During the period the Fund benefited from certain company selections, by both holding and avoiding ownership of specific stocks, For example, the Fund avoided holding NovoCure Limited (NVCR) whose medical device for treating lung cancer yielded disappointing clinical trial results. The Fund also saw a strong positive stock selection in biotechnology companies for example by holding a position in VectivBio AG (VECT) which was acquired in the period by Ironwood Pharmaceuticals, Inc.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">During the period, the Fund's allocation to healthcare equipment and services companies detracted from performance as these subindustry groups lagged their peers. The past year saw heavy losses for small cap public biotechnology stocks and while the Fund did not maintain large positions in small public biotechs, our nearly 10% allocation to private biotechnology companies detracted from performance.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">6 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=10,FOLIO='6',FILE='23-25130-2.ba.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:11pt; font-family: Arial, Helvetica;"><b>Portfolio Highlights as of September 30, 2023</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Among other investments, abrdn Healthcare Investors' performance benefitted in the past year by the following:</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Times New Roman, Times, serif;"><i>Vectivbio Holding AG (VECT)</i></font><font style="font-size:10pt; font-family: Arial, Helvetica;"> is a clinical stage biotechnology company developing treatments for severe, rare gastrointestinal conditions. Its lead candidate, apraglutide, is in development for Short Bowel Syndrome with Intestinal Failure (SBS-IF) and acute Graft versus Host Disease (aGvHD). The Fund held Vectivbio which had a strong positive return following announcement of Ironwood Pharmaceuticals' acquisition offer in May 2023.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Times New Roman, Times, serif;"><i>Novocure Ltd (NVCR)</i></font><font style="font-size:10pt; font-family: Arial, Helvetica;"> is an innovative medical device company whose tumor treating fields therapy uses electric current to kill cancer cells and disrupt their growth and migration. While the therapy has been approved for glioblastoma, an aggressive brain tumor, it has yet to see demonstrable success across more prevalent tumor types such as lung cancer. Novocure stock declined in the period and the Fund benefitted by not owning the stock during the period.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Among other examples, abrdn Healthcare Investors' performance was negatively impacted by the following investments:</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Times New Roman, Times, serif;"><i>Rallybio Corp. (RLYB)</i></font><font style="font-size:10pt; font-family: Arial, Helvetica;"> is a clinical stage biotechnology company developing therapies for patients with severe and rare disorders. Its lead candidate, RLYB212, is a monoclonal antibody for the prevention of fetal and neonatal alloimmune thrombocytopenia, a rare condition with no currently approved therapies. In the current risk-off environment, investor interest has shifted away from pre-commercial companies with early-stage assets and no revenue. Fund performance was negatively impacted by ownership of Rallybio during the period.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Times New Roman, Times, serif;"><i>Apellis Pharmaceuticals, Inc. (APLS)</i></font><font style="font-size:10pt; font-family: Arial, Helvetica;"> is a commercial stage biotechnology company with the first approved therapy for Dry AMD (Dry Age-related Macular Degeneration), a common disease in people over 50 where retina cells die off leading to blurred and reduced central vision and often blindness. The Fund owns APLS and performance was negatively affected when the stock suffered a price decline due to reported cases of ocular inflammation in treated patients that were not observed in the clinical trials.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Times New Roman, Times, serif;"><i>Sanofi (SNY)</i></font><font style="font-size:10pt; font-family: Arial, Helvetica;"> is a large pharmaceutical company that focuses on specialty care and vaccines. Over the course of the last year, Sanofi's lead drug, Dupixent, used principally in atopic dermatitis and asthma, has cemented itself as one of the best drug launches of all time, annualizing close to $10B in sales as of Q3 2023. Moreover, the drug showed promising results in COPD, a historically challenging disease to treat, which provides an additional significant market expansion. New leadership under CEO Paul Hudson is strategically focused on creating the best-in-class inflammation and immunology (I&amp;I) company and the Company has been active in business development and further enhancing the pipeline in these indications. The Company's stock outperformed while the Fund held a relatively small position.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 7</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=11,FOLIO='7',FILE='23-25130-2.ba.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><font style="font-size:11pt; font-family: Arial, Helvetica;"><b>Distributions</b></font><font style="font-size:11pt; font-family: Times New Roman, Times, serif;"><i> (Unaudited)</i></font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund intends to make quarterly distributions at a rate of 2% of the Fund's net assets. The Fund intends to use net realized capital gains when making quarterly distributions, if available, but would make return of capital distributions if the amount of the distribution exceeds the Fund's net investment income and realized capital gains. During the last fiscal year, the Fund made quarterly distributions totaling $1.61 per share, which were characterized as $1.61 per share of net realized long-term capital gains. Final determination of the tax character of the distributions paid by the Fund in 2023 will be reported to shareholders in January 2024.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Distributions of return of capital decrease the Fund's total assets and total assets per share and, therefore, could have the effect of increasing the Fund's expense ratio. In general, the policy of making quarterly distributions at a fixed rate does not affect the Fund's investment strategy. However, in order to make these distributions, the Fund might need to sell portfolio securities at a less than opportune time.</font></p>
<p style="margin:9pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund is covered under exemptive relief received by the Fund's investment adviser from the U.S. Securities and Exchange Commission (SEC) that allows the Fund to distribute long-term capital gains as frequently as monthly in any one taxable year.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">*The trademarks NASDAQ Biotechnology Index<sup>&#xae;</sup>&#x200b;, S&amp;P Composite 1500<sup>&#xae;</sup>&#x200b; Health Care Index, SPDR<sup>&#xae;</sup>&#x200b; S&amp;P<sup>&#xae;</sup>&#x200b; Biotech ETF and S&amp;P 500<sup>&#xae;</sup>&#x200b; Index referenced in this report are the property of their respective owners. These trademarks are not owned by or associated with the Fund or its service providers, including abrdn Inc.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">8 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=12,FOLIO='8',FILE='23-25130-2.ba.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>

<!-- Document name: 23-25130-2.ca-->
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><font style="font-size:19pt; font-family: Arial, Helvetica;">Schedule of Investments</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>September 30, 2023</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 221px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 100px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Shares</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 85px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Value</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 6pt 0pt; width: 414px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Convertible Preferreds and Warrants (Restricted) <sup>(a) (b)</sup>&#x200b; 5.8%</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 414px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><b><i>Biotechnology 3.6%</i></b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Abcuro, Inc. Series B</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">266,408</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,462,500</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Arbor Biotechnologies, Series B, 8.00%</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">82,076</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,359,999</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Arkuda Therapeutics, Inc. Series A, 6.00% <sup>(c)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,353,932</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">235</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Arkuda Therapeutics, Inc. Series B, 6.00% <sup>(c)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,044,322</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">536,259</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Flamingo Therapeutics, Inc. Series A3 <sup>(d)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">243,458</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,572,689</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Hotspot Therapeutics, Inc. Series B, 6.00%</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,875,000</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">7,725,988</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Hotspot Therapeutics, Inc. Series C, 6.00%</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">632,394</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,699,432</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">ImmuneID, Inc. Series A, 8.00%</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,020,000</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">488,070</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Incendia Therapeutics, Inc. Series A</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,769,383</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,399,993</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Invetx, Inc. Series A, 8.00% <sup>(c)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">7,187,500</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,816,344</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Invetx, Inc. Series B, 8.00% <sup>(c)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,089,091</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,070,000</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Priothera Ltd. Series A, 6.00% <sup>(c) (d)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">346,666</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,565,589</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Quell Therapeutics, Series B <sup>(d)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,553,631</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,229,999</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">ReCode Therapeutics, Series B, 5.00%</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">319,138</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,946,665</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>33,873,762</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 414px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><b><i>Health Care Equipment &amp; Supplies 0.1%</i></b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">IO Light Holdings, Inc. Series A2</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">421,634</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>640,378</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:3pt .7pt 0pt 0pt; width: 414px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><b><i>Pharmaceuticals 2.1%</i></b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Amolyt Pharma SAS Series C <sup>(d)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,602,836</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,626,441</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Biotheryx, Inc. Series E, 8.00%</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,295,238</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,040,000</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Curasen Therapeutics, Inc. Series A <sup>(c)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">18,203,119</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">8,728,396</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Endeavor Biomedicines, Inc. Series B, 8.00%</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">657,322</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,099,996</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">HiberCell, Inc. Series B </font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,773,472</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,285,782</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">HiberCell, Inc. Series C</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,529,261</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">708,965</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">HiberCell, Inc. Series C Warrants <br>(expiration date 09/15/28, exercise price $0.46) </font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,529,261</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>19,489,580</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total Convertible Preferreds and Warrants (Cost $73,743,773)</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>54,003,720</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; width: 221px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 100px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Principal Amount</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; width: 85px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 6pt 0pt; width: 414px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Non-Convertible Notes 0.1% (Restricted) <sup>(b) (c)</sup>&#x200b;</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 414px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><b><i>Pharmaceuticals 0.1%</i></b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Curasen Therapeutics, Inc.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">846,390</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">846,390</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total Non-Convertible Notes (Cost $846,670)</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>846,390</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><font style="font-size:6pt; font-family: Arial, Helvetica;">THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;"> abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT9</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=13,FOLIO='abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT9',FILE='23-25130-2.ca.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 221px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 100px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Shares</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 85px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Value</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 6pt 0pt; width: 414px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Common Stocks 87.7%</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 414px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><b><i>Biotechnology 56.9%</i></b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">89bio, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">56,488</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">872,175</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">AbbVie, Inc.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">115,116</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">17,159,191</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Affimed N.V. <sup>(a) (d)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">367,414</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">175,587</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Akero Therapeutics, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">40,050</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,025,729</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Alkermes plc <sup>(a) (d)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">173,907</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,871,135</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Alnylam Pharmaceuticals, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">124,587</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">22,064,358</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Amgen, Inc.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">257,888</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">69,309,979</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Apellis Pharmaceuticals, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">118,059</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,490,964</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Arcutis Biotherapeutics, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">86,869</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">461,274</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">argenx SE ADR <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">26,078</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">12,820,727</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Ascendis Pharma A/S ADR <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">92,961</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">8,704,868</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">BioCryst Pharmaceuticals, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">370,637</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,624,110</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Biogen, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">132,773</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">34,123,989</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">BioMarin Pharmaceutical, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">163,098</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">14,430,911</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">BioNTech SE ADR</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">66,396</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">7,213,261</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Black Diamond Therapeutics, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">90,404</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">259,459</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Bridgebio Pharma, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">124,341</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,278,872</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Caribou Biosciences, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">385,660</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,843,455</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Chinook Therapeutics, Inc. CVR (Restricted) <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">91,800</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">150,552</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Cytokinetics, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">132,081</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,891,106</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Denali Therapeutics, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">214,498</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,425,094</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Exelixis, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">584,656</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">12,774,734</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Fusion Pharmaceuticals, Inc. (Restricted) <sup>(b) (d)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">7,593</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">17,768</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">G1 Therapeutics, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">200,492</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">288,708</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Galera Therapeutics, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">296,462</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">51,911</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Gilead Sciences, Inc.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">655,681</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">49,136,734</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">I-Mab ADR <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">53,885</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">71,128</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Immunovant, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">314,275</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">12,065,017</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Incyte Corp. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">171,457</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">9,905,071</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Intellia Therapeutics, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">103,664</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,277,856</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Intercept Pharmaceuticals, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">33,437</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">619,922</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Ionis Pharmaceuticals, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">56,499</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,562,795</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Karuna Therapeutics, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">39,143</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6,618,690</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Madrigal Pharmaceuticals, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">10,540</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,539,262</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Mereo Biopharma Group plc ADR <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,063,799</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,372,301</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Moderna, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">182,904</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">18,892,154</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Neurocrine Biosciences, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">43,499</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,893,637</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Novavax, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">37,188</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">269,241</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><font style="font-size:6pt; font-family: Arial, Helvetica;">THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">10 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=14,FOLIO='10',FILE='23-25130-2.ca.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 221px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 100px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Shares</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 85px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Value</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 414px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><b><i>Biotechnology (continued)</i></b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Praxis Precision Medicines, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">51,406</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">87,904</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Precision BioSciences, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">154,807</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">52,836</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Pyxis Oncology, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">481,646</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">958,476</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Rallybio Corp. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">755,076</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,544,606</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Regeneron Pharmaceuticals, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">86,913</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">71,525,922</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Roivant Sciences Ltd. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">563,349</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6,579,916</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Sage Therapeutics, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">42,028</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">864,936</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Sarepta Therapeutics, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">113,095</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">13,709,376</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Scholar Rock Holding Corp. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">68,117</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">483,631</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Seagen, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">46,241</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">9,810,028</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Sutro Biopharma, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">69,389</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">240,780</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">TScan Therapeutics, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">138,057</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">353,426</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Ultragenyx Pharmaceutical, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">45,126</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,608,742</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">uniQure N.V. <sup>(a) (d)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">244,086</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,637,817</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">United Therapeutics Corp. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">17,837</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,028,843</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Vaxcyte, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">132,313</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6,745,317</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Vertex Pharmaceuticals, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">194,177</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">67,523,110</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Xencor, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">78,135</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,574,420</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>529,883,811</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:3pt .7pt 0pt 0pt; width: 414px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><b><i>Health Care Equipment &amp; Supplies 5.7%</i></b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Abbott Laboratories</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">114,588</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">11,097,848</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Baxter International, Inc.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">39,600</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,494,504</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Becton, Dickinson and Co.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,506</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">906,406</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Cercacor Laboratories, Inc. (Restricted) <sup>(b)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">160,000</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">127,080</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">DexCom, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">46,279</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,317,831</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Edwards Lifesciences Corp. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">75,377</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5,222,118</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Guardant Health, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">173,673</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5,147,668</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">IDEXX Laboratories, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">15,551</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6,799,986</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Inspire Medical Systems, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">21,488</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,264,079</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Insulet Corp. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">18,268</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,913,563</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Medtronic plc <sup>(d)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">52,381</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,104,575</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Stryker Corp.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">12,890</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,522,450</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Zimmer Biomet Holdings, Inc.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">24,137</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,708,654</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>52,626,762</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:3pt .7pt 0pt 0pt; width: 414px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><b><i>Health Care Providers &amp; Services 4.8%</i></b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Charles River Laboratories International, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">34,616</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6,784,044</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Elevance Health, Inc.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">18,435</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">8,026,968</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">HCA Healthcare, Inc.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">16,232</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,992,747</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Humana, Inc.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,847</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,358,162</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><font style="font-size:6pt; font-family: Arial, Helvetica;">THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 11</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=15,FOLIO='11',FILE='23-25130-2.ca.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 221px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 100px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Shares</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 85px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Value</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 414px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><b><i>Health Care Providers &amp; Services (continued)</i></b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">InnovaCare, Inc. Escrow Shares (Restricted) <sup>(b)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">222,222</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">28,422</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Medpace Holdings, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">12,199</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,953,744</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Molina Healthcare, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">18,161</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5,954,810</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Tenet Healthcare Corp. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">43,846</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,889,013</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">UnitedHealth Group, Inc.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">24,166</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">12,184,256</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>45,172,166</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:3pt .7pt 0pt 0pt; width: 414px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><b><i>Life Sciences Tools &amp; Services 4.3%</i></b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Adaptive Biotechnologies Corp. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">216,209</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,178,339</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Agilent Technologies, Inc.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">10,336</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,155,772</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Avantor, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">129,493</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,729,712</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Illumina, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">142,483</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">19,560,066</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Thermo Fisher Scientific, Inc.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">27,187</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">13,761,244</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">West Pharmaceutical Services, Inc.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5,474</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,053,900</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>40,439,033</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:3pt .7pt 0pt 0pt; width: 414px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><b><i>Medical Devices and Diagnostics 3.3%</i></b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Boston Scientific Corp. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">183,360</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">9,681,408</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Danaher Corp.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">44,068</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">10,933,271</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Intuitive Surgical, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">34,571</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">10,104,758</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>30,719,437</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:3pt .7pt 0pt 0pt; width: 414px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><b><i>Pharmaceuticals 12.7%</i></b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Amylyx Pharmaceuticals, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">136,497</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,499,260</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Assertio Holdings, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">14,226</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">36,418</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">AstraZeneca plc ADR</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">494,952</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">33,518,149</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Bristol-Myers Squibb Co.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">119,794</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6,952,844</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Catalent, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">42,400</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,930,472</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Eli Lilly &amp; Co.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">19,770</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">10,619,060</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Endo International plc <sup>(a) (d)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">465,507</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,771</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Intra-Cellular Therapies, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">19,220</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,001,170</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Jazz Pharmaceuticals plc <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">22,124</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,863,730</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Johnson &amp; Johnson</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">93,399</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">14,546,894</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Marinus Pharmaceuticals, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">385,154</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,100,490</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">McKesson Corp.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">12,176</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5,294,734</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Merck &amp; Co., Inc.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">114,534</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">11,791,275</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Mirati Therapeutics, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">42,638</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,857,311</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Oculis Holding AG <sup>(a) (d)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">557,945</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6,327,097</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Pfizer, Inc.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">223,242</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">7,404,937</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Royalty Pharma plc Class A</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">156,941</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,259,379</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Spectrum Pharmaceuticals, Inc. CVR (Restricted) <sup>(a) (b)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">79,790</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Tetraphase Pharmaceuticals, Inc. CVR <sup>(a) (b)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">28,747</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,725</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><font style="font-size:6pt; font-family: Arial, Helvetica;">THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">12 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=16,FOLIO='12',FILE='23-25130-2.ca.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 221px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 100px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Shares</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 85px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Value</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 414px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><b><i>Pharmaceuticals (continued)</i></b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Teva Pharmaceutical Industries Ltd. ADR <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">291,666</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,974,993</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">VYNE Therapeutics, Inc. <sup>(a)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5,265</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">21,060</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Zoetis, Inc.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5,547</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">965,067</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>117,969,836</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total Common Stocks and Warrants (Cost $786,438,844)</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>816,811,045</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:3pt .7pt 6pt 0pt; width: 414px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Exchange Traded Funds 0.8%</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">iShares Nasdaq Biotechnology ETF</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">24,569</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,004,543</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">SPDR S&amp;P Biotech ETF</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">57,000</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,162,140</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total Exchange Traded Funds (Cost $7,597,986)</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>7,166,683</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; width: 221px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 100px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Principal Amount</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; width: 85px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 6pt 0pt; width: 414px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Short-Term Investments 3.5%</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Repurchase Agreement, Fixed Income Clearing Corp., <br>repurchase value $32,741,365, 1.60%, dated 09/29/23, <br>due 10/02/23 (collateralized by U.S. Treasury Note 3.625%, <br>due 05/15/26, market value $33,391,823)</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">32,737,000</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">32,737,000</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total Short-Term Investments (Cost $32,737,000)</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>32,737,000</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total Investments Before Milestone Interests 97.9%<br>(Cost $901,364,273)</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>911,564,838</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; width: 221px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 100px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Interests</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; width: 85px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 6pt 0pt; width: 414px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Milestone Interests (Restricted) <sup>(a) (b)</sup>&#x200b; 1.5%</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 414px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><b><i>Pharmaceuticals 1.5%</i></b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Afferent Milestone Interest</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">280,950</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Ethismos Research Milestone Interest</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Impact Biomedicines Milestone Interest</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,081,983</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Neurovance Milestone Interest</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">12,658,771</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>14,021,704</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:3pt .7pt 0pt 0pt; width: 414px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Times New Roman, Times, serif;"><b><i>Biotechnology 0.0%</i></b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Amphivena Milestone Interest</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Rainier Therapeutics Milestone Interest</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Therachon Milestone Interest</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 73px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total Milestone Interests (Cost $7,952,967)</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 100px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>14,021,704</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total Investments 99.4% (Cost $909,317,240)</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:9pt .7pt 0pt 0pt; width: 100px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>925,586,542</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:3pt .7pt 0pt 0pt; width: 221px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Other Assets in Excess of Liabilities 0.6%</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:3pt .7pt 0pt 0pt; width: 100px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>5,756,449</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:3pt .7pt 0pt 0pt; width: 221px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Net Assets 100%</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:3pt .7pt 0pt 0pt; width: 100px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>931,342,991</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">The percentage shown for each investment category in the Schedule of Investments is based on net assets.</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">(a)&#xa0;&#xa0;Non-income producing security.</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">(b)&#xa0;&#xa0;Security fair valued using significant unobservable inputs. See Investment Valuation and Fair Value Measurements.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><font style="font-size:6pt; font-family: Arial, Helvetica;">THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 13</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=17,FOLIO='13',FILE='23-25130-2.ca.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">(c)&#xa0;&#xa0;Affiliated issuers in which the Fund holds 5% or more of the voting securities (total market value of $19,563,213).</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">(d)&#xa0;&#xa0;Foreign security.</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">ADR&#xa0;&#xa0;American Depository Receipt</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">CVR&#xa0;&#xa0;Contingent Value Right</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><font style="font-size:6pt; font-family: Arial, Helvetica;">THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">14 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=18,FOLIO='14',FILE='23-25130-2.ca.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>

<!-- Document name: 23-25130-2.da-->
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><font style="font-size:19pt; font-family: Arial, Helvetica;">Financial statements</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 18pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>STATEMENT OF ASSETS AND LIABILITIES</b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> SEPTEMBER 30, 2023</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 384px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>ASSETS</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Investments in unaffiliated issuers, at value (cost $874,751,297)</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">892,001,625</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Investments in affiliated issuers, at value (cost $26,612,976)</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">19,563,213</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Milestone interests, at value (cost $7,952,967)</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">14,021,704</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total investments (cost $909,317,240)</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>925,586,542</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Cash</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">161</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Foreign currency, at value (cost $56)</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">53</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Dividends and interest receivable</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">197,415</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Receivable for investments sold</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6,656,449</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Prepaid expenses</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">50,801</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Other assets (see Note 1)</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">272</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total assets</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>932,491,693</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="7" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 384px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>LIABILITIES</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Accrued advisory fee</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">789,431</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Accrued investor support service fees</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">40,903</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Accrued shareholder reporting fees</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">47,562</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Accrued trustee fees</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">31,083</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Accrued other</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">239,723</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total liabilities</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>1,148,702</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="7" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 384px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Commitments and Contingencies (see Notes 1 and 5)</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>NET ASSETS</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>931,342,991</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="7" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 384px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>SOURCES OF NET ASSETS CONSIST OF</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Shares of beneficial interest, par value $.01 per share, unlimited number of shares authorized, <br>amount paid in on 49,442,016 shares issued and outstanding</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">494,420</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Additional paid-in-capital</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">924,876,691</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Total distributable earnings (loss)</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5,971,880</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total net assets (equivalent to $18.84 per share based on 49,442,016 <br>shares outstanding)</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>931,342,991</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><font style="font-size:6pt; font-family: Arial, Helvetica;">THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 15</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=19,FOLIO='15',FILE='23-25130-2.da.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 18pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>STATEMENT OF OPERATIONS </b></font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i>YEAR ENDED SEPTEMBER 30, 2023</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 384px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>INVESTMENT INCOME</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Dividend income</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">8,809,608</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Non-cash dividend income</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">767,416</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Interest and other income</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">620,013</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Securities lending, net</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">94,792</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total investment income</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>10,291,829</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="7" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 384px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>EXPENSES</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Advisory fees</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">9,693,864</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Investor support service fees</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">487,541</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Shareholder reporting</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">178,582</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Legal fees</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">172,963</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Administration fees</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">172,589</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Custodian fees</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">156,108</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Trustees' fees and expenses</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">146,676</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Auditing fees</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">144,500</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Transfer agent fees</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">59,830</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Other (see Note 2)</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">264,657</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total expenses</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>11,477,310</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Net investment loss</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>(1,185,481</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 18px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="7" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 384px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>REALIZED AND UNREALIZED GAIN (LOSS)</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Net realized gain (loss) on</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 95px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Investments in unaffiliated issuers</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">90,152,826</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Foreign currency transactions</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(3,961</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Net realized gain</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>90,148,865</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Net change in unrealized appreciation (depreciation) on</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 95px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Investments in unaffiliated issuers</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(31,470,435</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Investments in affiliated issuers</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(6,316,755</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Milestone interests</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5,158,628</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Foreign currency</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Net change in unrealized appreciation (depreciation)</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>(32,628,556</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Net realized gain and change in unrealized appreciation (depreciation)</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>57,520,309</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 289px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Net increase in net assets resulting from operations</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>56,334,828</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><font style="font-size:6pt; font-family: Arial, Helvetica;">THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">16 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=20,FOLIO='16',FILE='23-25130-2.da.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 18pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>STATEMENTS OF CHANGES IN NET ASSETS</b></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:8pt .7pt 0pt 0pt; width: 225px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 96px; text-align: center;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Year ended<br>September 30,<br>2023</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 99px; text-align: center;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Year ended<br>September 30,<br>2022<sup>(1)</sup>&#x200b;</font></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 428px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>NET INCREASE (DECREASE) IN NET ASSETS FROM OPERATIONS</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Net investment loss</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">($</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,185,481</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">($</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,670,182</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 225px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Net realized gain</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">90,148,865</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">66,381,083</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Change in net unrealized depreciation</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(32,628,556</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(256,940,274</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 225px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Net increase (decrease) in net assets resulting from operations</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 21px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>56,334,828</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 21px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 60px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>(194,229,373</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 18px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>DISTRIBUTIONS TO SHAREHOLDERS (See Note 1)</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>(77,428,664</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 60px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>(84,311,515</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:6pt .7pt 0pt 0pt; width: 428px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>CAPITAL SHARE TRANSACTIONS</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Reinvestment of distributions (2,098,290 and 1,918,258 shares, <br>respectively)</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">35,872,239</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">38,203,392</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 225px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total capital share transactions</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 21px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>35,872,239</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 21px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 60px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>38,203,392</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Net increase (decrease) in net assets</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>14,778,403</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 60px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>(240,337,496</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 428px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>NET ASSETS</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 225px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Beginning of year</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">916,564,588</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,156,902,084</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 225px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>End of year</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 21px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>931,342,991</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 21px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 60px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>916,564,588</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:solid windowtext 1pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">(1)&#xa0;&#xa0;Audited by a different independent registered public accounting firm.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><font style="font-size:6pt; font-family: Arial, Helvetica;">THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;"> abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT17</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=21,FOLIO='abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT17',FILE='23-25130-2.da.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>

<!-- Document name: 23-25130-2.ea-->
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><font style="font-size:19pt; font-family: Arial, Helvetica;">Financial highlights</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 1.5pt 0pt; width: 170px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="19" valign="bottom" style="padding:0pt .7pt 1.5pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 427px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>For the years ended September 30,</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; width: 170px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 81px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>2023<sup>(1)</sup>&#x200b;</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 79px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>2022</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 78px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>2021</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 78px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>2020</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:1.5pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 79px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>2019</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 597px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>OPERATING PERFORMANCE PER SHARE</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Net asset value per share, beginning of year</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 37px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>19.36</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>25.47</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>24.04</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>20.33</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>25.62</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Net investment loss <sup>(2)</sup>&#x200b;</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 37px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(0.02</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(0.08</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(0.14</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(0.05</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(0.07</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Net realized and unrealized gain (loss)</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 37px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1.11</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(4.20</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3.63</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5.50</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(3.46</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total increase (decrease) from investment <br>operation </b></font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 37px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>1.09</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>(4.28</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>3.49</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>5.45</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>(3.53</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Distributions to shareholders from</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 81px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 79px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 78px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 78px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 79px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Net investment income</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 37px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(0.11</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(0.61</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(0.01</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(0.17</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Net realized capital gains</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 37px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(1.61</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(1.72</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(1.45</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(1.77</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(1.65</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total distributions</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 37px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>(1.61</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>(1.83</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>(2.06</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>(1.78</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>(1.82</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Increase resulting from shares repurchased <sup>(2)</sup>&#x200b;</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 37px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>&#x2014;</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>&#x2014;</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>&#x2014;</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>0.04</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>0.06</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Net asset value per share, end of year</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 37px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>18.84</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 24px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>19.36</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 24px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>25.47</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 24px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>24.04</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 24px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>20.33</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt; width: 24px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Per share market value, end of year</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 37px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">15.55</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">17.28</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">25.57</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">20.62</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">18.34</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Total investment return at market value </font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 37px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(1.24</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(26.01</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">34.64</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">23.38</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(12.88</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Total investment return at net asset value</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 37px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6.80</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(16.78</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">15.03</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">29.77</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(12.74</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 597px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>RATIOS</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Net investment loss to average net assets</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 37px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(0.12</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(0.36</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(0.54</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(0.20</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(0.31</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Expenses to average net assets</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 37px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1.18</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1.19</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1.11</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1.10</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1.12</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 597px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>SUPPLEMENTAL DATA</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Net assets at end of year (in millions)</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 37px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">931</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">917</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,157</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,055</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">871</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 170px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Portfolio turnover rate</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 37px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">42.99</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">41.21</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">69.19</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 34px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">52.44</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 35px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">47.65</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 24px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">%</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">(1)&#xa0;&#xa0;Beginning with the year ended September 30, 2023, the Fund's financial statements were audited by KPMG LLP. Previous years were audited by a different independent registered public accounting firm.</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">(2)&#xa0;&#xa0;Computed using average shares outstanding.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><font style="font-size:6pt; font-family: Arial, Helvetica;">THE ACCOMPANYING NOTES ARE AN INTEGRAL PART OF THESE FINANCIAL STATEMENTS.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">18 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=22,FOLIO='18',FILE='23-25130-2.ea.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>

<!-- Document name: 23-25130-2.fa-->
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><font style="font-size:19pt; font-family: Arial, Helvetica;">Notes to financial statements</font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> SEPTEMBER 30, 2023</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>(1)&#xa0;&#xa0;Organization and Significant Accounting Policies</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">abrdn Healthcare Investors (the Fund) is a Massachusetts business trust formed on October 31, 1986 and registered under the Investment Company Act of 1940 as a non-diversified closed-end management investment company. The Fund commenced operations on April 22, 1987. The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. In addition, the Fund seeks to provide regular distribution of realized capital gains. The Fund invests primarily in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc. (as of October 27, 2023) (prior to October 27, 2023, Tekla Capital Management, LLC) (the Investment Adviser or the Adviser), to have significant potential for above-average growth. The Fund may invest up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of U.S. issuers that are traded primarily in foreign markets.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The preparation of these financial statements requires the use of certain estimates by management in determining the Fund's assets, liabilities, revenues and expenses. Actual results could differ from these estimates and such differences could be material. The following is a summary of significant accounting policies followed by the Fund, which are in conformity with accounting principles generally accepted in the United States of America (GAAP). The Fund is an investment company and follows accounting and reporting guidance in the Financial Accounting Standards Board Accounting Standards Codification 946. Events or transactions occurring after September 30, 2023, through the date that the financial statements were issued, have been evaluated in the preparation of these financial statements.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The market value of the Fund's investments will move up and down, sometimes rapidly and unpredictably, based upon political, regulatory, market, economic and social conditions, as well as developments that impact specific economic sectors, industries or segments of the market, including conditions that directly relate to the issuers of the Fund's investments such as management performance, financial condition and demand for the issuers' goods and services. The Fund is subject to the risk that geopolitical events will adversely affect global economies and markets. War, terrorism, and related geopolitical events have led, and in the future may lead, to increased short-term market volatility and may have adverse long-term effects on global economies and markets. Likewise, natural and environmental disasters and epidemics or pandemics may be highly disruptive to economies and markets. This means that the Fund may lose money on its investment due to unpredictable drops in a security's value or periods of below-average performance in a given security or in the securities market as a whole.</font></p>
<p style="margin:0pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Investment Valuation</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Shares of publicly traded companies listed on national securities exchanges or trading in the over-the-counter market are typically valued at the last sale price as of the close of trading, </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 19</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=23,FOLIO='19',FILE='23-25130-2.fa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">generally 4 p.m. Eastern Time. The Board of Trustees of the Fund (the Trustees) has established and approved fair valuation policies and procedures with respect to securities for which quoted prices may not be available or which do not reflect fair value. Convertible, corporate and government bonds are valued using a third-party pricing service. Restricted securities of companies that are publicly traded are typically valued based on the closing market quote on the valuation date adjusted for the impact of the restriction as determined in good faith by the Adviser also using fair valuation policies and procedures approved by the Trustees described below. Non-exchange traded warrants of publicly traded companies are generally valued using the Black-Scholes model, which incorporates both observable and unobservable inputs. Short-term investments with a maturity of 60 days or less are generally valued at amortized cost, which approximates fair value. See also Subsequent Event Note 6. </font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Convertible preferred shares, warrants or convertible note interests in private companies, milestone interests and other restricted securities, as well as shares of publicly traded companies for which market quotations are not readily available, such as stocks for which trading has been halted or for which there are no current day sales, or which do not reflect fair value, are typically valued in good faith, based upon the recommendations made by the Adviser pursuant to fair valuation policies and procedures approved by the Trustees.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Adviser has a Valuation Sub-Committee comprised of senior management which reports to the Valuation Committee of the Board at least quarterly. Each fair value determination is based on a consideration of relevant factors, including both observable and unobservable inputs. Observable and unobservable inputs considered may include (i) the existence of any contractual restrictions on the disposition of securities; (ii) information obtained from the company, which may include an analysis of the company's financial statements, products, intended markets or technologies; (iii) the price of the same or similar security negotiated at arm's length in an issuer's completed subsequent round of financing; (iv) the price and extent of public trading in similar securities of the issuer or of comparable companies; or (v) a probability and time value adjusted analysis of contractual terms. Where available and appropriate, multiple valuation methodologies are applied to confirm fair value. Significant unobservable inputs identified by the Adviser are often used in the fair value determination. A significant change in any of these inputs may result in a significant change in the fair value measurement. Significant unobservable inputs identified by the Adviser are often used in the fair value determination. Additionally, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different from the valuations used at the date of these financial statements.</font></p>
<p style="margin:0pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Milestone Interests</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund holds financial instruments which reflect the current value of future milestone payments the Fund may receive as a result of contractual obligations from other parties. The </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">20 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=24,FOLIO='20',FILE='23-25130-2.fa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">value of such payments are adjusted to reflect the estimated risk based on the relative uncertainty of both the timing and the achievement of individual milestones. A risk to the Fund is that the milestones will not be achieved and no payment will be received by the Fund. The milestone interests were received as part of the proceeds from the sale of seven private companies. Any payments received are treated as a reduction of the cost basis of the milestone interests with payments received in excess of the cost basis treated as a realized gain. The contractual obligations with respect to the milestone interests provide for payments at various stages of the development of Afferent, Amphivena, Ethismos Research, Impact Biomedicines, Neurovance, Rainer Therapeutics and Therachon's principal product candidate as of the date of the sale.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The following is a summary of the impact of the milestone interests on the financial statements as of and for the year ended September 30, 2023:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; width: 231px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Statement of Assets and Liabilities, Milestone interests, at value</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 2pt 0pt; width: 19px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 2pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">14,021,704</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 2pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; width: 231px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Statement of Assets and Liabilities, Total distributable earnings</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 2pt 0pt; width: 19px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 2pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6,068,737</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 2pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; width: 231px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Statement of Operations, Change in unrealized appreciation (depreciation)<br>on Milestone interests</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 2pt 0pt; width: 19px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 2pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5,158,628</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 2pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Options on Securities</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">An option contract is a contract in which the writer (seller) of the option grants the buyer of the option, upon payment of a premium, the right to purchase from (call option) or sell to (put option) the writer a designated instrument at a specified price within a specified period of time. Certain options, including options on indices, will require cash settlement by the Fund if the option is exercised.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund's obligation under an exchange traded written option or investment in an exchange traded purchased option is valued at the last sale price or in the absence of a sale, the mean between the closing bid and asked prices. Gain or loss is recognized when the option contract expires, is exercised or is closed.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">If the Fund writes a covered call option, the Fund foregoes, in exchange for the premium, the opportunity to profit during the option period from an increase in the market value of the underlying security above the exercise price. If the Fund writes a put option it accepts the risk of a decline in the market value of the underlying security below the exercise price. Over-the-counter options have the risk of the potential inability of counterparties to meet the terms of their contracts. The Fund's maximum exposure to purchased options is limited to the premium initially paid. In addition, certain risks may arise upon entering into option contracts including the risk that an illiquid secondary market will limit the Fund's ability to close out an option contract prior to the expiration date and that a change in the value of the option contract may not correlate exactly with changes in the value of the securities or currencies hedged.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 21</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=25,FOLIO='21',FILE='23-25130-2.fa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">All options on securities and securities indices written by the Fund are required to be covered. When the Fund writes a call option, this means that during the life of the option the Fund may own or have the contractual right to acquire the securities subject to the option or may maintain with the Fund's custodian in a segregated account appropriate liquid securities in an amount at least equal to the market value of the securities underlying the option. When the Fund writes a put option, this means that the Fund will maintain with the Fund's custodian in a segregated account appropriate liquid securities in an amount at least equal to the exercise price of the option.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">There were no outstanding call options written and put options purchased at September 30, 2023.</font></p>
<p style="margin:0pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Other Assets</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Other assets in the Statement of Assets and Liabilities consists of amounts due to the Fund at various times in the future in connection with the sale of investments in one private company.</font></p>
<p style="margin:0pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Investment Transactions and Income</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Investment transactions are recorded on a trade date basis. Gains and losses from sales of investments are recorded using the "identified cost" method. Interest income is recorded on the accrual basis, adjusted for amortization of premiums and accretion of discounts. Dividend income is recorded on the ex-dividend date, less any foreign taxes withheld. Upon notification from issuers, some of the dividend income received may be redesignated as a reduction of cost of the related investment if it represents a return of capital. Stock dividends are reflected as non-cash dividend income on the Statement of Operations.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The aggregate cost of purchases and proceeds from sales of investment securities (other than short-term investments) for the year ended September 30, 2023 totaled $405,859,253 and $438,703,858, respectively.</font></p>
<p style="margin:0pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Securities Lending</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The securities lending arrangement was terminated on July 18, 2023. Prior to July 18, 2023, the Fund may have lended its securities to approved borrowers to earn additional income. The Fund received cash collateral from the borrower and the initial collateral received by the Fund was required to have a value of at least 102% of the current value of the loaned securities traded on U.S. exchanges, and a value of at least 105% for all other securities. The Fund invested its cash collateral in State Street Institutional U.S. Government Money Market Fund (SAHXX), which is registered with the Securities and Exchange Commission (SEC) as an investment company. SAHXX invests substantially all of its assets in the State Street U.S. Government Money Market Portfolio. The Fund received the benefit of any gains and bear any losses generated by SAHXX with respect to the cash collateral.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">22 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=26,FOLIO='22',FILE='23-25130-2.fa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund had the right to recall loaned securities on demand. If a borrower failed to return loaned securities when due, then the lending agent was responsible and indemnified the Fund for the lent securities. The lending agent used the collateral received from the borrower to purchase replacement securities of the same issue, type, class and series of the loaned securities. If the value of the collateral was less than the purchase cost of replacement securities, the lending agent was responsible for satisfying the shortfall but only to the extent that the shortfall was not due to any decrease in the value of SAHXX.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Although the risk of loss on securities lent was mitigated by receiving collateral from the borrower and through lending agent indemnification, the Fund could have experienced a delay in recovering securities or could have experienced a lower than expected return if the borrower failed to return the securities on a timely basis. The Fund received compensation for lending its securities by retaining a portion of the return on the investment of the collateral and compensation from fees earned from borrowers of the securities. Securities lending income received by the Fund was net of fees retained by the securities lending agent. Net income received from SAHXX was a component of securities lending income as recorded on the Statement of Operations.</font></p>
<p style="margin:0pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Repurchase Agreements</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">In managing short-term investments the Fund may from time to time enter into transactions in repurchase agreements. In a repurchase agreement, the Fund's custodian takes possession of the underlying collateral securities from the counterparty, the market value of which is at least equal to the principal, including accrued interest, of the repurchase transaction at all times. In the event of default or bankruptcy by the other party to the agreement, realization and/or retention of the collateral by the Fund may be delayed. The Fund may enter into repurchase transactions with any broker, dealer, registered clearing agency or bank. Repurchase agreement transactions are not counted for purposes of the limitations imposed on the Fund's investment in debt securities.</font></p>
<p style="margin:0pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Distribution Policy</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Pursuant to a Securities and Exchange Commission exemptive order, the Fund may make periodic distributions that include capital gains as frequently as 12 times in any one taxable year in respect of its common shares, and the Fund has implemented a managed distribution policy (the Policy) providing for quarterly distributions at a rate set by the Trustees. Under the current Policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund's net assets to shareholders of record. The Fund intends to use net realized capital gains when making quarterly distributions, if available, but the Policy would result in a return of capital to shareholders if the amount of the distribution exceeds the Fund's net investment income and realized capital gains. If taxable income and net long-term realized gains exceed the amount required to be distributed under the Policy, the Fund will at a minimum make distributions necessary to comply with the requirements of the Internal Revenue Code. The Policy has been </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 23</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=27,FOLIO='23',FILE='23-25130-2.fa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">established by the Trustees and may be changed by them without shareholder approval. The Trustees regularly review the Policy and the frequency and rate of distribution considering the purpose and effect of the Policy, the financial market environment, and the Fund's income, capital gains and capital available to pay distributions.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund's policy is to declare quarterly distributions in stock. The distributions are automatically paid in newly-issued full shares of the Fund unless otherwise instructed by the shareholder. Fractional shares will generally be settled in cash, except for registered shareholders with book entry accounts of the Fund's transfer agent who will have whole and fractional shares added to their accounts. The Fund's transfer agent delivers an election card and instructions to each registered shareholder in connection with each distribution. The number of shares issued will be determined by dividing the dollar amount of the distribution by the lower of net asset value or market price on the pricing date. If a shareholder elects to receive a distribution in cash, rather than in shares, the shareholder's relative ownership in the Fund will be reduced. The shares reinvested will be valued at the lower of the net asset value or market price on the pricing date. Distributions in stock will not relieve shareholders of any federal, state or local income taxes that may be payable on such distributions. Additional distributions, if any, made to satisfy requirements of the Internal Revenue Code may be paid in stock, as described above, or in cash.</font></p>
<p style="margin:0pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Share Repurchase Program</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">In March 2023, the Trustees approved the renewal of the repurchase program to allow the Fund to repurchase up to 12% of its outstanding shares in the open market for a one-year period ending July 14, 2024. Prior to this renewal, in March 2022, the Trustees approved the renewal of the share repurchase program to allow the Fund to repurchase up to 12% of its outstanding shares for a one-year period ending July 14, 2023. The share repurchase program is intended to enhance shareholder value and potentially reduce the discount between the market price of the Fund's shares and the Fund's net asset value.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">During the years ended September 30, 2023 and September 30, 2022, the Fund did not repurchase any shares through the repurchase program.</font></p>
<p style="margin:0pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Federal Taxes</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">It is the Fund's policy to comply with the requirements of the Internal Revenue Code applicable to regulated investment companies and to distribute to its shareholders substantially all of its taxable income and its net realized capital gains, if any. Therefore, no Federal income or excise tax provision is required.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">As of September 30, 2023, the Fund had no uncertain tax positions that would require financial statement recognition or disclosure. The Fund's federal tax returns are subject to examination by the Internal Revenue Service for a period of three years.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">24 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=28,FOLIO='24',FILE='23-25130-2.fa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Distributions</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund records all distributions to shareholders on the ex-dividend date. Such distributions are determined in conformity with income tax regulations, which may differ from GAAP. These differences include temporary and permanent differences from losses on wash sale transactions, passive foreign investment companies transactions, installment sale adjustments, foreign currency gains and losses and net operating losses. Reclassifications are made to the Fund's capital accounts to reflect income and gains available for distribution under income tax regulations. At September 30, 2023, the Fund reclassified ($192,907) from accumulated net realized loss on investment and $2,438,263 to undistributed net investment income, with a net impact of ($2,245,356) to paid in capital, for current period book/tax differences.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The tax basis components of distributable earnings and the tax cost as of September 30, 2023 were as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 152px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Cost of investments for tax purposes</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 54px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">923,509,603</font></p></td>
<td colspan="1" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 152px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Gross tax unrealized appreciation</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 54px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">191,398,301</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 152px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Gross tax unrealized depreciation</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">($</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 54px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">189,321,362</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 152px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Net tax unrealized appreciation on investments</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 54px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,076,936</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 152px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Late-year ordinary capital loss deferrals</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">($</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 54px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">260,997</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 152px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Undistributed long term capital gains</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 54px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,155,941</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund has designated the distributions for its taxable years ended September 30, 2023 and 2022 as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 161px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Distributions paid from:</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 77px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>2023</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 77px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>2022</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 161px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Ordinary income (includes short-term capital gain)</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5,266,396</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 161px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Long-term capital gain</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">77,428,664</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">79,045,119</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Commitments and Contingencies</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Under the Fund's organizational documents, its officers and Trustees may be indemnified against certain liabilities and expenses arising out of the performance of their duties to the Fund. Additionally, in the normal course of business, the Fund enters into agreements with service providers that may contain indemnification clauses. The Fund's maximum exposure under these agreements is unknown as this would involve future claims that may be made against the Fund that have not yet occurred. However, based on experience, the Fund expects the risk of loss to be remote.</font></p>
<p style="margin:0pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Investor Support Services</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Destra Capital Advisors LLC (Destra) provide the Fund investor support services in connection with the ongoing operation of the Fund. The Fund paid Destra a fee in an annual amount equal to 0.05% of the average aggregate daily value of the Fund's Managed Assets pursuant to the investor support services agreement.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 25</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=29,FOLIO='25',FILE='23-25130-2.fa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>(2)&#xa0;&#xa0;Investment Advisory and Other Affiliated Fees</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund entered into an Investment Advisory Agreement (the Advisory Agreement) with the Adviser. Pursuant to the terms of the Advisory Agreement, the Fund paid the Adviser a monthly fee at the rate when annualized of (i) 2.50% of the average net assets for the month of its venture capital and other restricted securities up to 25% of net assets and (ii) for all other net assets, 0.98% of the average net assets up to $250 million, 0.88% of the average net assets for the next $250 million, 0.80% of the average net assets for the next $500 million and 0.70% of the average net assets thereafter. The aggregate fee would not exceed a rate when annualized of 1.36%. For the fiscal year ended September 30, 2023, the Fund paid advisory fees at an effective rate of 0.99%.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund entered into a Services Agreement (the Agreement) with the Adviser. Pursuant to the terms of the Agreement, the Fund reimbursed the Adviser for certain services related to a portion of the payment of salary and provision of benefits to the Fund's Chief Compliance Officer. During the year ended September 30, 2023, these payments amounted to $120,156 and are included in the Other category of expenses in the Statement of Operations, together with insurance and other expenses incurred to unaffiliated entities. Expenses incurred pursuant to the Agreement as well as certain expenses paid for by the Adviser are allocated to the Fund in an equitable fashion as approved by the Trustees or officers of the Fund who are also officers of the Adviser. See also Subsequent Event Note 6.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund pays compensation to Independent Trustees in the form of a retainer, attendance fees, and additional compensation to Board and Committee chairpersons. The Fund does not pay compensation directly to Trustees or officers of the Fund who are also officers of the Adviser.</font></p>
<p style="margin:0pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>(3)&#xa0;&#xa0;Other Transactions with Affiliates</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">An affiliate company is a company in which the Fund holds 5% or more of the voting securities. Transactions involving such companies during the year ended September 30, 2023 were as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 81px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Affiliated Companies</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 85px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Beginning<br>Value as of<br>September 30,<br>2022</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 80px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Purchases at<br>Cost</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 74px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Proceeds<br>from Sales</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 80px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Net Realized<br>Gain/(Loss)<br>on sale of<br>Affiliated<br>Companies</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 95px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Change in<br>Unrealized<br>Appreciation/<br>Depreciation</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 85px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Ending Value<br>as of<br>September 30,<br>2023*</b></font></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 81px; background-color: #cceeff; text-align: left;">
<font style="font-size:7pt; font-family: Arial, Helvetica;">Arkuda <br>Therapeutics, Inc.</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">5,024,265</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">985,141</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 46px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">($</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 55px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">5,472,912</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">536,494</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 81px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;">Curasen Therapeutics, Inc.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">8,414,141</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">1,172,219</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 46px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 55px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">(11,574</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">9,574,786</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 81px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;">Invetx, Inc.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">6,886,344</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 46px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 55px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">6,886,344</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 81px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;">Priothera Ltd.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">3,397,500</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">358</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 46px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 55px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">(832,269</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:7pt; font-family: Arial, Helvetica;">2,565,589</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 81px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>23,722,250</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>2,157,718</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 46px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>&#x2014;</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>&#x2014;</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 22px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>($</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 55px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>6,316,755</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 18px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>19,563,213</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">26 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=30,FOLIO='26',FILE='23-25130-2.fa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 90px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Affiliated Companies</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 73px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Shares as of<br>September 30,<br>2023*</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 85px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Principal<br>Amount as of<br>September 30,<br>2023</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 76px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Dividend/<br>Interest<br>Income <br>from<br>Affiliated<br>Companies</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 86px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Capital Gain<br>Distributions<br>from Affiliated<br>Companies</b></font></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 90px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Arkuda Therapeutics, Inc.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,398,254</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 48px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 90px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Curasen Therapeutics, Inc.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">18,203,119</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">846,390</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 48px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">8,905</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 90px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Invetx, Inc.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">10,276,591</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 48px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 90px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Priothera Ltd.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">346,666</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 48px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 90px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>32,224,630</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>846,390</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 48px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>8,905</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>&#x2014;</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:4pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:7pt; font-family: Arial, Helvetica;">* Amphivena Therapeutics, Inc. was an affiliate as of September 30, 2022 but not an affiliate as of September 30, 2023.</font></p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>(4)&#xa0;&#xa0;Fair Value Measurements</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund uses a three-tier hierarchy to prioritize the assumptions, referred to as inputs, used in valuation techniques to measure fair value. The three-tier hierarchy of inputs is summarized in the three broad levels. Level 1 includes quoted prices in active markets for identical investments. Level 2 includes prices determined using other significant observable inputs (including quoted prices for similar investments, interest rates, credit risk, etc.). The independent pricing vendor may value bank loans and debt securities at an evaluated bid price by employing methodologies that utilize actual market transactions, broker-supplied valuations, and/or other methodologies designed to identify the market value for such securities and such securities are considered Level 2 in the fair value hierarchy. Level 3 includes prices determined using significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments). These inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. See also Subsequent Event Note 6.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">For the year ended September 30, 2023, the total amount of transfers between Level 3 and Level 1 was $3,137,593. The investment was transferred due to an initial public offering and the value is being supported by the market price.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The following is a summary of the levels used as of September 30, 2023 to value the Fund's investments.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 113px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Assets at Value</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 85px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Level 1</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 81px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Level 2</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 92px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Level 3</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 96px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 491px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Convertible Preferreds</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Biotechnology</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">33,873,762</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">33,873,762</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Health Care Equipment &amp; Supplies</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">640,378</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">640,378</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Pharmaceuticals</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">19,489,580</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">19,489,580</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 491px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Non-Convertible Notes</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Pharmaceuticals</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">846,390</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">846,390</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 491px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Common Stocks And Warrants</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Biotechnology</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">529,715,491</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">168,320</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">529,883,811</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Health Care Equipment &amp; Supplies</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">52,499,682</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">127,080</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">52,626,762</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 27</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=31,FOLIO='27',FILE='23-25130-2.fa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 113px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Assets at Value</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 85px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Level 1</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 81px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Level 2</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 92px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Level 3</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 96px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Health Care Providers &amp; Services</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">45,143,744</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">28,422</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">45,172,166</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Life Sciences Tools &amp; Services</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">40,439,033</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">40,439,033</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Medical Devices And Diagnostics</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">30,719,437</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">30,719,437</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Pharmaceuticals</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">117,968,111</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,725</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">117,969,836</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 491px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Exchange Traded Funds</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Exchange Traded Funds</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">7,166,683</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">7,166,683</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 491px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Short-term Investments</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Repurchase Agreement</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">32,737,000</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">32,737,000</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 491px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Milestone Interests</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Pharmaceuticals</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">14,021,704</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">14,021,704</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Biotechnology</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">*</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">*</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Other Assets</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">272</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">272</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 113px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>823,652,181</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>32,907,045</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>69,027,588</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>925,586,814</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:4pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:7pt; font-family: Arial, Helvetica;">* Represents security valued at zero.</font></p>
<p style="margin:6pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The following is a reconciliation of Level 3 assets for which significant unobservable inputs were used to determine fair value.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 63px; text-align: left;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Investments in <br>Securities</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 97px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Balance as of <br>September 30, <br>2022</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 100px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Net realized <br>gain (loss) and <br>change in <br>unrealized <br>appreciation <br>(depreciation)</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 78px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Cost of <br>purchases <br>and <br>conversions</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 90px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Proceeds <br>from <br>sales and <br>conversions</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 89px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Net <br>transfers <br>into <br>(out of) <br>Level 3</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 97px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Balance <br>as of <br>September 30,<br>2023</b></font></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="27" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 654px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Convertible Preferreds</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 63px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Biotechnology</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">43,293,435</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">($</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">10,275,493</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,993,413</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">($</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 49px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,137,593</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">33,873,762</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 63px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Health Care <br>Equipment &amp; <br>Supplies</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,423,015</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(783,389</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">752</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 49px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">640,378</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 63px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Pharmaceuticals</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">25,114,132</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(7,026,772</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,802,216</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(3,399,996</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 49px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">19,489,580</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="27" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 654px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Convertible Notes</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 63px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Biotechnology</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">*</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 49px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="27" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 654px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Non-Convertible Notes</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 63px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Pharmaceuticals</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(321</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">846,711</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 49px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">846,390</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="27" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 654px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Common Stocks and Warrants</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 63px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Health Care <br>Equipment &amp; <br>Supplies</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">618,886</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(491,806</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 49px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">127,080</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 63px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Health Care <br>Providers &amp; <br>Services</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">56,533</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">20,583</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(48,694</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 49px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">28,422</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 63px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Pharmaceuticals</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(6,383</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6,383</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 49px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">*</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">28 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=32,FOLIO='28',FILE='23-25130-2.fa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 63px; text-align: left;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Investments in <br>Securities</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 97px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Balance as of <br>September 30, <br>2022</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 100px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Net realized <br>gain (loss) and <br>change in <br>unrealized <br>appreciation <br>(depreciation)</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 78px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Cost of <br>purchases <br>and <br>conversions</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 90px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Proceeds <br>from <br>sales and <br>conversions</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 89px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Net <br>transfers <br>into <br>(out of) <br>Level 3</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 97px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Balance <br>as of <br>September 30,<br>2023</b></font></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="27" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 654px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Milestone Interests</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 63px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Biotechnology</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,529,091</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">($</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,529,091</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 49px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 63px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Health Care <br>Equipment &amp; <br>Supplies</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,090</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(948</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">(142</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 49px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 63px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Pharmaceuticals</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">7,340,318</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6,681,386</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 49px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">14,021,704</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 63px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Other Assets</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">272</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 60px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 22px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 49px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2014;</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 18px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">272</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 63px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Total</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>79,376,772</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 22px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>($</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 60px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>13,412,234</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>9,649,475</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 22px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>($</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>3,448,832</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 22px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>($</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 49px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>3,137,593</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 18px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>)</b></font></p></td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 21px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 57px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>69,027,588</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="23" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; width: 549px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Net change in unrealized appreciation (depreciation) from <br>investments still held as of September 30, 2023</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; width: 21px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">($</font></p></td>
<td colspan="1" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; width: 57px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">12,794,884</font></p></td>
<td colspan="1" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">)</font></p></td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:4pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:7pt; font-family: Arial, Helvetica;">* Represents security valued at zero.</font></p>
<p style="margin:6pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The following is a quantitative disclosure about significant unobservable inputs used in the valuation of the fair value of Level 3 assets.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:6pt .7pt 2pt 0pt; width: 91px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 86px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Fair Value at<br>September 30, <br>2023</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 75px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Valuation Technique</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 92px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Unobservable Input</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 159px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Range<br>(Weighted Average)</b></font></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 91px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Common Stocks</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">127,080<br> &#xa0;</font></td>
<td colspan="1" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 75px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Market approach<br> &#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 92px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Discount for lack of <br>marketability</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 99px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">75.00% (75.00%)</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 91px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 86px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 75px;">
 &#xa0;</td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 92px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Revenue Allocation</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 99px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">10.00%(10.00%)</font></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 0pt 0pt; width: 91px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
</td>
<td colspan="1" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">28,422<br> &#xa0;</font></td>
<td colspan="1" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 75px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Probability adjusted <br>value</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 92px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Probability of events <br>Timing of events</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 99px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">50.00%-100.00% (50.00%)<br> 0.50-2.50 (0.50) years</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 91px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Convertible Preferreds<br>and Warrants</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">54,850,110</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 75px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Transaction Price </font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 76px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">(a) </font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 99px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">N/A</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 91px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Milestones Interests</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
</td>
<td colspan="1" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">14,021,704<br> &#xa0;</font></td>
<td colspan="1" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 75px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Probability adjusted <br>value</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 92px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Probability of events<br>Timing of events</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 99px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">0.00%-100.00% (47.44%)<br> 0.00-12.25 (3.15) years</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 91px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Other Assets</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
</td>
<td colspan="1" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">272<br> &#xa0;</font></td>
<td colspan="1" valign="top" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 75px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Probability adjusted <br>value</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 92px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Probability of events<br>Timing of events</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 99px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">5.00% (5.00%)<br> 7.75 (7.75) years</font></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 91px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>69,027,588</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 75px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 92px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 159px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:4pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:7pt; font-family: Arial, Helvetica;">(a) The valuation technique used as a basis to approximate fair value of these investments is based on a transaction price or subsequent financing rounds.</font></p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>(5)&#xa0;&#xa0;Private Companies and Other Restricted Securities</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund may invest in private companies and other restricted securities if these securities currently comprise 40% or less of net assets. The value of these securities represented 7% of the Fund's net assets at September 30, 2023.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">At September 30, 2023, the Fund had a commitment of $2,491,466 relating to additional investments in three private companies.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 29</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=33,FOLIO='29',FILE='23-25130-2.fa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The following table details the acquisition date, cost, carrying value per unit, and value of the Fund's private companies and other restricted securities at September 30, 2023. The Fund on its own does not have the right to demand that such securities be registered.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Security<sup>#</sup>&#x200b;</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 135px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Acquisition<br>Date</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 81px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Cost</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 85px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Carrying Value<br>per Unit</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:4pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 80px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Value</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Abcuro, Inc. Series B Cvt. Pfd</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">08/10/23</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,462,500</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5.49</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,462,500</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Afferent Milestone Interest</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">07/27/16</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">377,701</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">10.72</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">280,950</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Amolyt Pharma SAS Series C Cvt. Pfd</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">01/25/23</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,767,700</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2.26</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,626,440</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Amphivena Milestone Interest</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">10/18/22</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.00</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Arbor Biotechnologies, Series B Cvt. Pfd</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">10/29/21</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,367,052</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">16.57</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,359,999</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 542px;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Arkuda Therapeutics, Inc.</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Series A Cvt. Pfd</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">05/16/19, 04/02/20, 07/15/21</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5,609,016</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.00</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">235</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Series B Cvt. Pfd</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">01/24/22,01/23/23</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,848,073</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.51</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">536,259</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Biotheryx, Inc. Series E Cvt. Pfd</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">05/19/21</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6,814,111</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1.58</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,040,000</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Cercacor Laboratories, Inc. Common</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">03/31/98&#x2020;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.79</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">127,080</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Chinook Therapeutics, Inc. CVR</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">08/14/23</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">35,802</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1.64</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">150,552</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Curasen Therapeutics, Inc. <br>Series A Cvt. Pfd</font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">09/18/18, 01/07/20, 10/21/21, 11/01/22</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">8,739,649</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.48</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">8,728,395</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Curasen Therapeutics, Inc. Promissory Note</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">08/15/23</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">846,670</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">100.00</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">846,390</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Endeavor Biomedicines, Inc. Series B Cvt. Pfd</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">01/21/22</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,103,846</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4.72</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,099,996</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Ethismos Research Milestone Interest</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">10/31/17</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.00</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Flamingo Therapeutics, Inc. Series A3 Cvt. Pfd</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">04/21/20, 10/28/20</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5,612,058</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6.46</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,572,690</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Fusion Pharmaceuticals, Inc. Common</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">09/20/22</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2.34</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">17,768</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">HiberCell, Inc. Series C Warrants</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">09/15/23</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 542px; background-color: #cceeff;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">HiberCell, Inc.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Series B Cvt. Pfd</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">05/05/21</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,406,945</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.46</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,285,782</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Series C Cvt. Pfd</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">05/05/21</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">708,965</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.46</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">708,965</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 542px;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Hotspot Therapeutics, Inc.</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Series B Cvt. Pfd</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">04/22/20, 06/17/21</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6,916,047</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2.69</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">7,725,988</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Series C Cvt. Pfd</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">11/15/21</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,053,056</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2.69</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,699,432</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">ImmuneID, Inc. Series A Cvt. Pfd</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">04/28/21</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,044,520</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.48</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">488,070</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Impact Biomedicines Milestone Interest</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">07/20/10</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">13.84</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,081,983</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Incendia Therapeutics, Inc. Series A Cvt. Pfd</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">08/12/21</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,407,492</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1.92</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,399,993</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">InnovaCare, Inc. Escrow Shares Common</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">12/21/12&#x2020;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">25,044</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.13</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">28,422</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 542px; background-color: #cceeff;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Invetx, Inc.</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Series A Cvt. Pfd</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">08/06/20</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,452,934</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.67</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,816,344</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Series B Cvt. Pfd</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">03/28/22</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,071,261</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.67</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,070,000</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">IO Light Holdings, Inc. Series A2 Cvt. Pfd</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">04/30/20, 05/17/21 09/15/21&#x2020;</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,395,511</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1.52</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">640,378</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">30 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=34,FOLIO='30',FILE='23-25130-2.fa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Security<sup>#</sup>&#x200b;</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 135px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Acquisition<br>Date</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 81px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Cost</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 85px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Carrying Value<br>per Unit</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 80px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Value</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Neurovance Milestone Interest</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">03/20/17</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,917,881</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">258.31</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">$</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">12,658,771</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Priothera Ltd. Series A Cvt. Pfd</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">10/07/20</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">4,045,332</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">7.40</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,565,589</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Quell Therapeutics, Series B Cvt. Pfd</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">11/29/21, 03/23/22</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,957,194</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2.08</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">3,229,999</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Rainier Therapeutics Milestone Interest</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">09/28/21</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">294,620</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.00</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">ReCode Therapeutics, Series B Cvt. Pfd</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">10/12/21, 02/16/22</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,960,511</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">9.23</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,946,665</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Spectrum Pharmaceuticals, Inc. CVR</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">08/02/23</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">6,383</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.08</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Tetraphase Pharmaceuticals, Inc. CVR</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">09/01/21</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">5,749</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.20</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,724</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Therachon Milestone Interest</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">07/01/19</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 53px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">2,362,765</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 19px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 58px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0.00</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 20px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 52px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">0</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 145px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 135px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 53px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>82,616,388</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 85px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 20px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>$</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 52px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>69,197,359</b></font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt; border-bottom:double windowtext 2.25pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:4pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:7pt; font-family: Arial, Helvetica;">#&#xa0;&#xa0;See Schedule of Investments and corresponding footnotes for more information on each issuer.</font></p>
<p style="margin:2pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:7pt; font-family: Arial, Helvetica;">&#x2020;&#xa0;&#xa0;Interest received as part of a corporate action for a previously owned security.</font></p>
<p style="margin:6pt 0pt 3pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>(6)&#xa0;&#xa0;Subsequent Event</b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Effective at the close of business on October 27, 2023, the Adviser assumed responsibility for management of the Fund from Tekla Capital Management, LLC (TCM). On the same date, the investment team at TCM joined abrdn and continues to manage the Fund. Also effective upon abrdn's appointment as adviser, four Trustees resigned from the Fund's Board, and Stephen Bird, Rose DiMartino, C. William Maher and Todd Reit, who were elected by shareholders, joined Jeffrey Bailey and Kathleen Goetz on the Fund's Board. Mr. Reit began serving as Chair of the Board on the same date.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Also effective upon abrdn's appointment as adviser, the Fund's assets are valued pursuant to the valuation procedures for funds advised by abrdn, as approved by the Board after the new Trustees began their term. Pursuant to the new valuation procedures, foreign equity securities that trade on a market that closes prior to the Fund's valuation time are valued by applying daily valuation factors to the last quoted sale price.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Services Agreement terminated on October 27, 2023.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Effective upon the close of business on October 27, 2023, the Adviser as Adviser of the Fund, entered into a written contract with the Fund to limit the total ordinary operating expenses of the Fund (excluding leverage costs, interest, taxes, brokerage commissions, acquired fund fees and expenses and any non-routine expenses) from exceeding 1.17% of the average daily net assets of the Fund on an annualized basis for twelve months (the "Expense Limitation Agreement").The Expense Limitation Agreement may not be terminated before October 27, 2025, without the approval of the Fund's trustees who are not "interested persons" of the Fund (as defined in the 1940 Act).</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 31</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=35,FOLIO='31',FILE='23-25130-2.fa.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>

<!-- Document name: 23-25130-2.ga-->
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><font style="font-size:19pt; font-family: Arial, Helvetica;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>To the Shareholders and Board of Trustees abrdn Healthcare Investors:</b></font></p>
<p style="margin:4pt 0pt 0pt 0pt"><font style="font-size:10pt; font-family: Times New Roman, Times, serif;"><b><i>Opinion on the Financial Statements</i></b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">We have audited the accompanying statement of assets and liabilities of abrdn Healthcare Investors (formerly, Tekla Healthcare Investors) (the Fund), including the schedule of investments, as of September 30, 2023, the related statements of operations and changes in net assets for the year then ended, and the related notes (collectively, the financial statements) and the financial highlights for the year then ended. In our opinion, the financial statements and financial highlights present fairly, in all material respects, the financial position of the Fund as of September 30, 2023, the results of its operations, the changes in its net assets and the financial highlights for the year then ended, in conformity with U.S. generally accepted accounting principles. The statement of changes in net assets for the year ended September 30, 2022 and financial highlights for each of the years in the four-year period ended September 30, 2022 were audited by other independent registered public accountants whose report, dated November 21, 2022, expressed an unqualified opinion on that financial statement and those financial highlights.</font></p>
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:10pt; font-family: Times New Roman, Times, serif;"><b><i>Basis for Opinion</i></b></font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">These financial statements and financial highlights are the responsibility of the Fund's management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</font></p>
<p style="margin:0pt 0pt 4pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the financial statements and financial highlights, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements and financial highlights. Such procedures also included confirmation of securities owned as of September 30, 2023, by correspondence with custodians and brokers; when replies were not received from brokers, we performed other auditing procedures. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements and financial highlights. We believe that our audit provides a reasonable basis for our opinion.</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: center;"><img src="tm2325130d1hqhar25130d2i010.jpg">
</p>
<p style="margin:4pt 0pt 4pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">We have served as the auditor of one or more abrdn investment companies since 2009.</font></p>
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Philadelphia, Pennsylvania<br>November 29, 2023</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">32 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=36,FOLIO='32',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 6pt 0pt; text-align: left;"><font style="font-size:19pt; font-family: Arial, Helvetica;">TRUSTEES AND OFFICERS</font><font style="font-size:9pt; font-family: Times New Roman, Times, serif;"><i> (AS OF OCTOBER 30, 2023, Unaudited)</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 3.5pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 529px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Name, Address<sup>1</sup>&#x200b;, Date of Birth,<br>Length of Time Served, Principal Occupation(s)<br>During Past 5 Years, at Minimum, and <br>Other Directorship Held</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 3.5pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 462px; text-align: center;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Position(s) Held with Fund,<br>Term of Office<sup>2</sup>&#x200b;</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 3.5pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 461px; text-align: center;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Number of Registered <br>Investment Companies <br>("Registrants") consisting <br>of Investment Portfolios <br>("Portfolios") <br>in Fund Complex<br>Overseen by Trustee<sup>4</sup>&#x200b;</b></font></td>
<td colspan="1">&#xa0;</td>
</tr>
</table>

<p style="margin:9pt 0pt 6pt 0pt; text-align: left;"><font style="font-size:12pt; font-family: Arial, Helvetica;"><b>INDEPENDENT TRUSTEES</b></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 529px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Jeffrey Bailey, Born: 1962<br></b> &#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 462px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Trustee since 2020<br> &#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 461px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Registrants consisting <br>of 4 Portfolios</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 4pt 0pt; width: 1452px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">CEO, IlluminOss, Inc. (2018-2020); Board Chairman, Aileron Therapeutics Inc. (since 2017); Director, Madison Vaccines, Inc. (since 2018); Director, Aurinia Pharmaceuticals, Inc. (since August 2023); Director and CEO, BioDelivery Systems, Inc. (since 2020-2022).</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 529px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Kathleen Goetz, Born: 1966<br></b> &#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 462px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Trustee since 2021<br> &#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 461px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Registrants consisting <br>of 4 Portfolios</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 4pt 0pt; width: 1452px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Independent Consultant (since 2020); Novartis Pharmaceuticals: Vice President and Head of Sales (2017-2019), Executive Director of Strategic Account Management (2015-2016).</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 529px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Rose DiMartino, Born: 1952<br></b> &#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 462px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Trustee since 2023<br> &#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 461px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">5 Registrants consisting <br>of 7 Portfolios</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 4pt 0pt; width: 1452px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Retired since 2019. Partner (1991-2017) and Senior Counsel (2017-2019) at the law firm of Willkie Farr &amp; Gallagher LLP.</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 529px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>C. William Maher, Born: 1961<br></b> &#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 462px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Trustee since 2023<br> &#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 461px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">7 Registrants consisting <br>of 7 Portfolios</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 4pt 0pt; width: 1452px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Mr. Maher is a Co-founder of Asymmetric Capital Management LLC from May 2018 to September 2020. Formerly Chief Executive Officer of Santa Barbara Tax Products Group from October 2014 to April 2016.</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 529px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Todd Reit, Born: 1968<br></b> &#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 462px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Trustee since 2023<br> &#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 461px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">9 Registrants consisting <br>of 9 Portfolios</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 4pt 0pt; width: 1452px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Mr. Reit is a Managing Member of Cross Brook Partners LLC, a real estate investment and management company since 2017. Mr. Reit is also Director and Financial Officer of Shelter Our Soldiers, a charity to support military veterans, since 2016. Mr. Reit was formerly a Managing Director and Global Head of Asset Management Investment Banking for UBS AG, where he was responsible for overseeing all the bank's asset management client relationships globally, including all corporate security transactions, mergers and acquisitions. Mr. Reit retired from UBS in 2017 after an over 25-year career at the company and its predecessor company, PaineWebber Incorporated (merged with UBS AG in 2000).</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
</table>

<p style="margin:9pt 0pt 6pt 0pt; text-align: left;"><font style="font-size:12pt; font-family: Arial, Helvetica;"><b>INTERESTED TRUSTEE</b></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 529px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Stephen Bird<sup>3</sup>&#x200b;, Born: 1967<br></b> &#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 462px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Trustee since 2023<br> &#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 461px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">15 Registrants consisting<br>of 33 Portfolios</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="11" valign="bottom" style="padding:0pt .7pt 4pt 0pt; width: 1452px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Mr. Bird joined the Board of SLA plc in July 2020 as Chief Executive-Designate, and was formally appointed Chief Executive Officer in September 2020. Previously, Mr. Bird served as chief executive officer of global consumer banking at Citigroup from 2015, retiring from the role in November 2019. His responsibilities encompassed all consumer and commercial banking businesses in 19 countries, including retail banking and wealth management, credit cards, mortgages, and operations and technology supporting these businesses. Prior to this, Mr. Bird was chief executive for all of Citigroup's Asia Pacific business lines across 17 markets in the region, including India and China. Mr. Bird joined Citigroup in 1998, and during his 21 years with the company he held a number of leadership roles in banking, operations and technology across its Asian and Latin American businesses. Before this, he held management positions in the UK at GE Capital&#x2014;where he was director of UK operations from 1996 to 1998&#x2014;and at British Steel.</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 1pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;"><sup>1&#xa0;&#xa0;</sup>&#x200b;The Address for each Trustee is: c/o abrdn Inc., 1900 Market Street, Suite 200, Philadelphia, PA 19103.</font></p>
<p style="margin:0pt 0pt 1pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;"><sup>2&#xa0;&#xa0;</sup>&#x200b;Each Trustee currently is serving a three year term.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;"> abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT33</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=37,FOLIO='',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 1pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;"><sup>3&#xa0;&#xa0;</sup>&#x200b;Trustee considered to be an "interested person" within the meaning of the Investment Company Act of 1940, as amended (the "1940 Act"), through position or affiliation with the Adviser.</font></p>
<p style="margin:0pt 0pt 1pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;"><sup>4</sup>&#x200b;&#xa0;&#xa0;As of October 30, 2023, the Fund Complex has a total of 18 Registrants with each Board member serving on the Boards of the number of Registrants listed. Each Registrant in the Fund Complex has one Portfolio except for two Registrants that are open-end funds, abrdn Funds and abrdn ETFs, which each have multiple Portfolios. The Registrants in the Fund Complex are as follows: abrdn Asia-Pacific Income Fund, Inc., abrdn Global Income Fund, Inc., abrdn Australia Equity Fund, Inc., abrdn Emerging Markets Equity Income Fund, Inc., The India Fund, Inc., abrdn Japan Equity Fund, Inc., abrdn Income Credit Strategies Fund, abrdn Global Dynamic Dividend Fund, abrdn Global Premier Properties Fund, abrdn Total Dynamic Dividend Fund, abrdn Global Infrastructure Income Fund, abrdn National Municipal Income Fund, abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn Healthcare Opportunities Fund, abrdn World Healthcare Fund, abrdn Funds (19 Portfolios), and abrdn ETFs (3 Portfolios).</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:7pt .7pt 3.5pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 559px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Name, Address<sup>1</sup>&#x200b;, Date of Birth,<br>Principal Occupation(s)<br>During Past 5 Years</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:7pt .7pt 3.5pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 527px; text-align: center;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Position(s) Held with <br>Fund, Term of Office<sup>2<br></sup>&#x200b;and Length of Time Served</b></font></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 559px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Joseph Andolina*, Born: 1978<br></b> &#xa0;&#xa0;<br> &#xa0;&#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 527px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Chief Compliance Officer and <br>Vice President Compliance <br>since 2023</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="7" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 1086px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Currently, Chief Risk Officer&#x2014;Americas for abrdn Inc. and serves as the Chief Compliance Officer for abrdn Inc. Prior to joining the Risk and Compliance Department, he was a member of abrdn Inc.'s Legal Department, where he served as US Counsel since 2012.</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 559px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Sharon Ferrari*, Born: 1977<br></b> &#xa0;&#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 527px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Treasurer and Chief Financial <br>Officer since 2023</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="7" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 1086px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Currently, Director Product Management&#x2014;US for abrdn Inc. Ms. Ferrari joined abrdn Inc. as a Senior Fund Administrator in 2008.</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 559px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Alan Goodson*, Born: 1974</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 527px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Vice President since 2023</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="7" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 1086px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Currently, Director, Vice President and Head of Product &amp; Client Solutions&#x2014;Americas for abrdn Inc., overseeing Product Management &amp; Governance, Product Development and Client Solutions for registered and unregistered investment companies in the U.S., Brazil and Canada. Mr. Goodson is Director and Vice President of abrdn Inc. and joined abrdn Inc. in 2000.</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 559px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Megan Kennedy*, Born: 1974<br></b> &#xa0;&#xa0;</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 527px; background-color: #cceeff; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">Secretary and Vice President <br>since 2023</font></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="7" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 1086px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Currently, Senior Director, Product Governance for abrdn Inc. Ms. Kennedy joined abrdn Inc. in 2005.</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 559px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Daniel R. Omstead, Ph.D., Born: 1953</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 527px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Vice President since 2023</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="7" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 1086px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Currently Head of Healthcare Investments at abrdn. Previously, President of HQH and HQL (from 2001 to October 2023), THQ (from 2014 to October 2023) and THW (from 2015 to October 2023); President, Chief Executive Officer and Managing Member of Tekla Capital Management, LLC from 2002 to October 2023).</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 559px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Christian Pittard*, Born: 1973</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 527px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">President since 2023</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="7" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 1086px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Currently, Director of Corporate Finance and Head of Listed Funds. Mr. Pittard joined abrdn from KPMG in 1999.</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 559px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Lucia Sitar*, Born: 1971</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 527px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Vice President since 2023</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="7" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 1086px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Currently, Vice President and Head of Product Management and Governance for abrdn Inc. since 2020. Previously, Ms. Sitar was Managing U.S. Counsel for abrdn Inc. She joined abrdn Inc. as U.S. Counsel in July 2007.</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">34 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=38,FOLIO='34',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 3.5pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 559px; text-align: left;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Name, Address<sup>1</sup>&#x200b;, Date of Birth,<br>Principal Occupation(s)<br>During Past 5 Years</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 3.5pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 527px; text-align: center;">
<font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Position(s) Held with <br>Fund, Term of Office<sup>2<br></sup>&#x200b;and Length of Time Served</b></font></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 559px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;"><b>Laura Woodward, Born: 1968</b></font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 527px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Vice President 2023</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="7" valign="bottom" style="padding:0pt .7pt 5pt 0pt; width: 1086px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Currently Vice President of Fund Administration at abrdn. Previously Chief Compliance Officer, Secretary and Treasurer of HQH and HQL (from 2009 to October 2023), THQ (from 2014 to October 2023) and THW (from 2015 to October 2023); Chief Compliance Officer and Vice President of Fund Administration, Tekla Capital Management, LLC (from 2009 to October 2023).</font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
</table>

<p style="margin:0pt 0pt 2pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;"><sup>1&#xa0;&#xa0;</sup>&#x200b;The Address for each officer is: c/o abrdn Inc., 1900 Market Street, Suite 200, Philadelphia, PA 19103.</font></p>
<p style="margin:0pt 0pt 2pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;"><sup>2&#xa0;&#xa0;</sup>&#x200b;Each officer serves in such capacity for an indefinite period of time at the pleasure of the Trustees.</font></p>
<p style="margin:0pt 0pt 2pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">*&#xa0;&#xa0;Each officer may hold officer position(s) in one or more other funds which are part of the Fund Complex.</font></p>
<p style="margin:4pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">The Fund's Statement of Additional Information includes additional information about the Fund's Trustees and is available without charge, upon request.</font></p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">Contact us:</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2022; Visit: https://www.abrdn.com/en-us/cefinvestorcenter</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2022; Email: Investor.Relations@abrdn.com; or</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:8pt; font-family: Arial, Helvetica;">&#x2022; Call: 1-800-522-5465 (toll free in the U.S.)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 35</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=39,FOLIO='35',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>ANNUAL MEETING REPORT (unaudited)</b></font></p>
<p style="margin:2pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">An Annual Meeting of Shareholders was held on June 8, 2023. Shareholders voted to elect Trustees of the Fund to hold office for a term of three years or until their respective successors have been duly elected and qualified. The following votes were cast with respect to each of the nominees:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 83px;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 66px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>For</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 62px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Withheld</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 83px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Jeffrey Bailey</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">37,534,845</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 46px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,257,309</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 83px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Rakesh Jain, Ph.D.</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">37,440,479</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 46px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,351,675</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Jeffrey Bailey and Rakesh Jain, Ph.D.* were elected to serve until the 2026 Annual Meeting.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Trustees serving until the 2024 Annual Meeting are Thomas Kent*, CPA and Daniel Omstead, Ph.D.*</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Trustees serving until the 2025 Annual Meeting are Kathleen Goetz and Mark Watson*, CPA.</font></p>
<p style="margin:8pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Shareholders ratified the appointment of Deloitte &amp; Touche LLP** as the independent registered public accountants of the Fund for the fiscal year ending September 30, 2023, by the following votes:</font></p>
<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 83px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>For</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 66px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Against</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 62px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Abstain</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 67px; background-color: #cceeff; text-align: right;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">37,910,220</font></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">587,007</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 46px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">294,927</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:4pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:7pt; font-family: Arial, Helvetica;">&#xa0;&#xa0;*&#xa0;&#xa0;Resigned effective October 27, 2023.</font></p>
<p style="margin:2pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:7pt; font-family: Arial, Helvetica;">&#xa0;&#xa0;**&#xa0;&#xa0;Resigned effective September 6, 2023.</font></p>
<p style="margin:4pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:7pt; font-family: Arial, Helvetica;">On September 7, 2023, upon the recommendation of the Audit Committee of the Board, the Board approved the engagement of KPMG LLP ("KPMG") as the independent registered public accounting firm for the Fund for the fiscal year ending September 30, 2023. During the Fund's two most recent fiscal years (ended September 30, 2022 and September 30, 2021) and the subsequent interim period prior to the engagement of KPMG, neither the Fund, nor anyone on the Fund's behalf consulted with KPMG regarding (1) the application of accounting principles to a specified transaction, either completed or proposed; (2) the type of audit opinion that might be rendered on the Fund's financial statements; or (3) the subject of any "disagreement," as defined in Item 304(a)(1)(iv) of Regulation S-K under the Exchange Act and the instructions thereto, or a "reportable event," as defined in Item 304(a)(1)(v) of Regulation S-K under the Exchange Act.</font></p>
<p style="margin:11pt 0pt 2pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>SPECIAL MEETINGS REPORTS (unaudited)</b></font></p>
<p style="margin:8pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">At a Special Meeting of Shareholders held on August 14, 2023, shareholders voted to elect four new Trustees of the Fund to hold office for a term of three years or until their respective successors have been duly elected and qualified. The following votes were cast with respect to each of the nominees:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 83px;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 66px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>For</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 62px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Withheld</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 83px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Stephen Bird</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">34,377,927</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 46px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,541,523</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 83px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Rose DiMartino</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">34,408,493</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 46px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,510,957</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 83px; background-color: #cceeff; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">C. William Maher</font></p></td>
<td colspan="1" style="background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">34,396,755</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 46px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,522,694</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 83px; text-align: left;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:8pt; font-family: Arial, Helvetica;">Todd Reit</font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">34,366,597</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 46px; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,552,854</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px;">
 &#xa0;</td>
<td colspan="1" style="width: 8px;">&#xa0;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">36 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=40,FOLIO='36',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Rose DiMartino and C. William Maher were elected to serve until the 2024 Annual Meeting.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Todd Reit was elected to serve until the 2025 Annual Meeting.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Stephen Bird was elected to serve until the 2026 Annual Meeting.</font></p>
<p style="margin:8pt 0pt 8pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Subsequent to the reporting period, at a Special Meeting of Shareholders held on October 13, 2023 (as adjourned from August 14, August 29, September 12 and October 3), shareholders voted to approve a new investment advisory agreement between the Fund and abrdn Inc. The October 13, 2023 results of the voting on this matter were as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 83px; text-align: center;">
<font style="font-size:7pt; font-family: Arial, Helvetica;"><b>For</b></font></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 66px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Against</b></font></p></td>
<td colspan="1">&#xa0;</td>
<td colspan="3" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt; width: 62px; text-align: center;">
<p style="margin:0pt 0pt 0pt 0pt"><font style="font-size:7pt; font-family: Arial, Helvetica;"><b>Abstain</b></font></p></td>
<td colspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 67px; background-color: #cceeff; text-align: right;">
<font style="font-size:8pt; font-family: Arial, Helvetica;">21,375,687</font></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 50px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,157,118</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 46px; background-color: #cceeff; text-align: right;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font style="font-size:8pt; font-family: Arial, Helvetica;">1,887,119</font></p></td>
<td colspan="1" valign="bottom" style="padding:2pt .7pt 0pt 0pt; width: 8px; background-color: #cceeff;">
 &#xa0;</td>
<td colspan="1" style="width: 8px; background-color: #cceeff;">&#xa0;</td>
</tr>
</table>

<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>FOR MORE INFORMATION (unaudited):</b> A description of the Fund's proxy voting policies and procedures and information on how the Fund voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available (i) without charge, upon request by calling 1-800-451-2597; (ii) by writing to abrdn Inc. at 1900 Market Street, Suite 200, Philadelphia, PA 19103; (iii) on the Fund's website at www.abrdnhqh.com; and (iv) on the SEC's website at www.sec.gov.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund's complete Schedule of Investments for the first and third quarters of its fiscal year will be filed with the SEC on Form N-PORT. These will also be available on the Fund's website at www.abrdnhqh.com or the SEC's website at www.sec.gov.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">You can find information regarding the Fund at the Fund's website, www.abrdnhqh.com. The Fund regularly posts information to its website, including information regarding daily share pricing, distributions, press releases and links to the Fund's SEC filings. The Fund currently publishes and distributes quarterly fact cards, which includes performance, portfolio holdings and sector information for each fiscal quarter. These fact cards will be available on the Fund's website and by request from the Fund's marketing and investor support services agent, Destra Capital Advisors LLC, at 1-877-855-3434.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>FEDERAL TAX INFORMATION (unaudited): </b>Certain information for the Fund is required to be provided to shareholders based on the Fund's income and distributions for the taxable year ended December 31, 2023. In February 2024, shareholders will receive Form 1099-DIV, which will include their share of qualified dividends and capital gains and return of capital distributed during the calendar year 2023. Shareholders are advised to check with their tax advisors for information on the treatment of these amounts on their individual tax returns.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>DISTRIBUTION POLICY (unaudited):</b> The Fund has a managed distribution policy as described in the Notes to Financial Statements. For more information contact your financial adviser.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 37</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=41,FOLIO='37',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>SHARE REPURCHASE PROGRAM (unaudited):</b> In March 2023, the Trustees reauthorized the share repurchase program to allow the Fund to repurchase up to 12% of its outstanding shares for a one year period ending July 14, 2024.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>PORTFOLIO MANAGEMENT (unaudited): </b>Daniel Omstead, Ph.D., Jason Akus, M.D./M.B.A., Timothy Gasperoni, M.B.A., Ph.D., Ashton L. Wilson, Christopher Abbott, Robert Benson, Kelly Girskis, Ph.D., Richard Goss, Christopher Seitz, M.B.A., and Loretta Tse, Ph.D. are members of a team that analyzes investments on behalf of the Fund. Dr. Omstead exercises ultimate decision making authority with respect to investments.</font></p>
<p style="margin:11pt 0pt 2pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>INVESTMENT OBJECTIVE, POLICIES AND RISK FACTORS (unaudited)</b></font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The following information in this annual report is a summary of certain information about the Fund and changes since September 30, 2022. This information may not reflect all of the changes that have occurred since you purchased the Fund.</font></p>
<p style="margin:11pt 0pt 2pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Investment Objective and Policies</b></font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">There have been no changes in the Fund's investment objective and policies since September 30, 2022 that have not been approved by shareholders.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">In an effort to achieve its investment objective, the Fund will invest primarily in securities of U.S. and foreign companies that are generally believed by the Investment Adviser to have significant potential for above-average long-term growth in revenues and earnings. The Investment Adviser expects that such companies generally will possess some or all of the following characteristics, in the Investment Adviser's judgment: current or anticipated strong market position for their services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital. For companies with earnings, the Investment Adviser generally will attempt to invest in securities that sell at price-earnings ratios or at multiples of underlying asset or potential values which, have upside potential.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund may invest in securities of emerging growth healthcare companies, which may offer limited products or services or which are at the research and development stage with no marketable or approved products or technologies. The Fund also may invest in securities of large, well-known companies with existing products in the healthcare industries that are believed by the Investment Adviser to be undervalued in relation to their long-term growth potential or asset value.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">38 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=42,FOLIO='38',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund also may invest up to 40% of its net assets in venture capital or other securities that are subject to legal or contractual restrictions on resale ("Restricted Securities").</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund also may invest up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of U.S. issuers traded in foreign markets ("Foreign Securities"). The Fund may buy and sell currencies for the purpose of settlement of transactions in Foreign Securities.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Under normal market conditions, the Fund expects to invest at least 80% of its net assets in securities of healthcare companies. This policy may not be changed without 60 days' prior notice to the Fund's shareholders (the "shareholders"). The Fund is required, except for temporary defensive purposes, to invest at least 25% of its net assets in such companies. For purposes of satisfying the foregoing requirements, a company will be deemed to be a healthcare company if, at the time the Fund makes an investment therein, 50% or more of such company's sales, earnings or assets arise from or are dedicated to, or are expected to arise from or be dedicated to, healthcare products or services or medical technology activities. Determinations as to whether a company is a healthcare company will be made by the Investment Adviser in its discretion.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The equity and related securities in which the Fund may invest consist of common stock of healthcare companies and, to a lesser extent, of preferred stock, convertible debt, limited partnership interests and warrants or other rights to acquire common or preferred stocks of such companies. The Fund's investments in venture capital opportunities, which are considered Restricted Securities, will be made primarily in convertible preferred stock. The Fund may also purchase non-convertible debt securities in connection with its venture capital investments, and otherwise when the Investment Adviser believes that such investments would be consistent with the Fund's investment objective. While these debt investments typically will not be rated, the Investment Adviser believes that, in light of the risk characteristics associated with investments in emerging growth companies (see "Risk Factors"), if such investments were to be compared with investments rated by S&amp;P or Moody's, they may be rated as low as "C" in the rating categories established by S&amp;P and Moody's. Such securities are commonly referred to as "junk bonds" and are considered, on balance, as predominantly speculative.</font></p>
<p style="margin:11pt 0pt 2pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Put or Call Options</b></font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Fund may purchase and sell (or write) put or call options on any security in which it is permitted to invest or on any index of securities or other index, the change in value of which has a high degree of correlation with the changes in value of the Fund's portfolio securities, and may purchase and sell (or write) on a covered basis financial futures contracts and options on such futures.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 39</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=43,FOLIO='39',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 2pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Changes to Risk Factors During the Prior Fiscal Year</b></font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">There have been no material changes to the Fund's Risk Factors since September 30, 2022.</font></p>
<p style="margin:11pt 0pt 2pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Risk Factors</b></font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Investing in any investment company security involves risk, including the risk that you may receive little or no return on your investment or even that you may lose part or all of your investment. Investors should consider the following Risk Factors and special considerations associated with investing in the Fund's shares.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Portfolio Market Risk.</b> As with any investment company that invests in equity securities, the Fund is subject to market risk&#x2014;the possibility that the prices of equity securities will decline over short or extended periods of time. The price of an equity security of an issuer may be particularly sensitive to general movements in the stock market, or a drop in the stock market may depress the price of most or all of the equity securities held by the Fund. In addition, equity securities held by the Fund may decline in price if the issuer fails to make anticipated distributions or dividend payments because, among other reasons, the issuer experiences a decline in its financial condition. As a result, the value of an investment in the Fund's shares will fluctuate with the market. You could lose some or all of your investment over short or long periods of time. Political and economic news can influence market-wide trends and can cause disruptions in the U.S. or world financial markets. Other factors may be ignored by the market as a whole but may cause movements in the price of one company's stock or the stock of companies in one or more industries. All of these factors may have a greater impact on initial public offerings and emerging company shares.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Instability in the financial markets has led the U.S. government and certain foreign governments to take a number of unprecedented actions designed to support certain financial institutions and segments of the financial markets that have experienced extreme volatility, and in some cases a lack of liquidity, including through direct purchases of equity and debt securities. Federal, state, and foreign governments, their regulatory agencies or self-regulatory organizations may take actions that affect the regulation of the issuers in which the Fund invests in ways that are unforeseeable. Legislation or regulation may also change the way in which the Fund is regulated. Such legislation or regulation could limit or preclude the Fund's ability to achieve its investment objective.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The value of your investment in the Fund is based on the market prices of the securities the Fund holds. The increasing interconnectivity between global economies and financial markets increases the likelihood that events or conditions in one region or financial market may adversely impact issuers in a different country, region or financial market. Securities in the Fund's portfolio may underperform due to inflation (or expectations for inflation), interest rates, global demand for particular products or resources, natural/environmental disasters, </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">40 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=44,FOLIO='40',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">pandemics, epidemics, cyber-attacks, terrorism, regulatory events and governmental or quasi-governmental actions. The occurrence of global events, such as terrorist attacks around the world, natural disasters, social and political discord or debt crises and downgrades, among others, may result in market volatility and may have long term effects on both the U.S. and global financial markets. A disruption of financial markets or other terrorist attacks could adversely affect Fund service providers and/or the Fund's operations as well as interest rates, secondary trading, credit risk, inflation and other factors relating to the shares. The Fund cannot predict the effects or likelihood of similar events in the future on the U.S. and world economies, the value of the shares or the NAV of the Fund.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Social, political, economic and other conditions and events, such as natural/environmental disasters, health emergencies (e.g., epidemics and pandemics such as COVID-19, avian influenza or HINI/09), cyber-attacks, terrorism, actual or threatened wars or other armed conflicts (such as the Russia/Ukraine and Israel/Hamas conflicts), may occur and could significantly impact issuers, industries, governments and other systems, reduce consumer demand or economic output, result in market closures, travel restrictions or quarantines, and generally have a significant impact on the economies and financial markets and the Investment Adviser's investment advisory activities and services of other service providers, which in turn could adversely affect the Fund's investments and other operations. These impacts could negatively affect the Fund's investments in securities and instruments that are economically tied to the applicable region, and include (but are not limited to) declines in value and reductions in liquidity. In addition, to the extent new sanctions are imposed or previously relaxed sanctions are reimposed, complying with such restrictions may prevent the Fund from pursuing certain investments, cause delays or other impediments with respect to consummating such investments or divestments, require divestment or freezing of investments on unfavorable terms, render divestment of underperforming investments impracticable, negatively impact the Fund's ability to achieve its investment objective, prevent the Fund from receiving payments otherwise due it, increase diligence and other similar costs to the Fund, render valuation of affected investments challenging, or require the Fund to consummate an investment on terms that are less advantageous than would be the case absent such restrictions. These types of events quickly and significantly impact markets in the U.S. and across the globe leading to extreme market volatility and disruption. The extent and nature of the impact on supply chains or economies and markets from these events is unknown, particularly if these types of events persist for an extended period of time. The value of the Fund's investments may decrease as a result of such events, particularly if these events adversely impact the operations and effectiveness of the Investment Adviser or key service providers or if these events disrupt systems and processes necessary or beneficial to the investment advisory or other activities on behalf the Fund.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">In March 2023, several financial institutions experienced a larger-than-expected decline in deposits and two banks, Silicon Valley Bank ("SVB") and Signature Bank, were placed into </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 41</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=45,FOLIO='41',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">receivership. Given the interconnectedness of the banking system, the Federal Reserve invoked the systemic risk exception, temporarily transferred all deposits-both insured and uninsured-and substantially all the assets of the two banks into respective bridge banks and guaranteed depositors' full access to their funds. This type of systemic risk event and/or resulting government actions can negatively impact the Funds, for example, through less credit being available to issuers or uncertainty regarding safety of deposits at other institutions. These risks also may adversely affect financial intermediaries, such as clearing agencies, clearing houses, banks, securities firms, and exchanges, with which the Fund interacts.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Security Market Risk&#x2014;Discount to NAV.</b> Market price risk is a risk separate and distinct from the risk that the Fund's NAV will decrease. The Fund's shares have traded in the market below NAV per share (a discount), at NAV per share and above NAV per share (premium) since the commencement of the Fund's operations. There can be no assurance that the Fund's shares will trade at a premium in the future, or that any such premium will be sustainable. The Fund cannot predict whether the shares will trade in the future at, above or below their NAV.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Non-Diversification Risk.</b> The Fund is non-diversified, meaning that the Fund is permitted to invest more of its assets in fewer issuers than "diversified" funds. Thus, the Fund may be more susceptible to adverse developments affecting any single issuer held in its portfolio, and may be more susceptible to greater losses because of these developments.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Selection Risk.</b> Different types of equity securities tend to shift into and out of favor with investors, depending on market and economic conditions. The performance of funds that invest in equity securities of healthcare companies may at times be better or worse than the performance of funds that focus on other types of securities or that have a broader investment style.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Concentration in the Healthcare Industries.</b> Under normal market conditions, the Fund expects to invest primarily in securities of healthcare companies representing a small number of industries and to invest at least 25% of its net assets in securities of healthcare companies. As a result, the Fund's portfolio may be more sensitive to, and possibly more adversely affected by, regulatory, economic or political factors or trends relating to the healthcare industries than a portfolio of companies representing a larger number of industries. This risk is in addition to the risks normally associated with any strategy seeking capital appreciation by investing in a portfolio of equity securities. As a result of its concentration policy, the Fund's investments may be subject to greater risk and market fluctuation than a fund that has securities representing a broader range of investments. The healthcare industries can be volatile. The Fund may occasionally make investments in a company with the objective of controlling or influencing the management and policies of that company, which could potentially make the Fund more susceptible to declines in the value of </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">42 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=46,FOLIO='42',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">the company's stock. The Investment Adviser may seek control in public companies only occasionally and most often in companies with a small capitalization.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Healthcare companies have in the past been characterized by limited product focus, rapidly changing technology and extensive government regulation. In particular, technological advances can render an existing product, which may account for a disproportionate share of a company's revenue, obsolete. Obtaining governmental approval from U.S. governmental agencies such as the Food and Drug Administration (the "FDA"), and from non-U.S. governmental agencies for new products can be lengthy, expensive and uncertain as to outcome. Such delays in product development may result in the need to seek additional capital, potentially diluting the interests of existing investors such as the Fund. In addition, governmental agencies may, for a variety of reasons, restrict the release of certain innovative technologies of commercial significance, such as genetically altered material. These various factors may result in abrupt advances and declines in the securities prices of particular companies and, in some cases, may have a broad effect on the prices of securities of companies in particular healthcare industries.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">A concentration of investments in any healthcare industry or in healthcare companies generally may increase the risk and volatility of an investment company's portfolio. Such volatility is not limited to the biotechnology industry, and companies in other industries may be subject to similar abrupt movements in the market prices of their securities. No assurance can be given that future declines in the market prices of securities of companies in the industries in which the Fund may invest will not occur, or that such declines will not adversely affect the NAV or the price of the shares.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Intense competition exists within and among certain healthcare industries, including competition to obtain and sustain proprietary technology protection. Healthcare companies can be highly dependent on the strength of patents, trademarks and other intellectual property rights for maintenance of profit margins and market share. The complex nature of the technologies involved can lead to patent disputes, including litigation that could result in a company losing an exclusive right to a patent. Competitors of healthcare companies, particularly of the emerging growth healthcare companies in which the Fund may invest, may have substantially greater financial resources, more extensive development, manufacturing, marketing and service capabilities, and a larger number of qualified managerial and technical personnel. Such competitors may succeed in developing technologies and products that are more effective or less costly than any that may be developed by healthcare companies in which the Fund invests and may also prove to be more successful in production and marketing. Competition may increase further as a result of potential advances in health services and medical technology and greater availability of capital for investment in these fields.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 43</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=47,FOLIO='43',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">With respect to healthcare industries, cost containment measures already implemented by national governments, state or provincial governments and the private sector have adversely affected certain sectors of these industries. The implementation of the Affordable Care Act ("ACA") has created increased demand for healthcare products and services, but potential changes to the ACA and future healthcare laws and regulations may impact demand for healthcare products and services and has had or may have an adverse effect on some companies in the healthcare industries. Increased emphasis on managed care in the United States and a shift toward value based payment models may put pressure on the price and usage of products sold by healthcare companies in which the Fund may invest and may adversely affect the sales and revenues of healthcare companies.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Product development efforts by healthcare companies may not result in commercial products for many reasons, including, but not limited to, failure to achieve acceptable clinical trial results, limited effectiveness in treating the specified condition or illness, harmful side effects, failure to obtain regulatory approval, and high manufacturing costs. Even after a product is commercially released, governmental agencies may require additional clinical trials or change the labeling requirements for products if additional product side effects are identified, which could have a material adverse effect on the market price of the securities of those healthcare companies.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Certain healthcare companies in which the Fund may invest may be exposed to potential product liability risks that are inherent in the testing, manufacturing, marketing and sale of pharmaceuticals, medical devices or other products. A product liability claim may have a material adverse effect on the business, financial condition or securities prices of a company in which the Fund has invested.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">All of these factors as well as others may cause the value of the Fund's shares to fluctuate significantly over relatively short periods of time.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Pharmaceutical Sector Risk.</b> The success of companies in the pharmaceutical sector is highly dependent on the development, procurement and marketing of drugs. The values of pharmaceutical companies are also dependent on the development, protection and exploitation of intellectual property rights and other proprietary information, and the profitability of pharmaceutical companies may be significantly affected by such things as the expiration of patents or the loss of, or the inability to enforce, intellectual property rights.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The research and other costs associated with developing or procuring new drugs and the related intellectual property rights can be significant, and the results of such research and expenditures are unpredictable. There can be no assurance that those efforts or costs will result in the development of a profitable drug. Pharmaceutical companies may be susceptible to product obsolescence. Many pharmaceutical companies face intense competition from new products and less costly generic products. Moreover, the process for obtaining regulatory </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">44 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=48,FOLIO='44',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">approval by the FDA or other governmental regulatory authorities is long and costly and there can be no assurance that the necessary approvals will be obtained or maintained.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The pharmaceutical sector is also subject to rapid and significant technological change and competitive forces that may make drugs obsolete or make it difficult to raise prices and, in fact, may result in price discounting. Companies in the pharmaceutical sector may also be subject to expenses and losses from extensive litigation based on intellectual property, product liability and similar claims. Failure of pharmaceutical companies to comply with applicable laws and regulations can result in the imposition of civil and criminal fines, penalties and, in some instances, exclusion of participation in government sponsored programs such as Medicare and Medicaid.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Companies in the pharmaceutical sector may be adversely affected by government regulation and changes in reimbursement rates. The ability of many pharmaceutical companies to commercialize and monetize current and any future products depends in part on the extent to which reimbursement for the cost of such products and related treatments are available from third party payors, such as Medicare, Medicaid, private health insurance plans and health maintenance organizations. Third-party payors are increasingly challenging the price and cost-effectiveness of many medical products.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Significant uncertainty exists as to the reimbursement status of health care products, and there can be no assurance that adequate third-party coverage will be available for pharmaceutical companies to obtain satisfactory price levels for their products.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The international operations of many pharmaceutical companies expose them to risks associated with instability and changes in economic and political conditions, foreign currency fluctuations, changes in foreign regulations and other risks inherent to international business. Additionally, a pharmaceutical company's valuation can often be based largely on the potential or actual performance of a limited number of products. A pharmaceutical company's valuation can also be greatly affected if one of its products proves unsafe, ineffective or unprofitable. Such companies also may be characterized by thin capitalization and limited markets, financial resources or personnel, as well as dependence on wholesale distributors. The stock prices of companies in the pharmaceutical industry have been and will likely continue to be extremely volatile.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Biotechnology Industry Risk.</b> The success of biotechnology companies is highly dependent on the development, procurement and/or marketing of drugs. The values of biotechnology companies are also dependent on the development, protection and exploitation of intellectual property rights and other proprietary information, and the profitability of biotechnology companies may be significantly affected by such things as the expiration of patents or the loss of, or the inability to enforce, intellectual property rights.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 45</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=49,FOLIO='45',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The research and other costs associated with developing or procuring new drugs, products or technologies and the related intellectual property rights can be significant, and the results of such research and expenditures are unpredictable. There can be no assurance that those efforts or costs will result in the development of a profitable drug, product or technology. Moreover, the process for obtaining regulatory approval by the FDA or other governmental regulatory authorities is long and costly and there can be no assurance that the necessary approvals will be obtained or maintained.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The biotechnology sector is also subject to rapid and significant technological change and competitive forces that may make drugs, products or technologies obsolete or make it difficult to raise prices and, in fact, may result in price discounting. Companies in the biotechnology sector may also be subject to expenses and losses from extensive litigation based on intellectual property, product liability and similar claims. Failure of biotechnology companies to comply with applicable laws and regulations can result in the imposition of civil and/or criminal fines, penalties and, in some instances, exclusion of participation in government sponsored programs such as Medicare and Medicaid.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Companies in the biotechnology sector may be adversely affected by government regulation and changes in reimbursement rates. Healthcare providers, principally hospitals, that transact with companies in the biotechnology industry, often rely on third party payors, such as Medicare, Medicaid, private health insurance plans and health maintenance organizations to reimburse all or a portion of the cost of healthcare related products or services. Biotechnology companies will continue to be affected by the efforts of governments and third party payors to contain or reduce health care costs. For example, certain foreign markets control pricing or profitability of biotechnology products and technologies. In the United States, there has been, and there will likely continue to be, a number of federal and state proposals to implement similar controls.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">A biotechnology company's valuation could be based on the potential or actual performance of a limited number of products and could be adversely affected if one of its products proves unsafe, ineffective or unprofitable. Such companies may also be characterized by thin capitalization and limited markets, financial resources or personnel. The stock prices of companies involved in the biotechnology sector have been and will likely continue to be extremely volatile.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Managed Care Sector Risk.</b> Companies in the managed care sector often assume the risk of both medical and administrative costs for their customers in return for monthly premiums. The profitability of these products depends in large part on the ability of such companies to predict, price for, and effectively manage medical costs. Managed care companies base the premiums they charge and their Medicare bids on estimates of future medical costs over the fixed contract period; however, many factors may cause actual costs to exceed what was estimated and reflected in premiums or bids. These factors may include medical cost inflation, </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">46 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=50,FOLIO='46',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">increased use of services, increased cost of individual services, natural catastrophes or other large-scale medical emergencies, epidemics, the introduction of new or costly treatments and technology, new mandated benefits (such as the expansion of essential benefits coverage) or other regulatory changes and insured population characteristics. Relatively small differences between predicted and actual medical costs or utilization rates as a percentage of revenues can result in significant changes in financial results.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Managed care companies are regulated at the federal, state, local and international levels. Insurance and Health Maintenance Organizations ("HMOs") subsidiaries must be licensed by and are subject to the regulations of the jurisdictions in which they conduct business. U.S. health plans and insurance companies are also regulated under state insurance holding company regulations, and some of their activities may be subject to other health care-related regulations. The health care industry is also regularly subject to negative publicity, including as a result of governmental investigations, adverse media coverage and political debate surrounding industry regulation. Negative publicity may adversely affect stock price, damage the reputation of managed care companies in various markets or foster an increasingly active regulatory environment, which, in turn, could further increase the regulatory burdens under which such companies operate and their costs of doing business.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The evolution of the ACA and other regulatory reforms could materially and adversely affect the manner in which U.S. managed care companies conduct business and their results of operations, financial position and cash flows. The ACA includes guaranteed coverage and expanded benefit requirements, eliminates pre-existing condition exclusions and annual and lifetime maximum limits, restricts the extent to which policies can be rescinded, establishes minimum medical loss ratios, creates a federal premium review process, imposes new requirements on the format and content of communications (such as explanations of benefits) between health insurers and their members, grants to members new and additional appeal rights, and imposes new and significant taxes on health insurers and health care benefits.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">New laws or regulations could drive substantial change to the way healthcare products and services are currently delivered and paid for in the United States. Health plans and insurance companies could face meaningful disruption or disintermediation if the U.S. migrates to a single payer healthcare system where the government acts as the sole payer of healthcare services for the entire population. A transformative overhaul of the U.S. healthcare system could impact the financial viability of managed care companies in which the Fund may invest.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Managed care companies contract with physicians, hospitals, pharmaceutical benefit service providers, pharmaceutical manufacturers, and other health care providers for services. Such companies' results of operations and prospects are substantially dependent on their continued ability to contract for these services at competitive prices. Failure to develop and </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 47</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=51,FOLIO='47',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">maintain satisfactory relationships with health care providers, whether in-network or out-of- network, could materially and adversely affect business, results of operations, financial position and cash flows.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Life Science and Tools Industry Risk.</b> Life sciences industries are characterized by limited product focus, rapidly changing technology and extensive government regulation. In particular, technological advances can render an existing product, which may account for a disproportionate share of a company's revenue, obsolete. Obtaining governmental approval from agencies such as the FDA, the U.S. Department of Agriculture and other U.S. and non-U.S. governmental agencies for new products can be lengthy, expensive and uncertain as to outcome. Such delays in product development may result in the need to seek additional capital, potentially diluting the interests of existing investors such as the Fund. In addition, governmental agencies may, for a variety of reasons, restrict the release of certain innovative technologies of commercial significance, such as genetically altered material. These various factors may result in abrupt advances and declines in the securities prices of particular companies and, in some cases, may have a broad effect on the prices of securities of companies in particular life sciences industries.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Intense competition exists within and among certain life sciences industries, including competition to obtain and sustain proprietary technology protection. Life sciences companies can be highly dependent on the strength of patents, trademarks and other intellectual property rights for maintenance of profit margins and market share. The complex nature of the technologies involved can lead to patent disputes, including litigation that could result in a company losing an exclusive right to a patent. Competitors of life sciences companies may have substantially greater financial resources, more extensive development, manufacturing, marketing and service capabilities, and a larger number of qualified managerial and technical personnel. Such competitors may succeed in developing technologies and products that are more effective or less costly than any that may be developed by life sciences companies in which the Fund invests and may also prove to be more successful in production and marketing. Competition may increase further as a result of potential advances in health services and medical technology and greater availability of capital for investment in these fields.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">With respect to healthcare, cost containment measures already implemented by the federal government, state governments and the private sector have adversely affected certain sectors of these industries. Increased emphasis on managed care in the United States may put pressure on the price and usage of products sold by life sciences companies in which the Fund may invest and may adversely affect the sales and revenues of life sciences companies.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Product development efforts by life sciences companies may not result in commercial products for many reasons, including, but not limited to, failure to achieve acceptable clinical trial results, limited effectiveness in treating the specified condition or illness, harmful side </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">48 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=52,FOLIO='48',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">effects, failure to obtain regulatory approval, and high manufacturing costs. Even after a product is commercially released, governmental agencies may require additional clinical trials or change the labeling requirements for products if additional product side effects are identified, which could have a material adverse effect on the market price of the securities of those life sciences companies.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Certain life sciences companies in which the Fund may invest may be exposed to potential product liability risks that are inherent in the testing, manufacturing, marketing and sale of pharmaceuticals, medical devices or other products. There can be no assurance that a product liability claim would not have a material adverse effect on the business, financial condition or securities prices of a company in which the Fund has invested.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Healthcare Technology Sector Risk.</b> Companies in the healthcare technology sector may incur substantial costs related to product-related liabilities. Many of the software solutions, health care devices or services developed by such companies are intended for use in collecting, storing and displaying clinical and health care-related information used in the diagnosis and treatment of patients and in related health care settings such as admissions, billing, etc. The limitations of liability set forth in the companies' contracts may not be enforceable or may not otherwise protect these companies from liability for damages. Healthcare technology companies may also be subject to claims that are not covered by contract, such as a claim directly by a patient. Although such companies may maintain liability insurance coverage, there can be no assurance that such coverage will cover any particular claim that has been brought or that may be brought in the future, that such coverage will prove to be adequate or that such coverage will continue to remain available on acceptable terms, if at all.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Healthcare technology companies may experience interruption at their data centers or client support facilities. The business of such companies often relies on the secure electronic transmission, data center storage and hosting of sensitive information, including protected health information, financial information and other sensitive information relating to clients, company and workforce. In addition, such companies may perform data center and/or hosting services for certain clients, including the storage of critical patient and administrative data and support services through various client support facilities. If any of these systems are interrupted, damaged or breached by an unforeseen event or actions of a third party, including a cyber-attack, or fail for any extended period of time, it could have a material adverse impact on the results of operations for such companies.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The proprietary technology developed by healthcare technology companies may be subject to claims for infringement or misappropriation of intellectual property rights of others, or may be infringed or misappropriated by others. Despite protective measures and intellectual property rights, such companies may not be able to adequately protect against theft, copying, reverse-engineering, misappropriation, infringement or unauthorized use or disclosure of </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 49</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=53,FOLIO='49',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">their intellectual property, which could have an adverse effect on their competitive position. In addition, these companies are routinely involved in intellectual property infringement or misappropriation claims and it is expected that this activity will continue or even increase as the number of competitors, patents and patent enforcement organizations in the healthcare technology market increases, the functionality of software solutions and services expands, the use of open-source software increases and new markets such as health care device innovation, health care transactions, revenue cycle, population health management and life sciences are entered into. These claims, even if not meritorious, are expensive to defend and are often incapable of prompt resolution.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The success of healthcare technology companies depends upon the recruitment and retention of key personnel. To remain competitive, such companies must attract, motivate and retain highly skilled managerial, sales, marketing, consulting and technical personnel, including executives, consultants, programmers and systems architects skilled in healthcare technology, health care devices, health care transactions, population health management, revenue cycle and life sciences industries and the technical environments in which solutions, devices and services are needed. Competition for such personnel in the healthcare technology sector is intense in both the United States and abroad. The failure to attract additional qualified personnel could have a material adverse effect on healthcare technology companies' prospects for long-term growth.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Healthcare Services Sector Risk.</b> The operations of healthcare services companies are subject to extensive federal, state and local government regulations, including Medicare and Medicaid payment rules and regulations, federal and state anti-kickback laws, the physician self-referral law ("Stark Law") and analogous state self-referral prohibition statutes, Federal Acquisition Regulations, the False Claims Act and federal and state laws regarding the collection, use and disclosure of patient health information and the storage, handling and administration of pharmaceuticals. The Medicare and Medicaid reimbursement rules related to claims submission, enrollment and licensing requirements, cost reporting, and payment processes impose complex and extensive requirements upon dialysis providers as well. A violation or departure from any of these legal requirements may result in government audits, lower reimbursements, significant fines and penalties, the potential loss of certification, recoupment efforts or voluntary repayments. If healthcare services companies fail to adhere to all of the complex government regulations that apply to their businesses, such companies could suffer severe consequences that would substantially reduce revenues, earnings, cash flows and stock prices.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">A substantial percentage of a healthcare services company's service revenues may be generated from patients who have state Medicaid or other non-Medicare government-based programs, such as coverage through the Department of Veterans Affairs ("VA"), as their primary coverage. As state governments and other governmental organizations face </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">50 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=54,FOLIO='50',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">increasing budgetary pressure, healthcare services companies may in turn face reductions in payment rates, delays in the receipt of payments, limitations on enrollee eligibility or other changes to the applicable programs.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Adverse economic conditions could adversely affect the business and profitability of healthcare services companies. Among other things, the potential decline in federal, non-U.S. government and state revenues that may result from such conditions may create additional pressures to contain or reduce reimbursements for services from Medicare, Medicaid and other government sponsored programs. Increasing job losses or slow improvement in the unemployment rate in the United States and elsewhere as a result of adverse or recent economic conditions may result in a smaller percentage of patients being covered by an employer group health plan and a larger percentage being covered by lower paying Medicare and Medicaid programs. Employers may also select more restrictive commercial plans with lower reimbursement rates. To the extent that payors are negatively impacted by a decline in the economy, healthcare services companies may experience further pressure on commercial rates, a further slowdown in collections and a reduction in the amounts they expect to collect. In addition, uncertainty in the financial markets could adversely affect the variable interest rates payable under credit facilities or could make it more difficult to obtain or renew such facilities or to obtain other forms of financing in the future, if at all. Any or all of these factors, as well as other consequences of the adverse economic conditions which cannot currently be anticipated, could have a material adverse effect on a healthcare services company's revenues, earnings and cash flows and otherwise adversely affect its financial condition.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Healthcare Supplies Sector Risk.</b> If healthcare supplies companies are unable to successfully expand their product lines through internal research and development and acquisitions, their business may be materially and adversely affected. In addition, if these companies are unable to successfully grow their businesses through marketing partnerships and acquisitions, their business may be materially and adversely affected.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Consolidation of healthcare providers has increased demand for price concessions and caused the exclusion of suppliers from significant market segments. It is expected that market demand, government regulation, third-party reimbursement policies, government contracting requirements and societal pressures will continue to change the worldwide healthcare industry, resulting in further business consolidations and alliances among customers and competitors. This may exert further downward pressure on the prices of healthcare supplies companies' products and adversely impact their businesses, financial conditions or results of operations.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Quality is extremely important to healthcare supplies companies and their customers due to the serious and costly consequences of product failure. Quality certifications are critical to the marketing success of their products and services. If a healthcare supplies company fails to </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 51</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=55,FOLIO='51',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">meet these standards or fails to adapt to evolving standards, its reputation could be damaged, it could lose customers, and its revenue and results of operations could decline.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Healthcare Facilities Sector Risk.</b> A healthcare facility's ability to negotiate favorable contracts with HMOs, insurers offering preferred provider arrangements and other managed care plans significantly affects the revenues and operating results of such healthcare facilities. In addition, private payers are increasingly attempting to control health care costs through direct contracting with hospitals to provide services on a discounted basis, increased utilization reviews and greater enrollment in managed care programs, such as HMOs and Preferred Provider Organizations ("PPOs"). The trend toward consolidation among private managed care payers tends to increase their bargaining power over prices and fee structures. As various provisions of the ACA evolve, it is not clear what impact, if any, the increased obligations on private payers imposed by the health care reform law will have on a healthcare facility's ability to negotiate reimbursement increases. Non-government payers may increasingly demand reduced fees. If a healthcare facility is unable to enter into and maintain managed care contractual arrangements on acceptable terms, if it experiences material reductions in the contracted rates received from managed care payers, or if it has difficulty collecting from managed care payers, its results of operations could be adversely affected.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Further changes in the Medicare and Medicaid programs or other government health care programs could have an adverse effect on a healthcare facility's business. In addition to the changes affected by the ACA, the Medicare and Medicaid programs are subject to other statutory and regulatory changes, administrative rulings, interpretations and determinations concerning patient eligibility requirements, funding levels and the method of calculating payments or reimbursements, among other things, requirements for utilization review, and federal and state funding restrictions. All of these could materially increase or decrease payments from government programs in the future, as well as affect the cost of providing services to patients and the timing of payments to facilities, which could in turn adversely affect a healthcare facility's overall business, financial condition, results of operations or cash flows.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Healthcare facilities are adversely affected by uninsured and underinsured patients, as well as a growing mix of Medicare and Medicaid patients that typically have lower reimbursement rates than commercial managed care patients As a result, healthcare facilities continue to experience a shift in payer mix and a high level of uncollectible accounts, which could worsen if there is an increase in unemployment. Healthcare facilities may continue to experience significant levels of bad debt expense and may have to provide uninsured discounts and charity care for undocumented immigrants who are not permitted to enroll in a health insurance exchange or government health care program. The trend of higher co-pays and deductibles and a focus on migrating healthcare utilization to lower cost sites of care, may </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">52 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=56,FOLIO='52',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">also pressure volumes and revenue at certain healthcare facilities which could adversely impact the financial condition of hospitals and facilities with high fixed cost structures.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Healthcare Equipment Sector Risk.</b> The medical device markets are highly competitive and a healthcare equipment company many be unable to compete effectively. These markets are characterized by rapid change resulting from technological advances and scientific discoveries.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Development by other companies of new or improved products, processes, or technologies may make a healthcare equipment company's products or proposed products less competitive. In addition, these companies face competition from providers of alternative medical therapies such as pharmaceutical companies.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Medical devices and related business activities are subject to rigorous regulation, including by the FDA, U.S. Department of Justice ("DOJ"), and numerous other federal, state, and foreign governmental authorities. These authorities and members of Congress have been increasing their scrutiny of the healthcare equipment industry. In addition, certain states have passed or are considering legislation restricting healthcare equipment companies' interactions with health care providers and requiring disclosure of certain payments to them. It is anticipated that governmental authorities will continue to scrutinize this industry closely, and that additional regulation may increase compliance and legal costs, exposure to litigation, and other adverse effects to operations.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Healthcare equipment companies are substantially dependent on patent and other proprietary rights and failing to protect such rights or to be successful in litigation related to such rights may result in the payment of significant monetary damages and/or royalty payments, may negatively impact the ability of healthcare equipment companies to sell current or future products, or may prohibit such companies from enforcing their patent and other proprietary rights against others.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Quality problems with the processes, goods and services of a healthcare equipment company could harm the company's reputation for producing high-quality products and erode its competitive advantage, sales and market share. Quality is extremely important to healthcare equipment companies and their customers due to the serious and costly consequences of product failure. Quality certifications are critical to the marketing success of goods and services. If a healthcare equipment company fails to meet these standards, its reputation could be damaged, it could lose customers, and its revenue and results of operations could decline.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Healthcare Distributors Sector Risk.</b> Companies in the healthcare distribution sector operate in markets that are highly competitive. Because of competition, many of these companies face pricing pressures from customers and suppliers. If these companies are </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 53</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=57,FOLIO='53',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">unable to offset margin reductions caused by pricing pressures through steps such as effective sourcing and enhanced cost control measures, the financial condition of such companies could be adversely affected. In addition, the healthcare industry has continued to consolidate. Further consolidation among customers and suppliers (including branded pharmaceutical manufacturers) could give the resulting enterprises greater bargaining power, which may adversely impact the financial condition of companies in the healthcare distribution sector.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Fewer generic pharmaceutical launches or launches that are less profitable than those previously experienced may have an adverse effect on the profits of companies in the healthcare distribution sector. Additionally, prices for existing generic pharmaceuticals generally decline over time, although this may vary. Price deflation on existing generic pharmaceuticals may have an adverse effect on company profits. With respect to branded pharmaceutical price appreciation, if branded manufacturers increase prices less frequently or by amounts that are smaller than have been experienced historically, healthcare distribution companies may profit less from branded pharmaceutical agreements.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The healthcare industry is highly regulated, and healthcare distribution companies are subject to regulation in the United States at both the federal and state level and in foreign countries. If healthcare distribution companies fail to comply with these regulatory requirements, the financial condition of such companies could be adversely affected.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Due to the nature of the business of healthcare distribution companies, such companies may from time to time become involved in disputes or legal proceedings. For example, some of the products that these companies distribute may be alleged to cause personal injury or violate the intellectual property rights of another party, subjecting such companies to product liability or infringement claims. Litigation is inherently unpredictable, and the unfavorable resolution of one or more of these legal proceedings could adversely affect the cash flows and balance sheets of healthcare distribution companies. Pharmaceutical distributors currently face lawsuits related to the abuse of opioid medications in the United States. The allegations include that pharmaceutical distributors failed to provide effective controls around the quantities of opioid medications distributed to certain pharmacies, failed to properly prevent the diversion of medications and failed to report suspicious orders. Pharmaceutical distributors are in discussions with federal, state and local jurisdictions related to their role in the distribution of opioid pharmaceuticals and it is possible that they will be required to pay multi-billion dollar settlements related to the ongoing litigation.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Healthcare distribution companies depend on the availability of various components, compounds, raw materials and energy supplied by others for their operations. Any of these supplier relationships could be interrupted due to events beyond the control of such companies, including pandemics, epidemics or natural disasters, or could be terminated. A sustained supply interruption could have an adverse effect on business.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">54 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=58,FOLIO='54',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Risks Associated with Regulatory and Policy Changes.</b> At any time after the date hereof, U.S. and non-U.S. governmental agencies and other regulators may implement additional regulations and legislators may pass new laws that affect the investments held by the Fund, the strategies used by the Fund or the level of regulation or taxation applying to the Fund. These regulations and laws impact the investment strategies, performance, costs and operations of the Fund, as well as the way investments in, and shareholders of, the Fund are taxed. In particular, changes to U.S. healthcare policy could affect the Fund and its investments. The affordability of healthcare in the U.S. will remain a topic of debate, and proposals, laws and regulations to reduce the costs of healthcare products and services could adversely impact healthcare companies that the Fund invests in.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Investment in Emerging Growth Companies.</b> The Fund may invest in equity securities of emerging growth healthcare companies. While these securities offer the opportunity for significant capital gains, such investments also involve a degree of risk that can result in substantial losses. There can be no assurance that securities of start-up or emerging growth companies will, in the future, yield returns commensurate with their associated risks.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Liquidity of Portfolio Investments.</b> The Fund may invest in securities that are traded in the over-the-counter markets or on regional stock exchanges where the low trading volume of a particular security may result in abrupt and erratic price movements or that are not traded in any market. An investment in such securities may have limited liquidity, and the Fund may find it necessary to sell at a discount from recent prices or to sell over extended periods of time when disposing of such securities. In addition, the Fund may invest up to 40% of its net assets in Restricted Securities, which by their terms are illiquid. In many cases, Restricted Securities in which the Fund may invest cannot be sold except in a public offering registered under the Securities Act of 1933, as amended, pursuant to an exemption from the Securities Act or in compliance with applicable Securities and Exchange Commission regulations.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Venture Capital Investments Risk.</b> The Fund may occasionally invest in venture capital opportunities. While these securities offer the opportunity for significant capital gains, such investments also involve a degree of risk that can result in substantial losses. Some of the venture capital opportunities in which the Fund may invest are expected to be companies that are in a "start-up" stage of development, have little or no operating history, operate at a loss or with substantial variations in operating results from period to period, have limited products, markets, financial resources or management depth, or have the need for substantial additional "follow-on" capital to support expansion or to achieve or maintain a competitive position. Such additional investments may dilute the interests of prior investors, such as the Fund. Some of these companies may be emerging companies at the research and development stage with no marketable or approved products or technology. There can be no assurance that securities of start-up or emerging growth companies will, in the future, yield returns commensurate with their associated risks.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 55</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=59,FOLIO='55',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">These investments, which are considered Restricted Securities, will be made primarily in convertible preferred stock. The Fund may also purchase non-convertible debt securities in connection with its venture capital investments, and otherwise when the Investment Adviser believes that such investments would be consistent with the Fund's investment objective. While these debt investments typically will not be rated, the Investment Adviser believes that, in light of the risk characteristics associated with investments in emerging growth companies, if such investments were to be compared with investments rated by S&amp;P or Moody's, they may be rated as low as "C" in the rating categories established by S&amp;P and Moody's. Such securities are commonly referred to as "junk bonds" and are considered, on balance, as predominantly speculative.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Restricted Securities and Valuation Risk.</b> Some of the Fund's investments are subject to restrictions on resale and generally have no established trading market or are otherwise illiquid with little or no trading activity. The valuation process requires an analysis of various factors. The Fund's fair value methodology includes the examination of, among other things, (i) the existence of any contractual restrictions on the disposition of the securities; (ii) information obtained from the issuer which may include an analysis of the company's financial statements, the company's products or intended markets, or the company's technologies; and (iii) the price of a security sold at arm's length in an issuer's subsequent completed round of financing. As there is typically no readily available market value for some of the Restricted Securities in the Fund's portfolio, such Restricted Securities in the Fund's portfolio are valued at fair value as determined in good faith by or under the direction of the Board pursuant to the Fund's valuation policy and a consistently applied valuation process. Because of the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Fund's investments determined in good faith by the Board may differ significantly from the values that would have been used had a ready market existed for the investments, and the differences could be material. There is no single standard for determining fair value in good faith.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment, while employing a consistently applied valuation process for the types of investments the Fund makes.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Foreign Securities Risk.</b> The Fund may invest up to 20% of its net assets in Foreign Securities. Foreign Securities involve special risks that are not typically associated with U.S. dollar denominated or quoted securities of U.S. issuers. Foreign Securities may be affected by changes in currency rates, changes in foreign or U.S. laws or restrictions applicable to such investments and changes in exchange control regulations (e.g., currency blockage). A decline in the exchange rate of the currency (i.e., weakening of the currency against the U.S. dollar) in which a portfolio security is quoted or denominated relative to the U.S. dollar would reduce the value of the portfolio security. In addition, if the currency in which the Fund </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">56 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=60,FOLIO='56',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">receives dividends, interest or other payments declines in value against the U.S. dollar before such income is distributed as dividends to Shareholders or converted to U.S. dollars, the Fund may have to sell portfolio securities to obtain sufficient cash to pay such dividends.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Brokerage commissions, custodial services and other costs relating to investment in international securities markets generally are more expensive than in the United States. In addition, clearance and settlement procedures may be different in foreign countries and, in certain markets, such procedures have been unable to keep pace with the volume of securities transactions, thus making it difficult to conduct such transactions.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Foreign issuers are not generally subject to uniform accounting, auditing and financial reporting standards comparable to those applicable to U.S. issuers. There may be less publicly available information about a foreign issuer than about a U.S. issuer. In addition, there is generally less government regulation of foreign markets, companies and securities dealers than in the United States, and the legal remedies for investors may be more limited than the remedies available in the United States. Foreign securities markets may have substantially less volume than U.S. securities markets and securities of many foreign issuers are less liquid and more volatile than securities of comparable domestic issuers. Furthermore, with respect to certain foreign countries, there is a possibility of nationalization, expropriation or confiscatory taxation, imposition of withholding or other taxes on dividend or interest payments (or, in some cases, capital gains distributions), limitations on the removal of funds or other assets from such countries, and risks of political or social instability or diplomatic developments which could adversely affect investments in those countries. Adverse diplomatic developments may include the imposition of economic or trade sanctions or other measures by the U.S. or other governments and supranational organizations or changes in trade policies. These developments may, among other things, limit the ability of the Fund to invest in certain securities or require the disposition of an investment.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Key Personnel Risk.</b> There may be only a limited number of securities professionals who have comparable experience to that of the Fund's existing portfolio management team in the area of healthcare companies. If one or more of the team members dies, resigns, retires or is otherwise unable to act on behalf of the Investment Adviser, there can be no assurance that a suitable replacement could be found immediately.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Concentration of Investments.</b> The Fund may from time to time concentrate its investments in a few issuers and take large positions in those issuers. As a result, the Fund may be subject to a greater risk of loss than an investment company that diversifies its investments more broadly. Taking larger positions is also likely to increase the volatility of the Fund's NAV reflecting fluctuation in the value of its large holdings. The Fund may make investments in any company with the objective of controlling or influencing the management and policies of that company. Investing for the purpose of controlling or influencing the management and policies of a company could potentially make the Fund less diversified and </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 57</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=61,FOLIO='57',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">more susceptible to declines in the value of the company's stock. The Investment Adviser may seek a control position in private venture capital investments where the Investment Adviser believes its knowledge and experience will be of significant benefit to the invested company and, therefore, to the Fund's investment. The Investment Adviser expects to seek control in public companies only occasionally and most often in companies with a small capitalization.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Anti-Takeover Provisions Risk.</b> The Fund's Amended and Restated Declaration of Trust ("Declaration of Trust"), dated April 21, 1987, as amended, has provisions that could have the effect of limiting the ability of other entities or persons to (1) acquire control of the Fund, (2) cause it to engage in certain transactions, or (3) modify its structure. The By-Laws also contain provisions regarding qualifications for nominees for Trustee positions, advance notice of shareholder proposals, and requirements for the call of special shareholder meetings. These provisions may be considered "anti-takeover" provisions.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Related Party Transactions Risk.</b> The majority of the Board is unaffiliated with the Investment Adviser; nevertheless, the Fund may be subject to certain potential conflicts of interest. Although the Fund has no obligation to do so, it may place brokerage orders with brokers who provide supplemental investment research and market and statistical information about healthcare companies and the healthcare industries. In addition, other investment companies advised by the Investment Adviser may concurrently invest with the Fund in Restricted Securities under certain conditions. The Fund also may invest, subject to applicable law, in companies in which the principals of the Investment Adviser or Trustees of the Fund have invested, or for which they serve as directors or executive officers.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Investment Company Act prohibits the Fund from engaging in certain transactions involving its "affiliates," including, among others, the Fund's Trustees, officers and employees, the Investment Adviser and any "affiliates" of such affiliates except pursuant to an exemptive order or the provisions of certain rules under the Investment Company Act. In the view of the staff of the Commission, other investment companies advised by the Investment Adviser may, in some instances, be viewed to be affiliates of the Fund. Such legal restrictions and delays and costs involved in obtaining necessary regulatory approvals may preclude or discourage the Fund from making certain investments and no assurance can be given that any exemptive order sought by the Fund will be granted.</font></p>
<p style="margin:8pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">The Investment Adviser's investment team is responsible for managing the Fund as well as three other closed-end investment companies. In the future, the investment team may manage other funds and accounts, including proprietary accounts, separate accounts and other pooled investment vehicles, such as unregistered hedge funds. In the future, a portfolio manager may manage a separate account or other pooled investment vehicle which may have materially higher fee arrangements than the Fund and may also have a performance-based fee. The side-by-side management of these funds or accounts may raise potential conflicts of interest relating to cross trading, the allocation of investment opportunities and the aggregation and allocation of trades.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">58 abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=62,FOLIO='58',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Special Purpose Acquisition Company Risk.</b> The Fund may invest in SPACs. SPACs are collective investment structures that pool funds in order to seek potential acquisition opportunities. Unless and until an acquisition is completed, a SPAC generally invests its assets (less an amount to cover expenses) in U.S. Government securities, money market fund securities and cash. SPACs and similar entities may be blank check companies with no operating history or ongoing business other than to seek a potential acquisition. Certain SPACs may seek acquisitions only in limited industries or regions. If an acquisition that meets the requirements for the SPAC is not completed within a predetermined period of time, the invested funds are returned to the entity's shareholders, unless such shareholders approve alternative arrangements. Investments in SPACs may be illiquid and/or be subject to restrictions on resale.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt">
</div>
<p style="text-align: center;"><font style="font-size: 13px; font-family: Times New Roman PS, Times New Roman, Times;">abrdn HEALTHCARE INVESTORS  |  ANNUAL REPORT 59</font></p>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=63,FOLIO='59',FILE='23-25130-2.ga.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div style="page-break-before:always"></div>

<!-- Document name: 23-25130-2.za-->
<div style="margin:8pt 0pt 8pt 0pt">
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:19pt; font-family: Arial, Helvetica;">abrdn Healthcare Investors</font></p>
<p style="margin:7pt 0pt 6pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">New York Stock Exchange Symbol: HQH<br>NAV Symbol: XHQHX</font></p>
<p style="margin:7pt 0pt 6pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">1900 Market Street, Suite 200<br>Philadelphia, PA 19103<br>1-800-522-5465<br>www.abrdnhqh.com</font></p>
<p style="margin:5pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Trustees</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Jeffrey Bailey<br>Stephen Bird<br>Rose DiMartino<br>Kathleen Goetz<br>C. William Maher<br>Todd Reit, Chair</font></p>
<p style="margin:5pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Investment Adviser</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">abrdn Inc.</font></p>
<p style="margin:5pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Administrator &amp; Custodian</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">State Street Bank and Trust Company</font></p>
<p style="margin:5pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Transfer Agent</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Computershare, Inc.</font></p>
<p style="margin:5pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Independent Registered Public Accounting Firm</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">KPMG LLP</font></p>
<p style="margin:5pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;"><b>Legal Counsel</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Dechert LLP</font></p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Shareholders with questions regarding share transfers may call</font></p>
<p style="margin:0pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:14pt; font-family: Arial, Helvetica;"><b>1-800-426-5523</b></font></p>
<p style="margin:6pt 0pt 0pt 0pt; text-align: left;"><font style="font-size:10pt; font-family: Arial, Helvetica;">Daily net asset value may be obtained from<br>our website (</font><font style="font-size:10pt; font-family: Times New Roman, Times, serif;"><i>www.abrdnhqh.com</i></font><font style="font-size:10pt; font-family: Arial, Helvetica;">)</font></p>
</div>
<hr style="height: 1px; width: 100%; border: 1px solid gray; background-color: gray; text-align: center;">
<!-- SEQ.=64,FOLIO='',FILE='23-25130-2.za.qxp',USER='',CD='Nov 30 03:38 2023' -->
<div></div>

<div style="font: 10pt Times New Roman, Times, Serif"><div style="Page-Break-Before: Always"></div><!-- BannerFile="tm2325130d1_item2-13.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2325130-1/tm2325130-1_ncsrseq1" -->
<p style="margin: 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 2. CODE OF ETHICS.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(a)</font></td><td>As of the end of the period covered by this report, the Registrant has adopted a code of ethics that applies to the Registrant&#x2019;s
principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions,
regardless of whether these individuals are employed by the Registrant or a third party.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(b)</font></td><td>No disclosures are required by this Item.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(c)</font></td><td>During the period covered by this report, the Registrant did not make any substantive amendment to the code of ethics.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(d)</font></td><td>During the period covered by this report, the Registrant did not grant any waiver, including any implicit waiver, from any provision
of the code of ethics.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(e)</font></td><td>Not applicable.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(f)</font></td><td>A copy of the Registrant&#x2019;s Code will be made available, free of charge, upon request, by writing or calling abrdn Inc., 1900
Market Street, Suite&#xa0;200, Philadelphia, PA, 19103, 1-800-522-5465.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 3. AUDIT COMMITTEE FINANCIAL EXPERT.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Registrant&#x2019;s Board of Trustees has determined that the Registrant
has at least one audit committee financial expert serving on its audit committee. As of the period ended September&#xa0;30, 2023 the audit
committee financial expert was Thomas M. Kent. As of October&#xa0;27, 2023, the audit committee financial expert is C. William Maher.
The financial expert is &#x201c;independent&#x201d; for the purposes of Item 3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 4. PRINCIPAL ACCOUNTANT FEES AND SERVICES.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(a)</font></td><td>Audit Fees. The aggregate fees billed for each of the last two fiscal years for professional services rendered by the principal accountant
for the audit of the Registrant&#x2019;s annual financial statements or services that are normally provided by the accountant in connection
with statutory and regulatory filings or engagements for those fiscal years were $118,500 for the fiscal year ended September&#xa0;30,
2023 and $114,230 for the fiscal year ended September&#xa0;30, 2022.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(b)</font></td><td>Audit Related Fees. The Registrant was not billed any fees in each of the last two fiscal years ended September&#xa0;30 for assurance
and related services by the principal accountant that are reasonably related to the performance of the audit of the Registrant&#x2019;s
financial statements and not otherwise included above.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(c)</font></td><td>Tax Fees. The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant
for tax compliance, tax advice, and tax planning were $0 for the fiscal year ended September&#xa0;30, 2023 and $6,670 for the fiscal
year ended September&#xa0;30, 2022. The nature of the services comprising the fees disclosed under this category was tax compliance.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(d)</font></td><td>All Other Fees. The Registrant was not billed any fees in each of the last two fiscal years ended September&#xa0;30 for products and
services provided by the principal accountant, other than the services reported in paragraphs (a)&#xa0;through (c)&#xa0;of this Item.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(e)</font></td><td>(1)&#xa0;Pre-approval Policies and Procedures.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">Pursuant to the Registrant&#x2019;s Audit Committee Charter
(&#x201c;Charter&#x201d;), the Audit Committee is responsible for approving in advance the firm to be employed as the Registrant&#x2019;s
independent auditor. In addition, the Charter provides that the Audit Committee is responsible for approving any and all proposals by
the Registrant, its investment adviser or their affiliated persons or any entity controlling, controlled by, or under common control with
the adviser that provides services to the Registrant to employ the independent auditor to render permissible non-audit services related
directly to the operations and financial reporting of the Registrant. In determining whether to pre-approve non-audit services, the Audit
Committee considers whether such services are consistent with the independent auditor&#x2019;s independence. The Charter further permits
the Audit Committee to delegate to one or more of its members authority to pre-approve permissible non-audit services to the registrant,
provided that any pre-approval determination of a delegate is for services with an estimated budget of less than $15,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">(2)&#xa0;None of the services described in each of paragraphs
(b)&#xa0;through (d)&#xa0;of this Item were approved by the Audit Committee pursuant to paragraph (c)(7)(i)(C)&#xa0;of Rule&#xa0;2-01
of Regulation S-X.All services described in paragraphs (b)&#xa0;through (d)&#xa0;of the NCSR were approved in advance by the Audit Committee
of each Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(f)</font></td><td>Not applicable.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(g)</font></td><td>None.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(h)</font></td><td>Not applicable.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(i)</font></td><td>Not applicable.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif">(j)</font></td><td>Not applicable.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 5. AUDIT COMMITTEE OF LISTED REGISTRANTS.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Registrant has a separately-designated standing Audit
Committee established in accordance with Section&#xa0;3(a)(58)(A)&#xa0;of the Securities Exchange Act (15 U.S.C. 78c(a)(58)(A)). As
of the period ended, September&#xa0;30, 2023, the members of the Audit Committee are Kathleen Goetz, Thomas Kent and W. Mark Watson.
As of October&#xa0;27, 2023, the members of the Audit Committee are Jeffrey Bailey, Rose DiMartino, Kathleen Goetz, C. William Maher
and Todd Reit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 6. INVESTMENTS.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Registrant&#x2019;s Schedule of Investments is included as part
of the Report to Shareholders filed under Item 1 of this form.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 7. DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END
MANAGEMENT INVESTMENT COMPANIES.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Registrant has adopted the following proxy voting policies and
procedures through the period ended September&#xa0;30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROXY VOTING POLICIES AND PROCEDURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><b><font style="text-decoration:underline">Polic</font></b></font><b>y</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following are the policies and procedures adopted and implemented
by Tekla Capital Management LLC (&#x201c;TCM&#x201d;) (the predecessor Adviser) for voting proxies with respect to portfolio securities
held by abrdn Healthcare Investors (formerly Tekla Healthcare Investors), abrdn Life Sciences Investors (formerly Tekla Life Sciences
Investors), abrdn Healthcare Opportunities Fund (formerly Tekla Healthcare Opportunities Fund) and abrdn World Healthcare Fund (formerly
Tekla World Healthcare Fund) (each a &#x201c;Fund&#x201d; and collectively the &#x201c;Funds&#x201d;) as of the period ended September&#xa0;30,
2023. The policies and procedures are reasonably designed to ensure that proxies are voted in the best interest of the Funds and the Funds&#x2019;
shareholders, in accordance with TCM&#x2019;s fiduciary duties and Rule&#xa0;206(4)-6 under the Investment Advisers Act of 1940 (the &#x201c;Investment
Advisers Act&#x201d;). TCM considers the &#x201c;best interests&#x201d; of the Funds and their shareholders to mean their best long-term
economic interests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TCM shall vote proxies for the exclusive benefit, and in the best economic
interest, of the Funds and their shareholders. Such exercise of voting rights shall be subject to the same standard of care as is generally
applicable to TCM&#x2019;s performance of its duties, as set forth in the advisory agreements with the Funds. The policies and procedures
contained herein are designed to be guidelines, however each vote is ultimately cast on a case-by-case basis, taking into consideration
the relevant facts and circumstances at the time of the vote. Any material conflicts that may arise will be resolved in the best interests
of the Funds and their shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A proxy committee has been designated and is responsible for administering
and overseeing the proxy voting process. The committee consists of the President of TCM, TCM&#x2019;s Chief Compliance Officer (&#x201c;CCO&#x201d;),
and the analyst responsible for oversight of the company that is the subject of the proxy. The committee considers proxy questions and
determines the vote on behalf of the Funds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><b><font style="text-decoration:underline">Procedures</font></b></font><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#xa0;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Logistics</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TCM&#x2019;s CCO shall be responsible for maintaining the proxy log,
monitoring corporate actions and confirming the timely voting of proxies. The proxy log shall contain the following information, in accordance
with Form&#xa0;N-PX:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">&#x25cf;</font></td><td>the name of the issuer;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">&#x25cf;</font></td><td>the exchange ticker symbol, if available;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">&#x25cf;</font></td><td>the CUSIP number, if available;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">&#x25cf;</font></td><td>the shareholder meeting date;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">&#x25cf;</font></td><td>a brief identification of the matter voted on;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">&#x25cf;</font></td><td>whether the matter was proposed by the issuer or a security holder;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">&#x25cf;</font></td><td>whether TCM cast its vote on the matter;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">&#x25cf;</font></td><td>how TCM cast its vote on the matter (for, against, abstain; for or withhold regarding the election of directors); and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">&#x25cf;</font></td><td>whether TCM cast its vote for or against management;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TCM&#x2019;s CCO shall also record whether any conflicts of interest
have been identified and, if so, what action was taken to resolve the conflict with respect to each vote cast and each abstention.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Substantive Voting Decisions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TCM&#x2019;s substantive voting decisions turn on the particular facts
and circumstances of each proxy vote. The following is a list of common proxy vote issues and TCM&#x2019;s standard considerations when
determining how to vote such proxies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Routine
Matters/Corporate Administrative Items</i></font>. After an initial review, TCM generally votes with management on routine matters related
to the operation of the issuer that are not expected to have a significant economic impact on the issuer and/or its shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Potential
for Major Economic Impact</i></font>. TCM may review and analyze on a case-by-case basis, non-routine proposals that are more likely to
affect the structure and operation of the issuer and to have a greater impact on the value of the investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Corporate
Governance</i></font>. TCM may review and consider corporate governance issues related to proxy matters and generally supports proposals
that foster good corporate governance practices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Special
Interest Issues</i></font>. TCM may consider: (i)&#xa0;the long-term benefit to shareholders of promoting corporate accountability and
responsibility on social issues; (ii)&#xa0;management&#x2019;s responsibility with respect to special interest issues; (iii)&#xa0;any economic
costs and restrictions on management; and (iv)&#xa0;the responsibility of TCM to vote proxies for the greatest long-term shareholder value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Limitations
on Director Tenure and Retirement</i></font>. TCM may consider: (i)&#xa0;a reasonable retirement age for directors, <i>e.g. </i>70 or
72; (ii)&#xa0;the introduction of new perspectives on the board; and (iii)&#xa0;the arbitrary nature of such limitations and the possibility
of detracting from the board&#x2019;s stability and continuity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Directors&#x2019;
Minimum Stock Ownership </i></font>. TCM may consider: (i)&#xa0;the benefits of additional vested interest; (ii)&#xa0;the ability of a
director to serve a company well regardless of the extent of his or her share ownership; and (iii)&#xa0;the impact of limiting the number
of persons qualified to be directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>D&amp;O
Indemnification and Liability Protection</i></font>. TCM may consider: (i)&#xa0;indemnifying directors for acts conducted in the
normal course of business; (ii)&#xa0;limiting liability for monetary damages for violating the duty of care; (iii)&#xa0;expanding
coverage beyond legal expenses to acts that represent more serious violations of fiduciary obligation than carelessness (<i>e.g. </i>negligence);
and (iv)&#xa0;providing expanded coverage in cases when a director&#x2019;s legal defense was unsuccessful if the director was found
to have acted in good faith and in a manner that he or she reasonably believed was in the best interests of the issuer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Director
Nominations in Contested Elections</i></font>. TCM may consider: (i)&#xa0;long-term financial performance of the issuer relative to its
industry; (ii)&#xa0;management&#x2019;s track record; (iii)&#xa0;background to proxy contest; (iv)&#xa0;qualifications of both slates of
nominees; (v)&#xa0;evaluations of what each side is offering shareholders as well as the likelihood that the proposed objectives and goals
can be met; and (vi)&#xa0;stock ownership positions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Cumulative
Voting</i></font>. TCM may consider: (i)&#xa0;the ability of significant stockholders to elect a director of their choosing; (ii)&#xa0;the
ability of minority shareholders to concentrate their support in favor of a director or directors of their choosing; and (iii)&#xa0;the
potential to limit the ability of directors to work for all shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Classified
Boards</i></font>. TCM may consider: (i)&#xa0;providing continuity; (ii)&#xa0;promoting long-term planning; and (iii)&#xa0;guarding against
unwanted takeovers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif"><i>Poison
Pills</i></font>. TCM may consider: (i)&#xa0;TCM&#x2019;s position on supporting proposals to require a shareholder vote on other shareholder
rights plans; (ii)&#xa0;ratifying or redeeming a poison pill in the interest of protecting the value of the issuer; and (iii)&#xa0;other
alternatives to prevent a takeover at a price demonstrably below the true value of the issuer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Fair
Price Provisions</i></font>. TCM may consider: (i)&#xa0;the vote required to approve the proposed acquisition; (ii)&#xa0;the vote
required to repeal the fair price provision; (iii)&#xa0;the mechanism for determining fair price; and (iv)&#xa0;whether these
provisions are bundled with other anti-takeover measures (<i>e.g.</i>, supermajority voting requirements) that may entrench
management and discourage attractive tender offers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Equal Access</i></font>.
TCM may consider: (i)&#xa0;the opportunity for significant shareholders of the issuer to evaluate and propose voting recommendations on
proxy proposals and director nominees, and to nominate candidates to the board; and (ii)&#xa0;the added complexity and burden.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Charitable
Contributions</i></font>. TCM may consider: (i)&#xa0;the potential benefits to shareholders; (ii)&#xa0;the potential to detract the issuer&#x2019;s
resources from more direct uses of increasing shareholder value; and (iii)&#xa0;the responsibility of shareholders to make individual
contributions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Stock Authorizations</i></font>:
TCM may consider: (i)&#xa0;the need for the increase; (ii)&#xa0;the percentage increase with respect to the existing authorization; (iii)&#xa0;voting
rights of the stock; and (iv)&#xa0;overall capitalization structures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Preferred
Stock</i></font>. TCM may consider: (i)&#xa0;whether the new class of preferred stock has unspecified voting, conversion, dividend
distribution, and other rights; (ii)&#xa0;whether the issuer expressly states that the stock will not be used as a takeover defense
or carry superior voting rights; (iii)&#xa0;whether the issuer specifies the voting, dividend, conversion, and other rights of such
stock and the terms of the preferred stock appear reasonable; and (iv)&#xa0;whether the stated purpose is to raise capital or make
acquisitions in the normal course of business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Director
Compensation</i></font>. TCM may consider: (i)&#xa0;whether director shares are at the same market risk as those of the shareholders;
and (ii)&#xa0;how option programs for outside directors compare with the standards of internal programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif"><i>Golden
and Tin Parachutes</i></font>. TCM may consider: (i)&#xa0;whether they will be submitted for shareholder approval; and (ii)&#xa0;the employees
covered by the plan and the quality of management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif"><i>Compensation.
</i></font>TCM may consider: (i)&#xa0;Whether the company has an independent compensation committee; (ii)&#xa0;whether the compensation
committee engaged independent consultants; (iii)&#xa0;whether the compensation committee has lapsed or waived equity vesting restrictions;
and (iv)&#xa0;whether the company has adopted or extended a Golden Parachute without shareholder approval. TCM will generally support
annual advisory votes on executive compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Limitations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TCM may abstain from voting a proxy if it concludes that the effect
on shareholders&#x2019; economic interests or the value of the portfolio holding is indeterminable or insignificant. TCM may abstain from
voting a proxy if it concludes that the cost of voting is disproportionate to the economic impact the vote would have on the portfolio
holdings. With respect to certain privately held companies, TCM may not have the opportunity to vote or may have a limitation on its ability
to vote. For example, in certain cases a company may be permitted by its charter or other governing documents to take action without a
shareholder meeting and with written consent of fewer than all shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Conflicts of Interest</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Proxy Committee identifies any potential conflicts of interest.
Each potential conflict must be addressed in a manner which will be in the best interest of the Funds and their shareholders. If any potential
conflict is identified the Proxy Committee consults with the Funds&#x2019; counsel. Where conflicts of interest arise between clients and
TCM, TCM may convene an ad-hoc committee to debate the conflict and to give a ruling on a preferred course of action. If the ad- hoc committee
determines that TCM has a conflict of interest in any instance, TCM&#x2019;s CCO shall disclose the conflict to the Board and seek voting
instructions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TCM may cause the proxies to be voted in accordance
with the recommendations of an independent third party service provider that TCM may use to assist in voting proxies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Disclosure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following disclosure shall be provided in connection with these
policies and procedures:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">&#x25cf;</font></td><td>TCM shall provide a description or a copy of these policies and procedures to the Boards of Trustees of the Funds annually and upon
request.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">&#x25cf;</font></td><td>TCM shall make available to the Funds its proxy voting records, for inclusion on the Funds&#x2019; Form&#xa0;N-PX.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">&#x25cf;</font></td><td>TCM shall include its proxy voting policies and procedures in its annual filing on Form&#xa0;N-CSR.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">&#x25cf;</font></td><td>TCM shall cause the Funds&#x2019; shareholder reports to include a statement that a copy of these policies and procedures is available
upon request (i)&#xa0;by calling a toll-free number; (ii)&#xa0;on the Funds&#x2019; website, (if the Funds choose); and (iii)&#xa0;on the
SEC&#x2019;s website.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">&#x25cf;</font></td><td>TCM shall cause the Funds&#x2019; annual and semi-annual reports to include a statement that information is available regarding how
the Funds voted proxies during the most recent twelve-month period (i)&#xa0;without charge, upon request, either by calling a toll-free
number or on or through the Funds&#x2019; website, or both; and (ii)&#xa0;on the SEC&#x2019;s website.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recordkeeping</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TCM shall maintain records of proxies voted in accordance with Section&#xa0;204-2
of the Advisers Act, including proxy statements, a record of each vote cast, and a copy of any document created by the Adviser that was
material to making a decision of how to vote the proxy, or that memorializes the basis for the Adviser&#x2019;s decision on how to vote
the proxy. TCM shall also maintain a copy of its policies and procedures and each written request from a client for proxy voting records
and the Adviser&#x2019;s written response to any client request, either written or oral, for such records. Proxy statements that are filed
on EDGAR shall be considered maintained by TCM. All such records shall be maintained for a period of five years in an easily accessible
place, the first two years in the offices of TCM.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 8. PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#xa0;(1)&#xa0;As of December&#xa0;11,
2023, Daniel Omstead, Ph.D., Jason Akus, M.D./M.B.A., Timothy Gasperoni, M.B.A., Ph.D., Ashton Wilson, Christopher Abbott, Robert
Benson, Kelly Girskis, Ph.D., Richard Goss, Christopher Seitz, M.B.A. and Loretta Tse, Ph.D. are members of a team that analyzes
investments on behalf of the Registrant. As of September&#xa0;30, 2023, Dr.&#xa0;Omstead exercised ultimate decision-making
authority with respect to investments. Dr.&#xa0;Omstead also made investments on behalf of abrdn Life Sciences Investors
(&#x201c;HQL&#x201d;), abrdn Healthcare Opportunities Fund (&#x201c;THQ&#x201d;) and abrdn World Healthcare Fund (&#x201c;THW&#x201d;).
The date each team member joined the portfolio management team and each team member&#x2019;s business experience for at least the
last five years is included below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Daniel R. Omstead, Ph.D. is Vice President of the Registrant and Head
of Healthcare Investments of the investment adviser. Previously he was President of the Registrant and Chief Executive Officer of the
predecessor investment advisor for the Registrant, where he was employed for over 40 years. He is also Vice President of the Registrant,
HQL, THQ and THW. He joined abrdn Inc. in October&#xa0;2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jason Akus, M.D./M.B.A. is Senior Investments Director of the investment
adviser and is responsible for investment research and due diligence in the biotechnology, medical device, and diagnostic areas. He joined
the predecessor investment adviser in 2001, where he was Senior Vice President, Research. Dr.&#xa0;Akus joined abrdn Inc. in October&#xa0;2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Timothy Gasperoni, M.B.A., Ph.D. is Senior Investments Director of
the investment adviser. He joined the predecessor investment adviser in 2015, where he was Senior Vice President, Research. He was also
previously a Senior Analyst and Founding Member of Sabby Capital. He joined abrdn Inc. in October&#xa0;2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ashton Wilson is Senior Investments Director of the investment adviser.
He joined the predecessor investment adviser in 2018, where he was Senior Vice President. He was previously a Vice President in equity
derivative trading at Goldman Sachs and Co. and was an equity derivative trader at Bank of America Merrill Lynch. He joined abrdn Inc.
in October&#xa0;2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Christopher Abbott is Investment Director of the investment adviser.
He joined the predecessor investment adviser in 2016, where he was Vice President, Research. Previously, Mr.&#xa0;Abbott was at Leerink
Partners where he was a Vice President on the Equity Research Team. He joined abrdn Inc. in October&#xa0;2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Robert Benson is Investment Director of the investment adviser. He
joined the predecessor investment adviser in 2016, where he was Vice President. Previously, Mr.&#xa0;Benson was at State Street Global
Advisors (SSgA) where he performed quantitative research for asset allocation, equities, and alternatives teams. He joined abrdn Inc.
in October&#xa0;2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Kelly Girskis, Ph.D. is Investment Director of the investment adviser.
She joined the predecessor investment adviser in 2021, where she was Vice President, Research. Previously, Dr.&#xa0;Girskis was an Equity
Research Associate at SVB Leerink. She joined abrdn Inc. in October&#xa0;2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Richard Goss is Investment Director of the investment adviser. He joined
the predecessor investment adviser in 2018, where he was Vice President, Research. Previously, Mr.&#xa0;Goss was at Leerink Partners where
he was a Vice President on the Large Pharma and Biotech Equity Research Teams and a Healthcare Analyst at Datamonitor. He joined abrdn
Inc. in October&#xa0;2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Christopher Seitz, M.B.A. is Investment Director of the investment
adviser. He joined the predecessor investment adviser in 2021, where he was Vice President, Research. Previously, Mr.&#xa0;Seitz was a
Healthcare Analyst Intern at Nantahala Capital Management and an Associate at Excel Venture Management. He joined abrdn Inc. in October&#xa0;2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Loretta Tse, Ph.D. is Investment Director of the investment adviser.
She joined the predecessor investment adviser in 2015, where she was Vice President. She previously ran a biotech consulting business
and worked at various venture funds and start-up companies and was Managing Director at Fred Hutchinson Cancer Research Center. She joined
abrdn Inc. in October&#xa0;2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#xa0;(2)&#xa0; The following table lists the
number and types of other accounts and assets under management in those accounts advised by the Registrant&#x2019;s portfolio management
team as of the end of the Registrant&#x2019;s fiscal year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">PORTFOLIO<br> MANAGER</td><td style="white-space: nowrap; text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="white-space: nowrap; text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">REGISTERED<br> INVESTMENT <br> COMPANY<br> ACCOUNTS</td><td style="white-space: nowrap; text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">ASSETS<br> MANAGED</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td><td style="white-space: nowrap; text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">POOLED<br> ACCOUNTS</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td><td style="white-space: nowrap; text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">ASSETS<br> MANAGED</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td><td style="white-space: nowrap; text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">OTHER<br> ACCOUNTS</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td><td style="white-space: nowrap; text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">ASSETS<br> MANAGED</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 22%; font: 10pt Times New Roman, Times, Serif; text-align: left">Daniel Omstead</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">3</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">2,027
million</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 1%; font-size: 10pt">&#xa0;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td><td style="width: 10%; font-size: 10pt; text-align: right">0</td><td style="width: 1%; font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jason Akus</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,027
million</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Timothy Gasperoni</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,027
million</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Ashton Wilson</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,027
million</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Christopher Abbott</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,027
million</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Robert Benson</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,027
million</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Kelly Girskis</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,027
million</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Richard Goss</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,027
million</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Christopher Seitz</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,027
million</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loretta Tse</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,027
million</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None of the funds or other accounts are subject to a performance-based
advisory fee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each member of the portfolio management team may perform investment
management services for other accounts similar to those provided to the Registrant and the investment action for each account may differ.
The portfolio management team may discover an investment opportunity that may be suitable for more than one account. However, the investment
opportunity may be limited so that all accounts may not be able to fully participate, or an investment opportunity or investment allocation
may be allocated to just one account or may be allocated between accounts at different levels based on an investment decision made by
the investment team. The investment team may subsequently make investment decisions that result in investment levels that make the accounts
more differentiated or, conversely, more closely or completely aligned. Such investment decisions may occur within a day or two. In addition,
the investment adviser may receive different compensation from each account. In that case, the portfolio management team may have an incentive
to direct investments to an account that could result in higher fees for the investment adviser. The registrant has adopted procedures
designed to allocate investments fairly across multiple accounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additionally, a portfolio manager may be perceived to have a conflict
of interest if he has other executive management responsibilities. In addition to managing the Registrant, HQL, THQ and THW, at September&#xa0;30,
2023, Dr.&#xa0;Omstead was the President of the investment adviser of the Registrant. Dr.&#xa0;Omstead periodically discussed the amount
of time he allocated to each of his responsibilities with the Registrant&#x2019;s Board of Trustees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The portfolio management team&#x2019;s management of personal accounts
may also present certain conflicts of interest. The Registrant has adopted a code of ethics designed to address these potential conflicts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(a)&#xa0;(3)&#xa0; As of September&#xa0;30, 2023, portfolio
manager compensation is comprised of a base salary and discretionary compensation as described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif"><i>Base
Salary Compensation</i></font>. The team members receive a base salary compensation linked to individual experience and responsibilities.
The amount of base salary is reviewed annually.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif"><i>Discretionary
Compensation</i></font>. Discretionary Compensation is in the form of a cash bonus, paid annually, which may be 50% or more of the team
member&#x2019;s base salary. Several factors affect discretionary compensation, which can vary by team member and circumstances. The discretionary
compensation component is determined based on factors including investment performance of accounts managed by the team predominantly relative
to the S&amp;P 500 Index and a blended consideration of appropriate healthcare indicies and related performance metrics during the Fund&#x2019;s
fiscal year, performance of specific investments proposed by the individual, financial performance of the investment adviser and a qualitative
assessment of the individual overall contribution to the investment team and to the investment adviser. Discretionary compensation is
evaluated annually after the completion of the Registrant&#x2019;s fiscal year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<!-- Field: Page; Sequence: 7 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#xa0;(4)&#xa0; As of September&#xa0;30, 2023,
the dollar range of Registrant&#x2019;s shares beneficially owned by the portfolio managers are as follows as of the end of the Registrant&#x2019;s
fiscal year:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 30%">PORTFOLIO MANAGER</td>
    <td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; width: 1%">&#xa0;</td>
    <td style="text-align: center; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 69%">DOLLAR RANGE OF SHARES BENEFICIALLY OWNED</td></tr>
  <tr style="font-style: normal; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal">
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">Daniel Omstead</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">&#xa0;</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">over $1,000,000</font></td></tr>
  <tr style="font-style: normal; vertical-align: bottom;  font-weight: normal">
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">Jason Akus</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">&#xa0;</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">none</font></td></tr>
  <tr style="font-style: normal; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal">
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">Timothy Gasperoni</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">&#xa0;</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">$10,001-$50,000</font></td></tr>
  <tr style="font-style: normal; vertical-align: bottom;  font-weight: normal">
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">Ashton Wilson</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">&#xa0;</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">none</font></td></tr>
  <tr style="font-style: normal; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal">
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">Christopher Abbott</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">&#xa0;</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">none</font></td></tr>
  <tr style="font-style: normal; vertical-align: bottom;  font-weight: normal">
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">Robert Benson</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">&#xa0;</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">none</font></td></tr>
  <tr style="font-style: normal; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal">
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">Kelly Girskis</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">&#xa0;</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">none</font></td></tr>
  <tr style="font-style: normal; vertical-align: bottom;  font-weight: normal">
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">Richard Goss</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">&#xa0;</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">none</font></td></tr>
  <tr style="font-style: normal; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal">
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">Christopher Seitz</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">&#xa0;</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">none</font></td></tr>
  <tr style="font-style: normal; vertical-align: bottom;  font-weight: normal">
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">Loretta Tse</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">&#xa0;</font></td>
    <td style="font: normal 10pt Times New Roman, Times, Serif"><font style="font-style: normal; font-weight: normal">none</font></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b)&#xa0;N/A.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 9. PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT
INVESTMENT COMPANY AND AFFILIATED PURCHASERS.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;<font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid">Period</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">(a) Total No.<br> of Shares<br> Purchased (1)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">(b) Average<br> Price Paid per<br> Share</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">(c) Total No.<br> of Shares<br> Purchased as<br> Part of <br> Publicly<br> Announced Plans<br> or Programs</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">(d) Maximum No.<br> of Shares that<br> May Yet Be<br> Purchased Under<br> the Plans or<br> Programs</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Month #1 (Oct.&#xa0;1, 2022-Oct.&#xa0;31, 2022)</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 2%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">&#x2014;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 2%; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 12%; font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,623,378</td><td style="width: 1%; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Month #2 (Nov.&#xa0;1, 2022 &#x2013; Nov.&#xa0;30, 2022)</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,623,378</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Month #3 (Dec.&#xa0;1, 2022&#x2013; Dec.&#xa0;31, 2022)</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,623,378</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Month #4 (Jan.&#xa0;1, 2023 &#x2013; Jan.&#xa0;31, 2023)</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,623,378</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Month #5 (Feb.&#xa0;1, 2023 &#x2013; Feb.&#xa0;28, 2023)</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,623,378</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Month #6 (Mar.&#xa0;1, 2023 &#x2013; Mar.&#xa0;31, 2023)</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,623,378</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Month #7 (Apr.&#xa0;1, 2023&#x2013; Apr.&#xa0;30, 2023)</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,623,378</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Month #8 (May&#xa0;1, 2023 &#x2013; May&#xa0;31, 2023)</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,623,378</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Month #9 (June&#xa0;1, 2023 &#x2013; June&#xa0;30, 2023)</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,623,378</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Month #10 (Jul.&#xa0;1, 2023 &#x2013; Jul.&#xa0;31, 2023)</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,864,076</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Month #11 (Aug.&#xa0;1, 2023 &#x2013; Aug.&#xa0;31, 2023)</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,864,076</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Month #12 (Sep.&#xa0;1, 2023&#x2013; Sep.&#xa0;30, 2023)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">19,000</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><sup>(2)</sup>&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15.57</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">5,864,076</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">19,000</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><sup>(2)</sup>&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15.57</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#x2014;</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right">&#xa0;</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td></tr>
  </table><div style="font-family: Times New Roman, Times, Serif; font-size: 10pt">



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&#xa0;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-size: 1pt">&#xa0;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">(1)</font></td><td style="text-align: left">On June&#xa0;30, 2011, the share repurchase program was announced, which has been subsequently reviewed
and approved by the Board of Trustees. On March&#xa0;17, 2022, the Trustees approved the renewal of the share repurchase program, allowing
the Registrant to repurchase up to 12% of its outstanding shares in the open market for a one-year period ending July&#xa0;14, 2023. On
March&#xa0;16, 2023, the Trustees approved the renewal of the share repurchase program, allowing the Registrant to repurchase up to 12%
of its outstanding shares in the open market for a one-year period ending July&#xa0;14, 2024.</td></tr><tr style="vertical-align: top">
<td>&#xa0;</td><td>(2)</td><td style="text-align: left">19,000 shares were purchased in Month #12 by Daniel Omstead in the open market. During the period ended September 30, 2023, Dr. Omstead
was a director of the Registrant and a controlling person of the Registrant&#x2019;s investment adviser. Accordingly, Dr. Omstead may be
deemed an &#x201c;affiliated purchaser&#x201d; of the Registrant&#x2019;s shares as such term is defined by Rule 10b-18(a)(3) under the Exchange
Act of 1934.</td></tr>
                                                                                                       </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<!-- Field: Page; Sequence: 8 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 10. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There have been no material changes, to the procedures by which the
shareholders may recommend nominees to the Registrant&#x2019;s Board of Trustees, where those changes were implemented after the Registrant
last provided disclosure in response to the requirements of Item 407(c)(2)(iv)&#xa0;of Regulation S-K (17 CFR229.407)(as required by Item
22(b)(15) of Schedule 14A (17 CFR240.14a-101)), or this Item.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 11. CONTROLS AND PROCEDURES.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">(a)</font></td><td style="text-align: left">In the opinion of the principal executive officer and principal financial officer, based on their evaluation
which took place within 90 days of this filing, the Registrant&#x2019;s disclosure controls and procedures are adequately designed and
are operating effectively to ensure (i)&#xa0;that material information relating to the Registrant, including its consolidated subsidiaries,
is made known to them by others within those entities, particularly during the period in which this report is being prepared; and (ii)&#xa0;that
information required to be disclosed by the registrant on Form&#xa0;N-CSR is recorded, processed, summarized and reported within the time
period specified in the Securities and Exchange Commission&#x2019;s rules&#xa0;and forms.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><font style="font-family: Times New Roman, Times, Serif">(b)</font></td><td style="text-align: left">There were no changes in the Registrant&#x2019;s internal control over financial reporting that occurred
during the Registrant&#x2019;s most recent fiscal half- year that have materially affected or that are reasonably likely to materially
affect the Registrant&#x2019;s internal control over financial reporting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 12. DISCLOSURE OF SECURITIES LENDING ACTIVITIES FOR CLOSED-END
MANAGEMENT INVESTMENT COMPANIES.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The following table shows the dollar amounts of income, and dollar amounts of fees and/or compensation paid, relating to the
Fund&#x2019;s securities lending activities during the fiscal year ended September&#xa0;30, 2023.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 10pt">(1) <b></b></font></td>
    <td colspan="2" style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 10pt"><b>Gross income from securities lending activities</b></font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">365,565</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left"><font style="font-size: 10pt">(2) <i></i></font></td>
    <td colspan="2" style="font-size: 10pt; text-align: left"><font style="font-size: 10pt"><i>Fees and/or compensation for securities lending activities and related services</i>&#xa0;</font></td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">&#xa0;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; width: 8%">&#xa0;</td>
    <td style="padding-left: 0.2in; font-size: 10pt; text-align: left; width: 5%">(a)</td>
    <td style="font-size: 10pt; text-align: left; width: 74%">Fee paid for services as securities lending agent</td><td style="font-size: 10pt; width: 1%">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left; width: 1%">$</td><td style="font-size: 10pt; text-align: right; width: 10%">16,728</td><td style="font-size: 10pt; text-align: left; width: 1%">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">&#xa0;</td>
    <td style="padding-left: 0.2in; font-size: 10pt; text-align: left">(b)</td>
    <td style="font-size: 10pt; text-align: left">Collateral management expenses not included in (a)</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#xa0;</td>
    <td style="padding-left: 0.2in; font-size: 10pt; text-align: left">(c)</td>
    <td style="font-size: 10pt; text-align: left">Administrative fees not included in (a)</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">&#xa0;</td>
    <td style="padding-left: 0.2in; font-size: 10pt; text-align: left">(d)</td>
    <td style="font-size: 10pt; text-align: left"> Indemnification fees not included in (a)</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">&#xa0;</td>
    <td style="padding-left: 0.2in; font-size: 10pt; text-align: left">(e)</td>
    <td style="font-size: 10pt; text-align: left"> Rebate (paid to borrowers)</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">254,035</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt; text-align: left">&#xa0;</td>
    <td style="padding-left: 0.2in; font-size: 10pt; text-align: left">(f)</td>
    <td style="font-size: 10pt; text-align: left">Other fees not included in (a)</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">0</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 10pt">(3) <b></b></font></td>
    <td colspan="2" style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 10pt"><b>Aggregate fees/compensation for securities lending activities</b></font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">270,763</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 10pt">(4) <b></b></font></td>
    <td colspan="2" style="padding-bottom: 1pt; font-size: 10pt; text-align: left"><font style="font-size: 10pt"><b>Net income from securities lending activities </b></font></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">94,802.31</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&#xa0;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b)&#xa0;Goldman Sachs Bank USA, doing business as Goldman
Sachs Agency Lending (&#x201c;GSAL&#x201d;) serves as securities lending agent for the Fund and in that role administers the Fund&#x2019;s
securities lending program pursuant to the terms of a securities lending agency agreement entered into between the Fund and GSAL.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>ITEM 13. EXHIBITS.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><a href="tm2325130d1_ex99-cert.htm" style="-sec-extract: exhibit"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;</font><font style="font-size: 10pt">(2)&#xa0;Separate certifications of the Principal Executive and Financial Officers as required by Rule&#xa0;30a-2(a)&#xa0;under the 1940 Act and Section&#xa0;302 of the Sarbanes-Oxley Act of 2002 are attached hereto (Exhibit&#xa0;1 and 2).</font></a></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><a href="tm2325130d1_ex99-sec19xa.htm" style="-sec-extract: exhibit"><font style="font-family: Times New Roman, Times, Serif">(a)&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;</font>(3)&#xa0;Notice to Fund&#x2019;s shareholders in accordance with Investment Company Act Section&#xa0;19(a)&#xa0;and Rule&#xa0;19a-1 (Exhibit&#xa0;3).</a></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> <a href="tm2325130d1_ex99-indpubacct.htm">(a)&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;(4)&#xa0;Change in Registrant&#x2019;s independent public accountant (Exhibit&#xa0;4)</a></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><a href="tm2325130d1_ex99-906cert.htm" style="-sec-extract: exhibit"><font style="font-family: Times New Roman, Times, Serif">(b)&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;</font>Certifications pursuant to Section&#xa0;906 of the Sarbanes-Oxley Act of 2002 are attached hereto (Exhibit&#xa0;5).</a></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<!-- Field: Page; Sequence: 9; Options: Last -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

</div></div><div style="font: 10pt Times New Roman, Times, Serif"><div style="Page-Break-Before: Always"></div><!-- BannerFile="tm2325130d1_sign.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2325130-1/tm2325130-1_ncsrseq1" -->
<p style="margin: 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by
the undersigned, there unto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%">(Registrant)</td>
    <td style="border-bottom: Black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 91%"> abrdn Healthcare Investors</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18%">By (Signature and Title)*</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 82%"> /s/ Christian Pittard</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Christian Pittard,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Principal Executive Officer of abrdn Healthcare Investors</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%">Date:</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">12/11/23</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%">&#xa0;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 18%">By (Signature and Title)*</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 82%"> /s/ Sharon Ferrari</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Sharon Ferrari,</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Treasurer and Chief Financial Officer</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%">Date:</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">12/11/23</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%">&#xa0;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 75%">&#xa0;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Print the name and title of each signing officer under his or her signature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.CERT
<SEQUENCE>2
<FILENAME>tm2325130d1_ex99-cert.htm
<DESCRIPTION>EXHIBIT 99.CERT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2325130d1_ex99-cert.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2325130-1/tm2325130-1_ncsrseq1/users" -->
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;99.CERT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;1: CERTIFICATION OF PRINCIPAL EXECUTIVE
OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Christian Pittard, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.</FONT></TD><TD>I have reviewed this report on Form&nbsp;N-CSR of abrdn Healthcare Investors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.</FONT></TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.</FONT></TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required
to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.</FONT></TD><TD>The registrant&rsquo;s other certifying officer(s)&nbsp;and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Rule&nbsp;30a-3(c)&nbsp;under the Investment Company Act of 1940) and internal control over financial reporting
(as defined in Rule&nbsp;30a-3(d)&nbsp;under the Investment Company Act of 1940) for the Registrant and have:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.85in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT></TD><TD>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.85in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></TD><TD>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.85in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT></TD><TD>Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report
based on such evaluation; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.85in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)</FONT></TD><TD>Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the period
covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control
over financial reporting; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.</FONT></TD><TD>The registrant&rsquo;s other certifying officer(s)&nbsp;and I have disclosed to the registrant&rsquo;s auditors and the audit committee
of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.85in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT></TD><TD>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize, and report financial information;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.85in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></TD><TD>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">Date: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-size: 10pt">12/11/23</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-size: 10pt">/s/
    Christian Pittard</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Christian Pittard</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: Principal Executive Officer of abrdn Healthcare Investors</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;2: CERTIFICATION OF CERTIFICATION
OF PRINCIPAL FINANCIAL OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Sharon Ferrari, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.</FONT></TD><TD>I have reviewed this report on Form&nbsp;N-CSR of abrdn Healthcare Investors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.</FONT></TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.</FONT></TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required
to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.</FONT></TD><TD>The registrant&rsquo;s other certifying officer(s)&nbsp;and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Rule&nbsp;30a-3(c)&nbsp;under the Investment Company Act of 1940) and internal control over financial reporting
(as defined in Rule&nbsp;30a-3(d)&nbsp;under the Investment Company Act of 1940) for the Registrant and have:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.85in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT></TD><TD>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.85in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></TD><TD>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.85in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT></TD><TD>Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report
based on such evaluation; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.85in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)</FONT></TD><TD>Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the period
covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control
over financial reporting; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.</FONT></TD><TD>The registrant&rsquo;s other certifying officer(s)&nbsp;and I have disclosed to the registrant&rsquo;s auditors and the audit committee
of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.85in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT></TD><TD>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize, and report financial information;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.85in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></TD><TD>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">Date: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-size: 10pt">12/11/23</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-size: 10pt">/s/
    Sharon Ferrari</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Sharon Ferrari</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: Treasurer and Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.SECTION 19(A)
<SEQUENCE>3
<FILENAME>tm2325130d1_ex99-sec19xa.htm
<DESCRIPTION>EXHIBIT 99.SECTION 19(A)
<TEXT>
<!-- Assembled by CompSci Transform  (tm) - http://www.compsciresources.com - version 1.2 -->
<!-- Created: Sat Dec 09 18:25:49 UTC 2023 -->
<html>
<head>
     <title></title>
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2325130d1_ex99-sec19a63023.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2325130-1/tm2325130-1_ncsrseq1" -->
<p style="margin: 0pt">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Exhibit&#xa0;99.Section&#xa0;19(a)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXHIBIT&#xa0;3: SECTION&#xa0;19(a)&#xa0;NOTICE
TO FUND&#x2019;S SHAREHOLDERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><font style="font-size: 10pt; font-variant: small-caps">Tekla
Healthcare Investors</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notification
of Sources of Distribution </b></font><font style="font-family: Times New Roman, Times, Serif"></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif">Distribution Paid Date: June</font>&#xa0;<font style="font-family: Times New Roman, Times, Serif">30,
2023</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif">Distribution Amount Per Common Share:	</font>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;<font style="font-family: Times New Roman, Times, Serif">$0.40</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The following table sets forth the estimated amounts of
the current distribution, paid June&#xa0;30, 2023, and the cumulative distributions paid this fiscal year-to-date from the following sources:
net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital
source. The Fund estimates that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution
may be a return of capital. A return of capital may occur, for example, when some or all the money that you invested in the Fund is paid
back to you. A return of capital distribution does not necessarily reflect the Fund's investment performance and should not be confused
with `yield' or `income'. All amounts are expressed per common share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td colspan="5" style="white-space: nowrap; font-size: 10pt">&#xa0;</td><td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td colspan="2" style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#xa0;</td><td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td><td style="white-space: nowrap; font-size: 10pt">&#xa0;</td>
    <td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: center">&#xa0;</td><td style="white-space: nowrap; font-size: 10pt">&#xa0;</td><td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td colspan="2" style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percentage</td><td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="5" style="white-space: nowrap; font-size: 10pt">&#xa0;</td><td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td colspan="2" style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percentage</td><td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td><td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td colspan="2" style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#xa0;</td><td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td><td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td colspan="2" style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Breakdown of the</td><td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; font-size: 10pt"><font style="font-size: 10pt">&#xa0;</font></td>
    <td style="white-space: nowrap; font-size: 10pt"><font style="font-size: 10pt">&#xa0;</font></td>
    <td colspan="3" style="text-align: center; white-space: nowrap; font-size: 10pt"><font style="font-size: 10pt">&#xa0;</font></td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><font style="font-size: 10pt">&#xa0;</font></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><font style="font-size: 10pt">Breakdown</font></td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><font style="font-size: 10pt">&#xa0;</font></td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><font style="font-size: 10pt">&#xa0;</font></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><font style="font-size: 10pt">Total
    Cumulative</font></td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><font style="font-size: 10pt">&#xa0;</font></td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><font style="font-size: 10pt">&#xa0;</font></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><font style="font-size: 10pt">Total
    Cumulative</font></td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap"><font style="font-size: 10pt">&#xa0;</font></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; white-space: nowrap; font-size: 10pt; text-align: center"><font style="font-size: 10pt">&#xa0;</font></td>
    <td style="vertical-align: bottom; white-space: nowrap; font-size: 10pt; text-align: center"><font style="font-size: 10pt">&#xa0;</font></td>
    <td colspan="2" style="vertical-align: bottom; text-align: center; white-space: nowrap; font-size: 10pt"><font style="font-size: 10pt"><b>Current</b></font></td>
    <td style="vertical-align: bottom; text-align: center; white-space: nowrap; font-size: 10pt"><font style="font-size: 10pt">&#xa0;</font></td><td style="vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><font style="font-size: 10pt">&#xa0;</font></td>
    <td colspan="2" style="vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><font style="font-size: 10pt">of
    Current</font></td><td style="vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><font style="font-size: 10pt">&#xa0;</font></td><td style="vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><font style="font-size: 10pt">&#xa0;</font></td>
    <td colspan="2" style="vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><font style="font-size: 10pt">Distributions
    for the</font></td><td style="vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><font style="font-size: 10pt">&#xa0;</font></td><td style="vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><font style="font-size: 10pt">&#xa0;</font></td>
    <td colspan="2" style="vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><font style="font-size: 10pt">Distributions
    for the</font></td><td style="vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><font style="font-size: 10pt">&#xa0;</font></td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; font-size: 10pt; text-align: center">&#xa0;</td><td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td colspan="2" style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Distribution</td><td style="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td><td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td colspan="2" style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Distribution</td><td style="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td><td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td colspan="2" style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Fiscal Year to Date<sup>1</sup></td><td style="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td><td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td colspan="2" style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Fiscal Year to Date<sup>1</sup></td><td style="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font: 10pt Times New Roman, Times, Serif; text-align: left">Net Investment Income</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net Realized ST Cap Gains</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net Realized LT Cap Gains</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">Return of Capital or Other Capital Source</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.4000</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1.2100</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">TOTAL (per common share):</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.4000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#xa0;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1.2100</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">%</td></tr>
  </table>



<p style="margin: 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> The table below includes information relating to the Fund&#x2019;s performance based on its NAV for certain periods. &#xa0;</p>



<p style="margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 87%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Average annual total return at NAV for the period April&#xa0;30, 2018 through April&#xa0;30, 2023</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">7.01</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Annualized current distribution rate expressed as a percentage of NAV as of April&#xa0;30, 2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.82</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative total return at NAV for the fiscal year, through April&#xa0;30, 2023<sup>2</sup></font></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10.55</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of April&#xa0;30, 2023<sup>1</sup></font></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5.91</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">You should not draw any conclusions about the Fund&#x2019;s
investment performance from the amount of this distribution or from the terms of the Fund&#x2019;s managed distribution policy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The composition of this and subsequent distribution may
vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the
net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $159,645,429 of which $141,616,078
represents net unrealized appreciation of portfolio securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">The amounts and sources of distributions reported in this
19(a)&#xa0;Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts
for tax reporting purposes will depend upon the Fund's investment experience during the remainder of its fiscal year and may be subject
to changes based on tax regulations. The Fund will send you a Form&#xa0;1099-DIV for the calendar year that will tell you how to report
these distributions for federal income tax purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif"><sup>1
</sup></font>The Fund&#x2019;s current fiscal year began on October&#xa0;1, 2022.&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif"><sup>2</sup></font>
Cumulative total return at NAV is the percentage change in the Fund&#x2019;s NAV and includes all distributions and assumes the reinvestment
of those distributions for the period of September&#xa0;30, 2022 through April&#xa0;30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Tekla Healthcare Investors&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">CUSIP: 87911J103</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#xa0;</p>


</div><div style="font: 10pt Times New Roman, Times, Serif"><div style="Page-Break-Before: Always"></div><!-- BannerFile="tm2325130d1_ex99-sec19a92923.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2325130-1/tm2325130-1_ncsrseq1" -->
<p style="margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"></font></p>

<p style="margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">&#xa0;</font></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt; font-variant: small-caps">Tekla
Healthcare Investors</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notification
of Sources of Distribution </b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distribution Paid Date: September</font><font style="font-size: 10pt">&#xa0;<font style="font-family: Times New Roman, Times, Serif">29,
2023</font></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">&#xa0;</font></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt"><font style="font-family: Times New Roman, Times, Serif">Distribution Amount Per Common Share:$0.40</font></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">The following table sets
forth the estimated amounts of the current distribution, paid September&#xa0;29, 2023, and the cumulative distributions paid this fiscal
year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital
gains and return of capital or other capital source. The Fund estimates that it has distributed more than its income and net realized
capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when
some or all the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect
the Fund's investment performance and should not be confused with `yield' or `income'. All amounts are expressed per common share.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">&#xa0;</font></p>
<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; white-space: nowrap; text-align: center; font-size: 10pt"><b>&#xa0;</b></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><b>&#xa0;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Current</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Distribution</b></p></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><b>&#xa0;</b></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><b>&#xa0;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Percentage<br>
                                            Breakdown<br>
                                            of Current</b></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Distribution</b></p></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><b>&#xa0;</b></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><b>&#xa0;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Total
                                            Cumulative<br>
                                            Distributions for the</b></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Fiscal
                                 Year to Date<sup>1</sup></b></p></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><b>&#xa0;</b></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><b>&#xa0;</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Percentage<br>
                                            Breakdown of the<br>
                                            Total Cumulative<br>
                                            Distributions for the</b></p> <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Fiscal
                                 Year to Date<sup>1</sup></b></p></td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><b>&#xa0;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 48%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.7pt">Net Investment Income</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.7pt">Net Realized ST Cap Gains</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.7pt">Net Realized LT Cap Gains</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.4000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">100</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.4000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">25</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.7pt">Return of Capital or Other</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">&#xa0;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">&#xa0;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">&#xa0;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left">&#xa0;</td><td style="font-size: 10pt; text-align: right">&#xa0;</td><td style="font-size: 10pt; text-align: left">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.7pt">Capital Source</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0000</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1.2100</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">75</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; padding-left: 0.7pt">TOTAL (per common share):</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">0.4000</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1.6100</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</td><td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
</table>

<p style="margin: 0">&#xa0;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td colspan="17" style="font: 10pt Times New Roman, Times, Serif; text-align: left">The table below includes information relating to the Fund&#x2019;s performance based on its NAV for certain periods.</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 48%">&#xa0;</td><td style="font-size: 10pt; width: 1%">&#xa0;</td>
    <td style="text-align: left; width: 1%">&#xa0;</td><td style="text-align: right; width: 10%">&#xa0;</td><td style="text-align: left; width: 1%">&#xa0;</td><td style="font-size: 10pt; width: 1%">&#xa0;</td>
    <td style="text-align: left; width: 1%">&#xa0;</td><td style="text-align: right; width: 10%">&#xa0;</td><td style="text-align: left; width: 1%">&#xa0;</td><td style="font-size: 10pt; width: 1%">&#xa0;</td>
    <td style="text-align: left; width: 1%">&#xa0;</td><td style="text-align: right; width: 10%">&#xa0;</td><td style="text-align: left; width: 1%">&#xa0;</td><td style="font-size: 10pt; width: 1%">&#xa0;</td>
    <td style="font-size: 10pt; text-align: left; width: 1%">&#xa0;</td><td style="font-size: 10pt; text-align: right; width: 10%">&#xa0;</td><td style="font-size: 10pt; text-align: left; width: 1%">&#xa0;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="11" style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.7pt">Average annual total return at NAV for the period July&#xa0;31, 2018 through July&#xa0;31, 2023</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4.81</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td colspan="11" style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.7pt">Annualized current distribution rate expressed as a percentage of NAV as of July&#xa0;31, 2023</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td colspan="11" style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.7pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative total return at NAV for the fiscal year, through July&#xa0;31, 2023<sup>2</sup></font></td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10.60</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td colspan="8" style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.7pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative fiscal year-to-date distribution rate expressed as a percentage of NAV as of July&#xa0;31, 2023<sup>1</sup></font></td><td style="text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="text-align: left">&#xa0;</td><td style="text-align: right">&#xa0;</td><td style="text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif">&#xa0;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#xa0;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">You should not draw any conclusions
about the Fund&#x2019;s investment performance from the amount of this distribution or from the terms of the Fund&#x2019;s managed distribution
policy.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">The composition of this and
subsequent distribution may vary from month to month because it may be materially impacted by future realized gains and losses on securities.
The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $111,223,639
of which $24,177,364 represents net unrealized appreciation of portfolio securities.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">The amounts and sources of
distributions reported in this 19(a)&#xa0;Notice are only estimates and are not being provided for tax reporting purposes. The actual
amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during the remainder
of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form&#xa0;1099-DIV for the calendar
year that will tell you how to report these distributions for federal income tax purposes.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>1
</sup></font><font style="font-size: 10pt">The Fund&#x2019;s current fiscal year began on October&#xa0;1, 2022.&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>2
</sup></font><font style="font-size: 10pt">Cumulative total return at NAV is the percentage change in the Fund&#x2019;s NAV and includes
all distributions and assumes the reinvestment of those distributions for the period of September&#xa0;30, 2022 through July&#xa0;31,
2023.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">&#xa0;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">Tekla Healthcare Investors
<br>
CUSIP: 87911J103</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#xa0;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#xa0;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-size: 10pt">&#xa0;</font></p>

</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.IND PUB ACCT
<SEQUENCE>4
<FILENAME>tm2325130d1_ex99-indpubacct.htm
<DESCRIPTION>EXHIBIT 99.IND PUB ACCT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2325130d1_ex99-indpubacct.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2325130-1/tm2325130-1_ncsrseq1/users" -->
<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-style: normal; text-transform: none"><B>Exhibit 99.IND PUB
ACCT</B></FONT></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px; font-size: 10pt"><B>Exhibit&nbsp;13.(a)(4)</B></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><B>Changes in Registrant&rsquo;s Certifying Accountant.</B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There was a change in the registrant&rsquo;s independent public accountant
during the reporting period. Below is the information called for by Item 4 of Form&nbsp;8-K, which was included in the Fund&rsquo;s current
report on Form&nbsp;8-K filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) on September&nbsp;12, 2023. Also attached
is the letter from the Fund to the SEC acknowledging its responsibilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96px; font-size: 10pt"><B>Item 4.01</B></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><B>Changes in Registrant&rsquo;s Certifying Accountant.</B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>(a)&nbsp;Resignation of independent registered public accounting
firm</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September&nbsp;6, 2023, Deloitte&nbsp;&amp; Touche LLP (&ldquo;D&amp;T&rdquo;),
the independent registered public accounting firm for the Tekla Healthcare Investors (the &ldquo;Fund&rdquo;), resigned due to an anticipated
independence issue arising as a result of a pending transaction between Tekla Capital Management LLC and abrdn Inc. On September&nbsp;7,
2023, the Audit Committee of the Board of Trustees (the &ldquo;Board&rdquo;) of the Fund approved D&amp;T&rsquo;s resignation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The reports of D&amp;T on the Fund&rsquo;s financial statements as
of and for the two most recent fiscal years ended September&nbsp;30, 2022 and September&nbsp;30, 2021 did not contain an adverse opinion
or a disclaimer of opinion, nor were such reports qualified or modified as to uncertainties, audit scope or accounting principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the Fund&rsquo;s two most recent fiscal years (ended September&nbsp;30,
2022 and September&nbsp;30, 2021) and the subsequent interim period through September&nbsp;6, 2023, there were no &ldquo;disagreements&rdquo;
(within the meaning of Item 304(a)(1)(iv)&nbsp;of Regulation S-K and the related instructions under the Securities Exchange Act of 1934,
as amended (the &ldquo;Exchange Act&rdquo;)) between the Fund and D&amp;T on any matter of accounting principles or practices, financial
statement disclosure or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of D&amp;T, would have caused
D&amp;T to make reference to the subject matter of the disagreements in its reports on the financial statements of the Fund for such years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Also during this same period, there were no &ldquo;reportable events&rdquo;
(within the meaning of Item 304(a)(1)(v)&nbsp;of Regulation S-K and the related instructions under the Exchange Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Fund has provided D&amp;T with a copy of the foregoing disclosures
under Item 4.01 on Form&nbsp;8-K prior to filing it with the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;) and has requested
that D&amp;T furnish to the Fund with a letter addressed to the SEC stating whether it agrees with the statements made by the Fund in
this Item 4.01 on Form&nbsp;8-K. A copy of D&amp;T&rsquo;s letter, dated September&nbsp;12, 2023, is attached as Exhibit&nbsp;16.1 to
this report on Form&nbsp;8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>(b)&nbsp;Engagement of new independent registered
public accounting firm</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in">On September&nbsp;7, 2023, upon the recommendation
of the Audit Committee of the Board, the Board approved the engagement of KPMG LLP (&ldquo;KPMG&rdquo;) as the independent registered
public accounting firm for the Fund for the fiscal year ending September&nbsp;30, 2023. During the Fund&rsquo;s two most recent fiscal
years (ended September&nbsp;30, 2022 and September&nbsp;30, 2021) and the subsequent interim period prior to the engagement of KPMG, neither
the Fund, nor anyone on the Fund&rsquo;s behalf consulted with KPMG regarding (1)&nbsp;the application of accounting principles to a specified
transaction, either completed or proposed; (2)&nbsp;the type of audit opinion that might be rendered on the Fund&rsquo;s financial statements;
or (3)&nbsp;the subject of any &ldquo;disagreement,&rdquo; as defined in Item 304(a)(1)(iv)&nbsp;of Regulation S-K under the Exchange
Act and the instructions thereto, or a &ldquo;reportable event,&rdquo; as defined in Item 304(a)&nbsp;(1)(v)&nbsp;of Regulation S-K under
the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*********</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit&nbsp;16.1 of Form&nbsp;8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">September&nbsp;12, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities and Exchange Commission&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 F Street, N.E.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Washington, DC 20549-7561</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Sirs/Madams:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have read Item 4.01 of Tekla Healthcare Investors&rsquo; Form&nbsp;8-K
dated September&nbsp;12, 2023, and we agree with the statements made therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Yours truly,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Deloitte&nbsp;&amp; Touche LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*********</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.906CERT
<SEQUENCE>5
<FILENAME>tm2325130d1_ex99-906cert.htm
<DESCRIPTION>EXHIBIT 99.906CERT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><!-- BannerFile="tm2325130d1_ex99-906cert.htm"   BannerFilePath="/apps/files/files/jms2files/gofiler/tm2325130-1/tm2325130-1_ncsrseq1/users" -->
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;99.906CERT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;5: CERTIFICATION PURSUANT TO SECTION&nbsp;906
OF THE SARBANES-OXLEY ACT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to Section&nbsp;906 of the Sarbanes-Oxley
Act of 2002, each of the undersigned officers of abrdn Healthcare Investors, do hereby certify, to such officer&rsquo;s knowledge, that
the report on Form&nbsp;N-CSR of abrdn Healthcare Investors for the period ended September&nbsp;30, 2023 fully complies with the requirements
of Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;of the Securities Exchange Act of 1934, as applicable, and information contained in the Form&nbsp;N-CSR
fairly presents, in all material respects, the financial condition and results of operations of abrdn Healthcare Investors for the stated
period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Dated:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">12/11/23</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 95%; margin-left: 0.5in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%">/s/ Christian Pittard</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%">/s/ Sharon Ferrari</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in">Name: Christian Pittard</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Name: Sharon Ferrari</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in">Title: Principal Executive Officer of abrdn Healthcare Investors</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; vertical-align: top">Title: Treasurer and Chief Financial Officer</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A signed original of this written statement required by Section&nbsp;906
has been provided to abrdn Healthcare Investors and will be retained by abrdn Healthcare Investors and furnished to the SEC or its staff
upon request. This statement accompanies this report on Form&nbsp;N-CSR pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2325130d1hqhar25130d2i001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2325130d1hqhar25130d2i001.jpg
M_]C_X0AK17AI9@  34T *@    @ #0$   ,    ! 1T   $!  ,    ! 1T
M  $"  ,    #    J@$&  ,    !  (   $2  ,    !  $   $5  ,    !
M  ,   $:  4    !    L $;  4    !    N $H  ,    !  (   $Q  (
M   A    P $R  (    4    X0$[  (    @    ]8=I  0    !   !&
M 5  "  (  @ +<;    G$  MQL   "<0061O8F4@4&AO=&]S:&]P(#(R+C4@
M*$UA8VEN=&]S:"D ,C R,SHQ,3HS," P,CHR,#HQ-0!!9&]B92!);D1E<VEG
M;B Q."XU("A-86-I;G1O<V@I       $D   !P    0P,C,QH $  P    '_
M_P  H ( !     $   ##H , !     $   ##          8! P #     0 &
M   !&@ %     0   9X!&P %     0   :8!*  #     0 "   " 0 $
M 0   :X" @ $     0  !K4         2     $   !(     ?_8_^T #$%D
M;V)E7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5
M#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,
M# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  O "\# 2(  A$! Q$!_]T
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M;Z'T_P!<_P"5?U5=S]?:^BLZ7T*OI9QOV<Q^2,<U'"=3 IL#MC^H.]-_Z?\
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M;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P
M   *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F
M    "7!R;V]F0TU92P X0DE-!#L      BT    0     0      $G!R:6YT
M3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B;V]L
M  !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS
M8F]O;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;
M    0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M          !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M    0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M        4G-L=%5N=$8C4'AL0'+            *=F5C=&]R1&%T86)O;VP!
M     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M              !4;W @56YT1B-2;'0               !38VP@56YT1B-0
M<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E
M8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC
M<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X
M0DE- ^T      ! !+     $  0$L     0 !.$))300F       .
M     #^    X0DE- _(       H  /_______P  .$))300-       $
M'CA"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          3A"24T#]0      2  O9F8  0!L9F8 !@
M 0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U     0 M
M    !@       3A"24T#^       <   ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H   X
M0DE-! @      !     !   "0    D      .$))300>       $     #A"
M24T$&@     #3P    8              ,,   ##    #0!A &( <@!D &X
M7P!K &\ 7P!, &\ 9P!O     0                         !
M      ##    PP                     !
M !     !        ;G5L;     (    &8F]U;F1S3V)J8P    $       !2
M8W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T
M;VUL;VYG    PP    !29VAT;&]N9P   ,,    &<VQI8V5S5FQ,<P    %/
M8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '
M9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN
M    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90
M  !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P
M(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   ,,
M4F=H=&QO;F<   ##     W5R;%1%6%0    !        ;G5L;%1%6%0    !
M        37-G951%6%0    !       &86QT5&%G5$585     $       YC
M96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH
M;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT
M"79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0
M   +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO
M;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<
M    #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P
M    .$))300H       ,     C_P        .$))3001       ! 0 X0DE-
M!!0       0    !.$))300,      ;1     0   "\    O    D   &G
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M_M.S[3_Z4L_RXDI__]D .$))300A      !7     0$    / $$ 9 !O &(
M90 @ %  : !O '0 ;P!S &@ ;P!P    % !! &0 ;P!B &4 ( !0 &@ ;P!T
M &\ <P!H &\ <  @ #( ,  R #$    ! #A"24T$!@      !P (     0$
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M(" @(" @(" @(" @(" \/WAP86-K970@96YD/2)W(C\^_^X #D%D;V)E &1
M     ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$! 0$! @(! @(#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,#_\  $0@ PP## P$1  (1 0,1 ?_=  0 &?_$ :(    & @,!
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M#&G(-2S1Y+^-O(_NO=$[_P"$]?R/_EQ?'G^8/L/>GS<ZJR0@?.5[=*]S[B[
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M_K]^Z]U__]7?X]^Z]T!WR%^2_0'Q.ZWR';_R3[?V%TIUKC:NEQT^[>P=P46
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M &:2W\,_AWF_V6W_ $9_[]K^^_E\'\6_R_[7Q?Y/[]U[K__6W^/?NO=?.O\
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M9-U#;'^C63HL8^ADWC%\>S2LN[%^4K1QQ?P]IF6I\!(Q9!^^)]U[JG?XW/\
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M_P"##$";[KR_M>#5J]-_?NO=?$\^5I_EEM\\<RWQ?7Y0+\ 3ON+^)KDVV/\
MZ9#MP9BL_O,>H#N!1CTVR]+H_NR-U*<NM)H_BEZCR>_=>ZN&_G^S?R39NGO@
MR/Y?O^D)N[XOBSU+'C&VH=J?Z/$Z/5\H<#%\FEJ!_>,_*1:MJXU9HS]T$)_B
MEX?X7;W7NEK_ "ZY?Y!Z?R6OG#'\G6[X_P!F'DR72W^E:,-U\O<,N^4R6YVZ
M3_V2DU*M@1M%<G_%_P"\G\7#52T_W'\6_P B.*O[KW1 ?Y!C?RVT_F3]/O\
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M@J9LJL"&?"*N/BKECFEDCI_=>Z1/\K3^1G\UOYFNR>].TNH<-7;%ZYZ\ZN[
M;9>^-PRQ8/ =S=S8RBH1A>@MNY&KKJ%14[EAKG_B&1F!Q.,B"+62QFHB#>Z]
MT1GI_P#EU_,WO'Y7M\)-B=#[TD^2E#N6LVON;KS.4:X&IV/4XFK2ES^4WMD,
MD\..V[M_;JL9JRMFD\*0*64O=0?=>Z,?_->_E'?*/^5M\A)^MNV,9E]_=>[Q
MK$DZ;[ZQ>-G.V.W:5J'&U%=3TL8K,G68G=> KJ_[*NQE6RU2R1K-&)*::":3
MW7NM]+_A*K\$^[OY>OP4[M[9^7%/!TR_R(WYM_LK"[,WKEJ'$2['ZQV?M:3%
MXO>.]I:RJBQ^U,AO"HRU3,:6HD66#&TM)).4>4PQ>Z]UM!==]L=6=O8>HW%U
M-V5L#M';]+6/CZK.==;RV[O;#T]?&BR24,^3VUD<G10UB1N&,3.' (-N??NO
M=-%'WOT?D.PZCJ*@[EZIKNV*0U"U?6%'V'M&I[#I321>>J%1LJ',/N2$TT'K
MDU4PT)R;#W[KW4[LCN7J#IRCQN1[>[5ZVZKQ^:JI:'#U_9&^=L;'H\M6P)')
M-28VJW/E,7!7U4,<JLT<3.ZA@2.1[]U[I6R[FVY!MYMW3[@PD.TTQ W ^YY<
MK0Q[=3 M2"O&;;-O.,:N(-"?-]R9?#X?7JT\^_=>Z2G7'</4G<6-KLQU%VEU
MSVGB,95K09+*]<;WVSOC'8^N=#(E'75VV,GE*:DJWC!81R,KE1>UO?NO=-[]
M[]'Q]AKU$_<O5*=L.P5.L'[$V@O8;LT'W*JNRCF!N1F:F_< %-RGJ^G/OW7N
MG/L;M[J?I[%T>;[<[/Z\ZLPN0JC04&7[&WKMK9&+KJX)Y#1T=?N;)XRDJ:H1
M^KQH[/IYM;W[KW2GI-S[:K]N1;PH=PX.LVE/B3GH-T4F6H*G;LV"%,:W^-19
MN&H?&28G[-3-]P)3#XAJU:>??NO=)#KCNCIWN*GRM9U%VQUKVI28*IBHLW5=
M<;ZVOOBGPU9.KM!296;;&5RD>/JIEB8I'*49@I('!]^Z]U%R/>W2&(["HNH\
MMW)U5B^U\D:08[K'(]A[1HNPJ\U\?FH11;+J<O%N2J-9#ZXM%,WD7E;CW[KW
M3SV'VIUAU'A(]R]K]C[#ZQVY+5QX^+/]A[OV]LO"2U\RL\-%'E=R9'&T+U<J
MHQ6,2%V -AQ[]U[I\PV[-K;CVY1[QV]N7;^>VCD<<<OC]TX;,X[*;<KL2J-(
M<I1YRAJ9\958X1HS&=)6CT@G58>_=>Z+?V#N#J#YF=#_ ")Z1Z9[ZZSW3DM]
M]2=D=597/];;]VQOBJV#7]A[-SNTJ/+Y2':N8R%1CJC&SY+SHDAB=FB(7D>_
M=>Z^,EW=_+G^9OQ]^5L?PI[$Z*WC'\B\GN6DVQM#8V!H_P"/MV%-EJ^3'[>R
M^P<CCR]%N3;^Y&C$M%51,%:)@9!&P95]U[H\G\SK^1/\V_Y:?6/1'<?;.WJ_
M>G77875^R:KL+=&WVILOB^B.XLN*XY7HO==7093)JTF#IXX#1Y:$#$Y%Y)HJ
M:1S3NS>Z]TLOBG_PGX_F%_*?^7[W9\R=@=>[EI<;BZK8&:Z2ZAF^UIMT?)G;
M--79^E[#W)L[#U&0II2NP**I@J,9]RB/FV:MIZ 2U$:QR>Z]T4[^6%_*]^4?
M\Q?Y9;3Z/ZFVKN;;&-VIO+ U/=_:E12/C*'HK:-%F5_CFY\I)6RT,AW-0Q4,
MR8O&QL*JMR2Q1#0I>6/W7N@R^6?\N'Y??$?Y9UWQ#[3Z@W?)V[F=WR83K6CQ
M% ^;A[BQN5W#5X3:6ZNOZS'-4PY[%[PDA62G 9:B)W,51'#.DD:>Z]UL8?\
M0-Y_,Y_T#?W$_P!'E;_>C_AI;R_PO^]FTOX!_IY_X<D_V8__ &4G[S^\.O\
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MOAGJ4E]U[H4?Y!'RF^27QV_FD_$'$=#[IW6N+[I[TZ\ZC[8Z\Q]7DZS;&_\
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M_O[O[L_8:_V_MO?NO='-^3'^A7_H'(^-GWO_  QO_HO_ -->Y?X%_"/]G_\
M]'_W/\/S/\-_T+?P#_G,+_9NOXAJ_OC_ 'C_ ,D_AGF^_P#\BT>_=>Z"#_A+
MK_HI_OI\H/[D?\-)_P!Y_P#97.W?[P_WK_V=#_9@OX?HQ?\ #O[U_P"S"?\
M&(/]E5UZ_P"_G]U_]R?VOV?WWH\?OW7NJ/.J/]EK_P!GYH_LO^&.O#_?V/\
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*_7]_OW[]U[K_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2325130d1hqhar25130d2i002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2325130d1hqhar25130d2i002.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[ $91'5C:WD  0 $    9  " (     ^
M $, ;P!P 'D <@!I &< : !T "@ 0P I #( ,  P #  +0 R #  ,  V "
M00!D &\ 8@!E "  4P!Y ', = !E &T <P L "  20!N &, +@ @ $$ ; !L
M "  4@!I &< : !T ', ( !2 &4 <P!E '( =@!E &0 +@ # (     ^ $,
M;P!P 'D <@!I &< : !T "@ 0P I #( ,  P #  +0 R #  ,  V "  00!D
M &\ 8@!E "  4P!Y ', = !E &T <P L "  20!N &, +@ @ $$ ; !L "
M4@!I &< : !T ', ( !2 &4 <P!E '( =@!E &0 +@  _^X #D%D;V)E &3
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M#_7D7%OQ[]U[K@^/IY"7B+02D<RQLRN1];:T*2!#;Z!AS[]U[H,^TMT[@F&
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M^MC]?]ZO_A8WO_O/OW7NHYI^?I_MP;_3C_?7]^Z]U@: @7^A_P"(_P!A^/\
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MI_P(/XN.3?\ /OW7NFB; 3QW*:6 %C<:3^3]+FY][Z]TTR4$L5P\;CZWX/\
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M7_+JI7HDF_\ X5T"JU3M?*S8"KBB:2?&[GDF97J200E+44F+AGI4"WL)(Y;
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MTW')5;<&WY7^@]^Z]TS3[<D4_M'_ ! 8?T_QX)]^Z]TU2XFJAO>-B ?JO/\
MB ;'_6/O?7NHIB9/U*P-@+%>?\/Z?3W[KW76BW^W_P!;^IO[]U[KF$!_'/\
ML3_O0]^Z]T GR0FQ>/ZUJLCEY*:GQM#DZ*:JFK(EDIHT>.JIU,B%6)+2RA0
M"2Q  N?>CPZV./57>+[)ZHKLQ]JN0P))FB6)ZC S4\6LN0&6IJ*)(D%P.20!
M[I4=.4/5S&V(?MMMX%:9],:8;&:3&/&A HX?5XB;)<\VM?VYTT>E M5,O#JK
M_D,/2?\ ;$V)/]??NO=2TK$)&HZ2>+,; _ZQ/_%>??NO=3DF4CAN+@\$?[#C
M_6_Q]^Z]U(66W];'@<_U_'YX_P!C[]U[KN6.GJ !-&DEK@%E4V! %U8\@$?X
M^_=>Z;FPL(.NEEDIGU^3T-Z?(JV5FL1J95X&J_'OW7NAYZ]^1W<W64%)C:3+
MP[GV[0Z4IL#N:D3-T--!&H5(*&64IE,7%&H]*TD],B_@>Z%%;JP8C[.CE;"^
M8/5&Y)J:+>N,S'6N=,BF3-4!GSN#\S$:I7JJ=J;=E K.?2A.11/\; >VS&PX
M9'5@P\\='6V;V'E,A":K9>^,!V7BT0/)34.2IL_6TJ.UX_NFQQ&<H'8$"U52
M1+'?U'VV1ZBG5P3Y9Z%?&=GXNI0+G*2MVS.'\;2U*K58YI"0++7P*\.G4"#J
M"Z3P2/=2OIU:O2^I<I3UL*55#/2Y.C>]JK&U,52GI^OIC=]5B/HK,W^'NO6^
ML=90X/-J*?(45!7Z5:T%;31/-$'&AF$4Z>:'4#:X /OV1U[!Z#'>/3>#W'AI
M</3T^+:@D*M)A<YBZ7,X2I,)62F2>DK(YT*P5"+(NM)=+*" "!:P8@UZJ5Z)
M!VO\0<15TM7D9]LO29%UGF;([2I(8L:CB-0'DQM)&U-%3!KD@14\C$\MSPZL
MGSZH4ZK]W+\>]Z8-9ZC#0R92EBE>,Q4T;K5W.@JIQTG[LCR!K@1&4V%S;VZ'
M!ZH5/0*5]#D\;.]-E<=4TD\9TR(\$L;H18>N&55D0G_6]VZKTW,B/RIU_P!=
M/XYLNH?4&_\ 7WOKW422'_#\< #Z<7O[]U[J*R6^H'_(_P G_7O[]U[K$4']
M.2/J?S]?KQ;Z^_=>ZPLO  ']H?UL/R;\'W[KW6%DL+<?6UK&W'UX'^'^\^_=
M>ZCNH^MA]3]/K_06)M_K^_=>ZPM]/]<F]OP>/Q<_X^_=>ZQL?K^.#_O _P!<
M<^_=>ZPL?K?^@M_C]/Q_JC[]U[J-58R?-T>0Q-*8EJ,CC,I0Q/."84>HH*B(
M/* KDHMR38'W[KW52NQ/B9M>KS=1)7;FSQKVDK3Y*.*@IZ5':X ^WE@J9&0$
M_0R G_#VV%Z=+8ZLMZRVH-C;'PVU%K#D(\*V5IXZQH13O-"^9R-1$6A5Y51U
MCF"L Q%P2./=P*8Z;)J>ENS6-Q]/R"?Z?6_]/>^M=8C)]?R!_KWX_P ;^_=>
MZCM)?Z7_ !^;_P"WN/?NO=1Y'M?_ 'OGCGC^A(]^Z]U"DE47Y_'TO_O)%QQ^
M/?NO=-LL_/!YN1>Y/^M87X]^Z]U!=R;\\<7_ #8'DW_/('^Q]^Z]T'.Z]KBM
M#Y"@B450!,].H]-6M^38<>>W_)0_Q]ZZV#T!V0QZJ&/C(56(*E?W()%-BK@B
MXTM[UU?J7MK=66VY5J:2N>CD"Z8:AXWJ$@-Q9S3BHIO,$^NC6E_I<>_=:(Z/
MWA,-\?N_\7@S\CML8K<3;;QU=#ALD]/*NXS]]1O E M12U5-6/0F65I:>G9V
M*SVD721J/B*\./6@:8/1=L+L/8774]9MW8.V*O;>&HZN2/[REI*&:OEI7JF2
M.?-9:M@EK,K6!6 NSECPJ*!I7WL"G6JUR>E**:*JIWILE#!D896<&&MI:6:-
MXFOI2:%D>FD8)^HA=)/'^OOK728HNL>M<?FX]P8[9^)P&82.:&2MVW3Q8(U$
M-0C)+%5TE D6/K-1(:\L3,&4$$$#WJ@X];J?/IQ_N3D*^N-/AJR@G28@4\5=
M5PXV=&(6\<DE7)'22%GOI*O<_P"I!]^ZW7]O2E7H/MMPK1[;61&&H-'E<2RL
M#^585G*D?3WZO7L=3H.A^VH[%MK27'^IR>)-O\>*T'W[KW3DO1':%0/WMH"I
MXMIJ:O!U"\?T%15O:W^'OW7L]--;\6^P<B&,6QJJBF/TEHJ_%R0DB]B]-)DV
M-C_5"+#^R?>L=;ST ._>JM\]:5T=-N7"9'#O,OFI*IXR:>I3_5P54)>GE9?[
M2AM2?D#W[K=>EOU=WYG-G@;8W3%_>K8N29(,KMO+,U11R4[_ +;U%*)"S4&0
MA1B8:B+3+$PN#_7W6J>G0G[\V%B:?%T^^]A5[;@Z_P K,L:S:EDRFUJZ<,Z8
M/<D<)O%+I4BGJ;+%5*IM9PR#?6N@,D@7[AG"#6552P OI4NP!;D^DL?]O[]U
M[J6%N"I ((M]/ZBUO?NO<.F&LB/J1;:XFNA/TN/H#^0'4D'_  /OW7OEUAQV
M5K,!E,;G\9*8*W%U<-=3N#I]<,@9HWY_0ZW5U_()!]^Z]Y=!Q\V?EAO;#-UW
MMG8V9I\72P[8P^>SM))C\5EHZK,/4.*>DR-/DZ6MIZBFH8J(%J>1#%+Y3Y%8
M6 JQ(X=65:\>@T^/OR*W-NVEW%5=A4.*W)+1U%#'CI:#'8;9\%)"Z3&6(4>U
M,+CJ>JDE< ZY%=@  +"_ORDGCUME X=&9_TO;:E)=MHR*38CP[FDC ^@X$^$
MF/(]VKU33UR_TL[4(LVU\FOT'IWA1<<_6S[6)/\ M_>J];IUS3MG9'/EP.:C
M-OU+NK$L!]#]&VZAN0?Z\^_5ZUIZ\_:VPK$_P[.1VO8'-X67_P"1\!X]^J.O
M4/0/]O\ >J[4VR^Y-F4R2RT,M/Y:#.PQ5U%6EJA%='JL97T,\2%&MI0!OJ0X
MXMHFF1UL+4T/4#X]=_9;NBHW%2YO"8'"U>%AHIX$P0R:PSP5+RQNTD>4R63F
M#I)']0X!!^GORFO7F&GHS]@/Z$?3\_X?7ZC\^[=:_P /7K<?XW/]/]\#[]UZ
MO71'/]+_ $]^Z]\^CRV/_#:?T_[GFM_[ .W^]^Z?Z+_M?\O5OP?GT$F0XKZX
MWM_EE3;_ !(G?\_[S[<Z;ZA?\B_WWX]^Z]UX'^G^^_J>?IS[]U[K,I'(^A_
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MKJU!UG6$$?B_^%OK:_\ O7OW7J==_;_3C^GT_P!C_K^_=>H.NC37'T_V%O\
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M"D@<W(/YN;VXY ]^Z]U%:)U&ED(M_M-_I^3^#Q]>?>^O=<=%_P##\?@&]_\
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M!_O)Y/T/OW7NIR2< _[[_8>]5\NM]2TD'']>/]C^?J/>^O=2D?G_ &%C]/\
M#W[K74I)CQS;\_U''^/)Y]ZZM7J8DP_KQ]!SS_L+DW]^ZW3J9'/;BWU_K_O/
MT/U ]ZIUJG4Z.4, ?\!]>?SQ[]7UZV#Z]38Y ;'_ 'UAS_A<6]^(ZWY=9=0_
MJ/P/]?\ XU[KU[KQ M_3ZW^GY_V'Y]['7NL953S87X'^'/T_KQ[]GKW6%H1S
M_0'Z?X_4B_O?7J=8&@O?CZ_[$7YY]^IU6G21WIM*#=^U\WMF>=Z2/,T$M$:E
M$\C0,]F27QET\@611==2W'%Q]??LCKV1T2&H^'6X(S+]OF-LR:4D,,A.3IY9
M6 .C6@I9UB+D"Y\CZ?\ 'WNHZ]7J9TIV)G-N;WJ.MMZU$[09.NJ,?CC5N)),
M1N2.H=4H_,[!UH\E('A\8##[EHF32#)JWU[H[#4G]!^+WM^2+6XXO[U7KU.H
MKTG/T'U(%K_[?_;>]UZU0CJ.U%R?2/\ ;?GD\7'OU1U[[>H<F,5C<K_QOW[K
M73=-AD>]Q>X/X_J+#Z?6P]^Z]TTS[>^I7TWYL 2+_4V!%OK[]U[IGFPE4GJ4
M!@"" >/I_@ +V][Z]TWR4LL?#QLO^W -A_B"+CW[KW41E-N1_O'OW7NL#+;C
MZC_6_P!X_P!?W[KW6%HPW]/\/\+6M_L;_P"^_K[KW4>2F#?3ZV^MK&XO^;WO
M[]U[J&R31_H;5^;,/]ASP#S_ +'W[KW6 U;Q_P"<1A_5D]0'X^OU/'OW7NNU
MR*$@:_TFUB.1^>18&W_$^_=>ZR???[43;Z$_X\<_X'_B??NO=8)'@E]1&EOJ
M'0Z3<WY!4VN2/]?CW[KW0M[ ^0G<O6"BEVEOBNEPA73)MG<'ASVW)8K@M'_"
M,O'6T<+R?0RQ+'* ?2PO[J45N(ZV&(X=')V)_,+V_#$E-VAUI+C:RS [BV,6
MRU$5=41XSMO/9**6"-Q'ZO#7I$MSIB_!;,1_">KA_7HY_7/R9ZQWM'CIMK[P
MQ68K L=*V(%=3XS,O0@LT%'-A\TV.KJFNQA/C1J7[V,QG2TK&SALH1QZL&!Z
M?-P_)+IK8%#5+O'>6WH,M42--54$>6BRU9K9C(T346V/XY61R!SPLR1"UKD$
M6&M#'@.O:@./1=MS_P R_K/!TTU'L?:N[MR5*EM,AI<5MC%,3QJ^_K:C-Y.9
M+#G_ "2%O];W<0GSZUX@'#HD'8'SO[IW=55;8.#;6S*6;R(C08\;CRZ0O>UL
MEN7^))!. >6IXZ<7^@'MP1J.JER>B.UT3Y*KJJ_(2R5577SR5%9*PCA$\\DC
M32.\<"1IS(Y(%K GVYU3K&D$-."(HT3406TK^K@VUF]V/OW7NO$GC_B?]A8?
MU_'OW7NL6HWM^+V_!)^G^O>_OW7NN[VO;CZ?6WTY(X M[]U[K$UK6^G^/^PY
M_//]/?NO=8&-A_MOZ_[;Z^_=>Z@54,-7!-354:S4]1&T4T4@U+(C@AE(/#"Q
MM_A[]U[H#XWKNM]P(MVJ,!D966 F^DT[MZZ.8GA98U(L;_4!A8_375N(^?0T
M+-!44T%91/YJ2I4M#)>S6OZH954G1-$S#4/SP1<$>]]5ZQ'ZW_!_V'U_Q(M<
M^_=>ZPL0 ;GZG\G_ (W>WOW7NH[LS$A06Y/]?H?Z6Y /OW7NL?@E-_2%Y(Y/
M-C^"/K]/?NO=,VX)ZNBQDD4<[I!5RQK5I&S*)UA$DL4<A!&N,2#58\$J#^/>
MNMCH#LGN.2DR4U$D!:.)4#2Z;?NR4ZRA@FM5,8=BH)(#%3<CZ^]5ZM3J"NY8
MI"(ZJEFC+*MGIR)/60H8-&Q1C;Z\$FUN.1[]UZG[>I4BB1?+"Z3Q'^U$=5OZ
M%E_4MP/S[WU[IO;F_P#3@6_WD@@>_=>ZE4>2J:$^@ZXK^J-OT_T.G\*;^]=>
MZ5U+EHJM+HWK LR-PZG\BU^;6][ZU\NLS3?0?6_/]/H+'_8$^_=>/4=IO\?I
M]/\ '\_UY^GOW7NL)J +<\?C_6XL;_6UC[]U[RZX&J"_ZWT_'/\ L#^+^_=>
MZ%#J+OCL#H[==+NO8><J,;51LJ5U$SE\;EZ/4&DH<I1EQ'54\FGB]F1AJ4JP
M!]Z(!%#UL?+J[WJ_YB[9[SVZM502'%[GI*=&S^VZB1#+2S^/]^JH'+DUN.EE
M!"/PZWLX!M=O13[.K5KTYUNZ7J9674;'DKJ((O\ 4B]^+G\<?['WNG7N@;[@
M?:.2V!N;^^U(M?MZGQU145,5D-0DL0*TS44K>J*L,[*L; @:F%^+^]BM>M'J
MA_-82CI\A/605!CI(II9*&)R'J@FIS$964*@9%(Y Y(O8>[4ZUU!>MTKH@'C
M4BY87+OQ]6:]_P#>??J];ITG\Y,?X+F&&IF_AE?8*+LQ%+-I  _!/O7EU[JI
MX8JNRVX8<?2TTLE1D<C!14Z+$Y,DU5.D,:"PY)=P/I[;Z<\NK7,9UUE:;&8^
MC6D8QTE'34P5? Z#[>!46U[_ $"_[S[=ICIJHZEG861 *''R%;W T4]KVL&T
MB_/'U]^IUNHZQ?W&R:*R)CYE5_U*L,>D\6.H J#<#WZG7J]1SL;(*&MCI02"
MI ID]0-B1P_TX'OU.O5'3?6;3JL=3S5E3 U'301EIZF:)(HH85LSL\TDBI&@
M Y)( ]^Z]7JNKM6K?>_9]11X5ER'GK*#!XL4S"6.IF>1*>-8'C+"19*J6P(N
M#?CVV>/5Q@=7'=:[.I]A;'VUM. +?$8RG@J)$!TSUSKY:Z?D MYJN1VO];&W
MMT"@ITR34UZ75OKQ86^MS;GCZ&Q]^Z]UQT_3G_6^AXN./Z\^]]:Z\5/X -K?
MU_V'^/U]ZZWT>+3_ -BUK6_[GBO]/^_"?7_7]T_T7_:_Y>K?@_/JO_)M_N2R
M%P?37U5_Z_YZ3_;<^[]5X=0+@GB]_P#$VO\ [X_3W[K?78>W]/K_ *W^/]/I
M[]UKI48C=>2Q:B(.*JE_XX5!9P@/U6.2^J/C\<K_ (>_=>X]"O@]T8S+A8TD
M%-5,!_DL[ $\<^%C99+'^G/]0/>^M=+%"/\ 57_%A]01_OOZ>_=>ZR#^H_)^
MG/\ QJWOW7NN1-KK8&WT_'_$?U]^Z]UV@)-R/]N?P;C^G-Q[]U[J#DY_%!XT
M-FDX(!-PO )^MQ?W[KW2:O?_ (C_ (ISSQ[]U[KD/\?Z&WU_IS_7\>_=>ZR
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M>Z]>H.H[XP$?H_PYM8_X6/U]^KUZGSZ;9\0C W3_ 'C_ 'OCCWOKU.F*JV[
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M0ZOZE3[]U[HLV^\-3UU7D(*=H*2CSDL=52G012X[/TVIJ=K(?VX:V-I(6((
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M4VW.M%IE;^R:K<-11;D8*&^JR2'C\^]=W7NT<.DY7?%[LS<$7D[A^<^".O\
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M$@A>5UHXXE:6JE8+Z8T4RL;!5)]^Z]FO51>1CW#W9V;)CL#CJO\ RJLEAH*
MQRN<1B()-,U;7J+B$QI^Y.QM^XP0$^D>VN)Z=PHZOO\ C3B=I;$V%B=D86CC
MH%QT(^Z:5(TJ<ED)4C^]R-8P4&6IJG7F]]*A5'I4 .@4%.F3D]"=NC:.#HY\
MENW$86B;._PN1)I**@I_XKDZ6D62IAQT56D?W4B/,O[<.K1K(L ?K[K70C[%
M^QV1UEM.;=-?3XJM;#P97-FMECI=.;SGDS68B F96$B9"NE15Y8*H'X]^ZV>
MDG!VY0;ORU7B]M">IH:".%ZFKA,<7E,]2E.#$9GB/@B0M(["[E4TJK$CW[KQ
MKTA^P, [4LF56KJ9Z;A*RDE8S)&LAT"5 5]419@K*P8B_P!;?3?6NBK^:79F
M;6OQDA;&SLRS0,KF*,2<2P2QL KT\BW%CQ8V/^.NK<1TN,E/2O#3Y6AG(QV0
M-D0N3]I5 :I:*1[\Z>&C)_4G^(:WNM=3\94M+$L:!I')( %R2+\?[ ^_=>/2
MKIZ&6P:5='!.G@L;?ZH&X7Z^]]:ZE& 6(_XG_!O\?I;Z_P!??NO=)'.X:*6.
MK<4WW5%6Q&GS6-T!Q6TUC:JIP?2N2HKZXG^MQ8W!(.NM@] #E,9_=>O6-*Q?
ML)E63'5J1Z:6MI;D+P /#40:2KJ/7&PTD$6U:ZMQZ$K']E3;9Q$LLDDU-6*1
M!'E:.O>&7[1F\B1TWB?6J&;4[A&TEKG\7][ZUQ/0[]5_+'-X"2GH]XI%V#LZ
MK1:=X,[JR-1C:6=@)Y\=),Q*5'C;_.(R5  ]$H_.J#RZ]T/F1VWUSE*:;>W4
M]%1[N.2IC&<>RQ5-?MA]25DLAHH:.26JCU1",R^-71"1,L9;5)X$^?6OLZ-M
M\<^X*O?F0VYTSF$Q&SVJHI]LY.FI(\-15>YL7*98*7%8;'UV,J,=%.^'=X7C
MF,G\1D:-/$)2SU%'%.[JRFN.B^?.#^7CE^OX]P=N]38>H;8U)]SDMQ;9:D^P
MFV[0"TZYK$K4U"O78N>GF5YZ6.%)\<X9&2PLOD<'!X];*TSY=4^NFD_['_7'
M^'^/MSK7RZ;ZNE692RV$@''XU6_'/Y/]?Z^_=>X=)^0,I*L+,#8@CD6%C?@<
M7]UZWTTY.@BR5,:2<_L.RF5"JN)%4_H8."GU(8$@V90>?I[UU[H-\IG*;:,V
M-PF-PU1)#4U$=*'@0 "1DC_=F94=JB65!:_IL$)N1PN^&!UOI^JZ\1WN;>GZ
M7YN>>?S;WKK763;WR FZ.RT&[Z>666,.E%5XI9"L>8IY?W'HI?JJW$>I9+$Q
MLH(!^A]6F>O4KCHY7QU^<>U>\\MD]K[@HZ+9FXXWDGPT$]<%H\S1W),%.]4=
M2UU*EM2EB91=E5;6%@U>JLI'1M\G()*2JLP*M!*18W%BAL>."#?W;JO1;PA!
M/^N1_P 3]/KR?>NM]<[?U (_V)O;_'_ ^]]:Z]IMR?I_L.=7U//%[>_=;ZX:
M>!]+7N;$$#_"]_I;WKKW7K>F_'T_%QQ_M[\_[W[WUKKB5!Y_'/\ O?/T]ZZW
MUC*<#_B1_3ZV-OR?\??NO?;UPTFW']?^-_7W[K9QCKB1]?I_R/\ PXX]^Z]U
MQ5/R?J?]XYOR1;W[K71XM/\ V+:M;_N>'Z?C_F0W^]7]T_T7_:_Y>K_@_/JH
M3*I_N4R=_P#G85G_ +DR7_I[MU[J!I*@\V_/Y!L?]< "WOW7NNU# \7)'-O]
MO_@;<^_9Z]U+BJZJ'B.HE7Z^E')!M_56-OS[]U[J;'E\BEOW5<"]_)&G('_!
M=))O_C[]U[J?'N&J4C7%$W_!6=?KSSJU_@?[?W[K5.I\>Y%^KPS+_P $9&O^
M3^HI;Z^_5Z\1U/AW!1MINSH3;_.1,#]"/QJ L?>^O4Z<HLM2/])XC_@7 /\
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M'T%[?GW[KU>L3;4H7^GF3DBXD!_)^EPWOU.O5ZP?W8JJ9A)C\G44[J=2@EU
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M0#_4_P"VO_2_ (^OOW7NDY5SW+#F_P#MOZGZG_6]^ZUTP53@(?IS>WX_UO\
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M4HJIE/D6*6>&*2VEU#>**P->M<#T1IN";\6N#P;_ %Y_K^?>^M]-U92"<%T
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M1;A92T'X'_'55%^?Z^_=>Z?X:F&87AEBE%A8Q2+(MK\'TD_7W[KW4M7Y'/\
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M#L1;WZG6ZCJ95;UZTVM0I@MLX7(;@SH2"&KRM5XL?3(2T45;)2TTM!4A)O!
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M7XY_V'^]CCD^_9Z]URT_U_Q/^N/IR!^/>^O=<M/('_%.?]8?CW[KW7M -_\
M7X%A_O5_Z_3W[KW7(I:PM_0G@WMP.#;^OOW7NNPEN?Z'C@CCZ#@V'^\?CW[K
MW7,Q@?CF_P".;WN..+>_=>Z]X[#](^G^N?\ 86]^Z]UV$M_A;Z7O>W];_P"
M]^Z]UGCDJ([B.:9.?HLK@?47-M7Y]^ZUCJ8F3R,8LM2QM8?N*LGYYY92;_XW
M][ZUU.3.UR6U+#)_7TNIXXOZ9 O^\>_=;IU-CW)(IL]*;7N=$HM8?X%?P?\
M'W[KW3E%N.FX#"6._P"&34!>WT*%OH/?NM=.,6:HW'IJ(Q_P=M!_PY>W'/OW
M7J=.$>0B?Z2*P//I8,/\/HWOW6J=3$JQ^&O?_'^EQ[]U[J2E63]2#>_]/]O<
M?U]^Z]U(6J']2/Q]?K_4_P!!;W[KWEU(2K'^JXM]/I8<<7L+^_=>QU(%8.+-
M_KW(_P +_P!/K^?>^M=9UK#Q8GG_ !M;_8"P'OW7NIB5C7X?_8 _3^O^]>_=
M>ZEID)#:Y_VYX_XG\'W[KW3C3Y4H0P9D86 *,4-_Z^D@W!//OW7NGZEW5DHC
M^UDJQ0.0KSM*O]>4E++8^_=>Z4M+OW)IQ))2U'/UDCT-^/[431B_Y^GOW7NH
MN[>]=O\ 7^V,INO=ICH<5BJ5YY&CJ8_-5S*K&"AHH9M'W%95R#1'&&N6/X )
M&B:9ZV!4T'55^.;L7YV]F/F][9/([.Z5V[52/!30F;^'T<,+#3C\:KHU)6[E
MK*>2]16.K+ G)%O'&U,L?EU?"#''HV>Z-W;6V-@(NK^E\?2[8V90J8Z^KQ*&
M"MW#6>,4]155E<&%76K-'&HDFD8RU%K$Z J^[?9UK)R>@*9'E?40S'Z_D6OS
MR?[-[>_=;ZFP43/:RV_H% M_@?ZDGW[KW2DHL',]F=1&.+&06(' X3DWN?S[
MWUH]*.#%T\=KKY3Q^H< VM;3^?\ 8D^_=:KTZ10!?2D:KQ^E% /].0/Z>_=:
MZ<HL=52"R02>KZ>@W/\ K7 O]??NO<.E9A^NM\9Y9#A-H[DS CD6*4XK"9+(
MB.5PY2-S14L^B1A&U@;$A3_0^_=;^SKCF=A[PVY-!3;AVQGL'45"L\%/F,/D
M\9/,L<CPR-##74L+R+'+&RL0" RD'D'W[CPZ\#TWT^W<U5/'%2XRNJ99C:&.
MGI*F9Y6XL(UCB9G)O^/Z^_=>KUAJ\3DJ%M%;0U=(]RI2H@F@:ZVU+ID5#<7Y
M'XO[]UJO4 H1;4I'^N+7_P!8V]^ZWTGJG:6VZO,TNXI\'C&W!1JZ4N:^Q@7)
MPQRP/3O&*Q4$\D7AE90K$@7X%_?OGU[Y=-N1P(>LAED >&1GIY9"+J(Y^%9P
M>%\4A#<\#Z^_4ZW7H2MG;$J<L1#@,'5YNICTI/(T/@QU#*5!*5,[.D2LH-QK
MD4,.0"/?N'5:]#Q-U?A-GX.;<?8^7$D%*NJ# 8B1::GJ:@K>&B2;1')-/*W!
M$2)I%R7(!]^Z]T$.T,'7]B;L,5'0)C\7)5QU-8M+'II,+AXW.B%7:X:JEB4*
MA<F21[LQ/J(]U[RZL$I5@H:6GI*9?'34=/#301@DK'#"BQ1(-7X5% _V'O6>
MO=<VJ;?G_"U_S^+_ $_/O=.O5ZCO5\?7_6^AYX_QX]^QU[INEJS<^H_[ \#_
M  OQS[]GK74-ZJY'/];V-OZ?[U[]U[J'+5FQN0.+DW/-O\./>^O=-<U7<'U<
M_P!?J?S_ %XM[]U[IIEG'#?4WO\ GZ?G_;>_=>Z:Y9B;W(YOQ^+BY^H_H1[]
MU[IJFDU7%^;GZG_8VOQ]/?NO=-<KDWO_ *U_Z <<D_U]^Z]THL8@BHPS  RD
MO?\ )'"*+7^A4 _FWOW7NBJ[\7*X7/=@U&&<4^6CQ29+#2:8"S54M3BI:<4X
MJ8Y8&E,SZ$NOZ_H00/>CU8=%0CW)V)DHI:C/;BW!*,@62OGGR];*<JNDF-:I
MY:C561+'(8TU7CTC0MPONN>K8Z'_ *SZ\ILMC1ELC)28S%0$^'(5TU+0T;24
M^EI--54LG[J!U]$=Y"2 !S[L.JD^0Z$.$[0QAHGP\57EZQ:G[I4JX(A2)&(X
MWBI:B\,<<ABEUEW\:HP4#\EE]UK/'I[I\?NW/58IER<M-BW:.HBI**>DIJ:*
MH10@=GH(8%,I5C:]_J.;\^_=>Z&O;%=O+9L62JMOUU?55-'C:RN6JFJLQ)%*
MM) -:Y#QU0I:_'@IY95<7"W-P!<>('GU[H!MK;!R67J,M6YF3-[CR&4J*6#&
MZGJZP2UE96QI55U95".5A(E&[!&8D(S78 Z0?=;KT(NUH>[^J&IMU[5BSV$Q
M&"RD]'%3JC5V$:IE:FK(W$-351)HJ:/]Q98I$5FIG#-?5[]0''7J]6A?';LG
M:/8%5)MWLZ;#4.;KZY<G)59&ER=9'DYDEADFCH\Y-'2T6&J)XX9(XGBJH&2:
M., O&9-;; @57K:D'CTENVOBEMU\O4TN^JJAI-LKD:N6'>F=WU2X"HQ^W1-,
MV,J8YJ_;5=1RQ4F&>&.*1:NLCE\$=/*8YM:1^#U&.O::'JFG?NVL?M7<F7P^
M&W)AMY8G'ULM)2[EVY4+6X7(F%8WE-%70&6BK!"90KO3RSP:OT2,I!]N<1UK
MH)<E2)5.K7>.:-M22PN8I5/)(5P=0##W[K?1@.HX\-A8Y:VLDJ"\U.6_B#ST
M\<-'11JTF6K:BOKJE$IY(*="&)*F*$.0Q5Y%'NM'H3]V08V5:V@CT#&5,(@B
M--5E7\%>9*:>BAFAF\WAFIU>I@DB(\1C)!4M(?>^J]5];<^&595[GWEN+-;Z
MR5=3[/V_F][X::DD:KJYHL?]^V$I\W5Y*"334R5E*OW$<8(:)6T2 L&5O33)
MZ<U8Z C=72&SZ]LAN"#'[KQ-779-9_LZ-J>MP]/+5R9)ZJGH912LXHVJ8P*9
M96618D96)*ZO?BHX];J>C0=5]%9?8^VVS&;6G@C?$1G&03UM(C0TF2K$EFC6
M$S U.2JV*/+'!Y#! HUL"2!8"G52:]&DZRS-17XVKQ-6)6EPKQQ+*^HWIY@_
MA5G(_6OC/^-[_P!/>QU4]"4_ _K;_6)MR3^>#^/>^M=5][AHY(]Z9VHD TRY
MK/:#;DZMR3"_(Y"CZ>Z^?3@X=#+N/[C&[TWV]/-)33YSH]*BA>"1HIY<CB:G
M)TP>!XV5_N88ZV/25.L "WOWG^75?\_1@,0DJXC&)4,[SKCJ)9VD):1Y131"
M1G=F)9V<$DGDGW;JO16_E)\@MK=3;8J=OFEQNX]XY^B88[;U6D=32T5.]UBS
M.9A)NE/%-'>GCX>61+@@*6%6-/MZLJDGY=49[BW#E]QY2KR^7KJK(Y.MF:6H
MJJF62:34WTY9FX0"RK]%4    >VNGN'1^/B=NG>F9HZO#9JGKZ_ XZG1L?FJ
MH2.J*'6)L::B4DU 3ZJ06**+-_9]W4^75&Z'_>=0^%S6/BC\]'1UHC<5Z1.8
M()VDD40M)8I&/1<D\#5_3GW8\>M#AT8[I[L?-[(S-)DZ6J=(7*T6;IO\Y39#
M'2CQ3F6FN(IF6)V*A@022OZ6(.^/53U87OC8M%!C\9O+:,LN;P&?QRSI4T\B
M5-2M*U/'-6X^ M'(]8*.235$&;7H:.UR]CX'RZT1Y]%0WKF,++3K!2O&_P!O
M&12Q31P30QSQAX)]<)EUQ3-&JZ5(612;'Z*/>^M=%JS-#'YIJFDC*1%RS1!P
M^F,DZ9 55#I-N;J"#[UU88X])VP_/U/U)MS_ (?[#_B/>NM]%=^1'5%7NRB@
MW/@():G+XF#P2T$=W-71F1Y6\$0O:>.20D6 U VY-O=6'IU8&G1?=J]!9FN\
M55NB<XFG.ESCZ;3+D&6X)264AJ:D:P^@$K#\@>ZT]>K%NC#X#86W-M1 8C%4
MU/,$*/6-&)JZ538MY*N77,0S+^D$+?Z >[=5K7I4+#XS] #S8_7_ %C_ $X/
M]?>NO= GW'L),SCI-Q8VG_W*8^)C7)&@+UM$BW9B%%VEIU%P?J5O_0>]=;!Z
M[^)'<3[ WA_<W/U[1[4W1((J8U$A%/C,RSJM-4#6VB&.I'[4OTY*D_3WM30_
M+K3"HKY]6YBS68$%2 ;@\$6N"#]"/I[=Z:ZXM_7_ &'TL+_3Z_7Z>_=>ZX_0
M'FW/Y%OQ]/S;W[KW6)FL>#>_T '%K\F_^/O76^N <?3\_CD'\$?T^OOW7NN6
MDG^PUSS^DVXO_A[]U[K@5L>5^@YOP+CZ?D>_=>KUA>9([W=!].+J>?I^/\![
M]U[J#+D8$N?(I/U_H?\ 'D-R1;W[KWRZ.U_%(_\ AM+[G4-'^ST>"_\ Y0+7
M;_7]T_T7_:_Y>KT[/SZJRRH_W*9(_P#5PK/_ '(<?F_X'O?7NFXK_L?]?_;?
MX6]^Z]UVJVX'/Y_WW^P][Z]US"?3Z"X^O^%[?C_>O>J=>ZYA!].#]./Z<?[#
MWOKW7,(+'Z_FWT^HM?@\7M_A[]U[KOQ_X?06)XY_WKW[KW7806N!:_Y(M8?4
MW^GOW7NN03\?3^@_%N.";>_=>Z["?0_[&WU_/^PX][Z]UR"6'^]$6_UO]AQ[
M]UKKF([6X^G^M]/S]/Z^_=>KUV$ 'Y_-_P#>_P#7-_?NO=<@@/Y_V%A_MN/?
MNO=<O&3]/]<_\4_U_?NM?/KWC/'']!_B?S]?\/?NM]<M!_I_M^/][]^Z]3KV
MGZ?ZXY_QO_0^_=>ZY:/Z6)M]>?\ ;?2_!]^Z]U[Q_4V_I8_X'_ ^_=>IUWX^
M38'^H_WW)M?W[KW7?C/^POS_ %Y^GU_UO?NO=>$9'T)'''XM>PX'OW7NI"25
M,?Z)Y%YOP[<<?7ZV]^Z]QZEQY/(1WM4,?\&"G@<#DBYM;W[KU!U.CSU8EM:1
MO;D\,O-K\D$VX_P]^Z]0=3TW']-<#K:]RKJWT^OX6QL/?NM4SCJ;'N*E/ZA*
MGY!*W_( _2Q/^QX]^Z]0].4.9I&L5G0?X,2O^ MKL??NO=3TR,3V*S*W]"&!
M_P!A<>_=:IU-6N!MZK_ZWX)XYMS]/?NO4ZEK6BUM7^L#^+?U_P ./?NO=2EJ
M[&^HGBXYY_I_MC[]U[J0M;8<L!8F][_X_P!#<@7][Z]0]5L=E[ASGR?[IH>L
M]OU,T&Q=IUU0,C51M^Q(E!4)!F<X^G7'*Q)\%&#<%G6^D.Y#9[C3RZ< TK7S
MZ.?G*K$;%VKB^O\ :<"8W'TE(D)@I[ K2#7<3.!JDJ:Z0&25SZGY)OJ]WX8'
M5!DU/05A&?U-RS?DB_U (M^?K_K\^]5SU;I\QN(FJ3JM9 ;,[ @?F]B!ZB1_
MC;W[K72RI<?!2@:%!<<%V'J^GU7\* /Z>]]:KTZT]'/4&T49(OZG^B"PN;D\
MW Y-OH/?NO5Z./TO\+.S.U\(F[YC2[6V<-$J9;,0U[U.2HE6JFJZO!8JEIVF
MR4-'3T,K-+))2TY*A!*7('NI8#'GUX ]6+X3^6IU+B,3'60[VSO9.67*Q8Q(
M-O/MRGH*ZOHZR9<MCU@I\Q,V+-/#-!%*U56L\$L<CB.1&55;\0^G5]/1_P#;
MO1/QHZ<HMLT6XL=UIM#<-%@JC,R^-<=MZIKX,9CJ6+<>2JLOE<G5[AKZ6DD;
MS.&R'A5([K'Q,7IJ=N%:=6HHX\>D1NSMWXH[-HM]4VSM^['E["S<LU;49""N
MI)ZNBJIJ]A+5SYO*U$6 Q=%C_OI'C1ZB!)";6E>0AM@.:5K3K1*BM./5-/R9
MILIONIJ-_8S=6.SV$J(,=2X]*6>JJZ6NR%%1FEJJ<55%22X]<O1,SM(C.L1B
MEUK:20AGUP*=-GC7HCE+OG);7KWQDTL=+5JY<_:QFAJ*:1PJ)*^3A_RN0Q:!
M958+QPH+&^^M=#U@^[=Q4^#I,'DX<=O';D=5Y84KY)3D*2BIL<]+_#L,\4T5
M'08]D!%1^PSN@L]R!;U/3KWR/46MZ>I]YX*NWKT_739"#'^"ISG7N64OF,/2
M3)4!JBDRLE0T573EJ-C"H#'5)H<@A1[U7UZWT7Q=#F>.6.6AK*64P5F/K4--
M6TLX<HT<]-(%D0EU(%P#<$$ @VWU[KHQ*UXW0,I%B& *L#<'BPOQ[]UKHTW2
M6YL/C=N9G'58AQW\'ME*JI=N:FCDC6!II)'9I998'@"V-_\ .*%^MA[KW0-[
MUW!FNX=XT>+PT$OV$1:#$T4I*Q10JQ:HR^0*:TCU"Q8\V50HN?K[KW#[>C7;
M)VICME8.GQ%$JO/99<E6A=,M=6LH\L[_ %*QAN(U_L( /ZW]UKI5M4$CZV'T
MX^GUO^3^+^_=>ZCR5 47)O\ X<?2_P#A[]U[J%)4ZCP;V_U[?CZ?ZP]^Z]U"
M>;GDW)_'^Q_/^N?>^O=17J+<?X?\2;_4"WOW7NFZ>HN".+#^E^1Q_L??NO=-
M,LQ<_7^O^QX_V!^O/OW7NHLDUN">>?Z?UY_US?CW[KW37+/R;'C_ &'TYXL/
M?NO=0I)0?SS86_WH_6UN![]U[J(6+L +DEE 4<W8FP%B/S[]U[I8*NF.*(?V
M(T3_ ))%KG_8>_=>Z+MWQM:/+TD<SMX8,UC:K;=5,K:#3U3I+58BKUV/JIZH
M%PWU!B7WHYZV.BQUV-.WDVY5;MI(*O)''4=?%A(H:JD:2%X()F.2GJ8(9Z>&
M:8NNB#R L'TR>D$:^WJW'ATK(=Q93*4M'C)JDQ8>B3ST>'IXA34%$]0J-(T<
M2*HFE=44-,]Y'T\GWOKW#H1.OX8<CG/M7",#3O(L;,BQB5&71J8D7!:ZD WT
MFXY%O?NJGAT)^X]WGK^IHXL3C<>:JNH(J^G7)P+5T5$9)'B%0F-F_:FJ!)3R
M ),&AMZBC$@CQZ\!TFZ;Y*]ITE6C_P!]*>=$N@QM5B-O2XP(5,;1#'G'?;1Q
MLC:2%4&Q]ZH.MYZ-+T9\K=O8G,8]=Y[8@P3(\L:[BV-1T<40%</'4O7;>JG-
M*I&H2I-3,)(Y44JAM[T148Z\#3CU=-V!MGX][IZ7S7=6-_N_@J+,8W(Y';OW
M-<*:DJ=UY?4M?(V(IZJ:AK-RY:H2U/ D6KSA7*AF;2R"X;2>G"%*UZUY]\;^
MW%U_OZMR&S*"MQ&2V7N^E-'D\_'68A9LC1Y!()7.VJF@ILS.:FJ:*I*53T;1
M-$UCK:P?XCY=-4ST:O=VTY]T;+S7;G85?+V/O"#:J9J@K\G+0R;,VLM/E\=1
M5>/V%L6A:EVQCH,--F9I(W:">H0^67R:I!KT!0T'5JU%>BK; Q.+WK#N+"YS
M%HRY7[,#-X^EH:W-8)I*EJR2IH:&IFQ]/,Y:FTJD=12ZU)@>18I&M;JO1;-Z
M[6JMJ;AR^&J"THQV2R-#%5F"2G2K2AK:BB^ZABDU.L,STS$ DE2"I]2D>]=6
MZ:\=F)L;#- 23 S"9. Q@J4(*S*"=.@CAQ]&!(/!/O?7B.GN?L_4:9LLZ)7U
MTST\,:RHRM42EYI?"J*@2,Z;+Q95 ^C,P]^KUJG2HVGV3C\+1;TCS"5GV^X,
M)'AY5I8HG>IH:NH:EK:5I)9$\#+!6F1&7U70BXO?W[KU.D[09JBB;^'["VF6
ME,HDBR>:"Y2M1A)4M%-!!*C4-&R-5O9M+LH8^O\ /OWV=>^WH4L-TON_=+QY
M;<V[L0DDJ*YI?XO!55Z+?4(G62:&EB 'TTR.%^EO?NO5'62L.2V9F,?M^BAQ
MT=#+EJ.GJ:F/755-:]1.J223U#D(S31H>44!?HI M[]UKCT),]5#$C2/2Q-I
M5B5+5"AK GBTZD?3WOK71$=VO'-7S5Z*$>HS&>=E%_1&V;AE1 6+'TF9N;W(
M]U/5QT:;+;,PNYI-MY+(BIBK<%XYZ.HI)_MVEAE2!IZ*K]#>:BE>%&*\,K+=
M6')][IU6O0/_ ".^1&#Z,VYIB\&3WKEX9%V]@]:LD *NHR^6"LKQ8RGD!"J#
MKGD]*\!W31-.MJM3\NJ(]W;NSN\<[D]Q;@R-1E<WE:B2JKJVH?6[2.;!$ LD
M<<8LJ(H"HB@   #VUQZ> IPZ,/\ &CXN[D[GRL&:RHDQ77^/KH_XMF)5>.HR
MOC97FQ."!B*SU3+Z9)C^U3J=1U/:-K*M?LZJS4^WJYG']>;-VQ245#C]LPC
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M^ZW\^HKU)_+?UO\ X_[?^GOW6J=0Y*H<^H?6]B?]@?K?W[K?422L6Y]0_/\
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M'OW6NNBE[#G_ 'UK<_GZ^_=;KU[QD?C@#Z<#^OTM_O/OW7NNO$!^ /\ ??\
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MU%"MPM>ED96J*13SK5T*JNI60.K:ZWT O9O7B-CJKL?:T+5>$K99JS*4U-'
MIP=?4SS 5*4D"SQT^$S9]=-H"_;5 EI6 DA*C1ZL.@&V_NK)XQ)),5-5)5S1
MS,]3!(SPT8.N"-U2-[E]3Z=/%P;'Z@KZO6Z=.^/[ JX?]Q-?JR35$XK*FIF=
M4CI"Q"2>.300J(A)TK87']/?J]:IT0#O[O+*YC>\]'L;/9+'X7;LLE)#68K(
MSTRY6NCE(J:V]+(JSTOE31#<LK(I8?KM[H6SCJZKC/1S?CANS<N^-@Q5^[:-
MS41U4U!%6ST_BBS=%'%"ZUWC:-8Y/7*T3LJZ&>,_0W LIJ,]584..AJCHEH,
ML4IHUBI:FG\QBC31%')&^@Z% TJI# V _/NW5>ASW)EXJSJ[K2LJVUYG;.7W
MKB*>=F$=6,+1OMS)XHK.8W>2*EK,Q5)#<V0(0. +:\^O8ZC;HW=)D^K,?3Y.
MLAJ9ZC<55/15#2U+Y1VAAG^\:1FJ6IS3,U2I=T5&>2P.K2?>^M>?22ZCDE;>
MM!C8\VN%EJU2+[N6HU,742+]JD+2Q"J6N+Z$AU%WF\9C]8LWNMGH;.IMTR4.
M\M\;.R>!QF1P]?38O#R96EC,==0Y;+N\&.JYJG&^:DR=)E?XG()HR9)I98H!
M&X6%8_>O.O7O+HM^]\1_"L_D:=(S%&*CRP1%!&RTU6@J:>-HRD9C,2/I(TK]
M/I[WUX=)RAQ-+G7&(JG>%:B6CJZ:H@*K44M=BJN#(TD],\BNJ2H]-P;'Z_GW
M[KW#H4LC#!086KHZ6-$$>.J8XXXP $CCII H6WT5(UX_H![]UKSZ ;/J'ZJ5
MW7D;KI0#QS=-P-^ /JR\^]'AU;SZ,7OB"GQG4.'W>N*RV9KL%M7;&C'86EJ*
MZLJZ:H3&05 6BIXYI9/MHJEYB5465"6(7D;\NJ^=.D9MO;.Z=S8G'Y?%8B/$
M8_)TT=5 V?,F-JECF!(,N*C@EK(WX^D@CN.0;$$^ZV:=+B+JK)2T=52Y3>-?
M2QUE/-3R)MVGCQPC\T;1LZ3UC9$L\>JZG0OJ X_'OW6J]%*RNWHL%A*W#T=1
M+54VV<E4X>*2;Q_<2T^-RU-CH9Y_&J1>:81AFT@+<FP X]ZICJ_0._,_H/<^
M5RD?:FTGKMS4=9BL?!G,3"]1D:_!/1TB1"JHZ8-*QP\D2781@"F>Y*Z&NE6'
MGUM&'#H-?B]\4EWY-2;Y['AK:':-+5NU)@IJ>>DJMSF 0/$XG<QO'A6D+K+(
M@#R%-,9]3.GE6N3PZ\STP./5O^/?$XFAI<9B:*DQN.H8(J:BH:*"&EHZ2FB3
M3%3T]- D<4,* 6"@  ?CVYTUU.%? UB9%X-Q:W_%3Q[]U[KMLE1(.64G\DO_
M ,0#^![]U[J&^=I5N%$9^O)(N/\ $&WT _V/OW7ND[7UZ&9ZW'R)1UKPO3SE
M4!I<C2R6$M!E*;_-UM',!9E8&WXL0"-=;'3,^%H,I":K;U-,,DA9\KM1Y!--
MXU _RS;4TI:3+TBMRU-8U,*<^M 77W6\])E2DJ1Q*I9PSQE)4N"Q(#J?JL<K
M/Z3J(9N+FY%_=:ZBA8X:Q:>4.B,X?Q&P$D)%YXXV*/X'==5AIMJL0 PL?=;Z
M$E=\/183^&XW[OQ0/)4!6/W$BQF5&%I5=G2&_JEC1R@D%]+ (4]UJG0)9.1*
M^HE76KL;RTT@/!3\0WU-:XY %O\ BONM],'C/]+'\@\?3^O].?\ ;>_=;ITP
MY['^2$5:)=XK+)8>HI8D$@6_3Q_M_>NM](UXB;W%[G\#Z?U-^?Z6]^Z]TBJ[
M<F$IFJ[5T4\E"42:&G)D<U$K,D%)3Z1HJ*N9XRJHK%M0Y M[U7KW3O@%RE>T
M3U:!)JR>.2.A10PQU* H\<L@YDD"^J1CP&-AQ8#PKU[HMGR+VI!B-[OD*" 1
M4>?I8\BNA0J+D4=HZL+:P#,Z+(?\7]U;CU=>%.C<]1;O?/=>;<JII#)5TE$F
M-JV9BSF;'J(%9R3<M)$JL;_6_NP..J'CT($N5 N3+&G]-4J+>_TO?\^]]>Z@
MOF(A>]5'QSZ7#'_DVYN+^_=>ZARYN ?[N9N> J.>>?\  #\_GWK/7NF^3.)?
MTQRM_0DA1_M[DV][Z]U$?-2G]$ ' N2Y;GZ_V0/>NO=0Y,K6'Z>->/JJ7)X'
MY8D<>_=>ZBO6UK<><C^FD*O'_(*@^_5Z]U8=YY_^&F-?F?7_ ,.)Z-6IKZ/]
MEIOI_P!:_-OI?W3\?^U_R]6_#^?12,K_ ,73)?\ 4?6$<?3_ "B7_$GVYU7I
MM-S].1?_ &'TO_C<>_=>ZZL;V/(!_P!XX-[?7G\_7W[KW60"_P#7_>OZ_@>_
M=:ZYC_8_G_B+ _FW/O?7L>760?[?_7^G^]<V'OW6NN7^^_U^1_K^_=;ZYC^O
MUX^I-^;<CW[KWV=<K?X\FU_]MQ]1QS[]U[K*#]+W('Y(^G^/T_/OW7NN[WY(
M_K]+?CZ7^I_'OW7NN0 )O:WYY_UO]X_V_OW7NLHM^/\ >?\ '^O^Q]^Z]]O7
M,?@W_H/Z_P"]6_/OW7L]<U^O]/ZF_P#MN#_K>_=>ZR '_7'T_P ;'_;?7W[K
MW7/2./\ >_R/Q?@7]^Z]PZY  ?7\?T_UP/K?_#W[K762P(_QO_OKW_P]^Z]U
MS'')(L#P!S_C?@>_=:ZY'F_'/^L?\?I_6_OW7NO  ?7_  X-Q8B_'^''OW7N
MNM(^G^N+6XL#;^O^/OW7OGUR"V/^O^;G_>>/^*^_=;^77B#]./Z_7FWXO[]U
M[KD%M;\&PXO^?\.?\??NO=<@.#]3S_QK_7O[]UX?RZXV)X%_K_M_K[]U[KO3
M^;<V'^^_I?GW[KWRZ[(^G%O]]^??NO?9UT0/K_R/_>[?GW[KQZ[_ -[]^Z]U
M[C_>!^;?3^EO?NO= YWQMN;<77&9CI8_)58DP9R", ZG_A[,]2J@#Z_922D#
M\D>]-PZV./RZR]*9^FW)USMYX9 T^)I(L%6I<:HY\7&M-&7%[J)J98Y!_4-[
M\O#KQX]*O;&RL#M_,[ES6+QM/0UN>JJ?[]J=!&D[4R.ZR+$MDB:1JHE]( =O
M4>;GWZE#UZI(^70HXR&.G5JMU5C<1Q!@Q4EB%"DJ5(621@I(((%_>^J]<^Q,
MO+#10U'VU%#7[GR$E6T=&E'34442UDC*E&D::*:CFG9P+  JMV;CU>ZV,]-6
M9K$IL1A]M8]2,A,L<F3JTGD5A]QPU!*HA$)C#,-95F)"V;^@]U[Y^73YFYFP
M6U*+%I#6PM/X*F:>.G%/35,]/Y2T-75U-6]14_:QS:E"4Z*&D"ZOV['W7NG_
M &>F7J\;'D(*:HD$,;U-3,L;/'34T::PS@#Z&-6M<\G^GU'NM'H5=S[_ #U[
MB1B:&I>/=-3!0U&?R;Q0QQ8)7AEEH\110H@\V:2"KO42OJ,+CQI<IK'NO4Z+
MO+NFKSM3)-2+5YRLF):6NJ)9)$)O<M+/,S<_\&L/Z'W[K=.O&EW+*>:O&TO(
M_;42,5_%B?#(O ^MB??NO8Z8]QY+.;8QIR-=]E5TJS00M)&VEHVGD6)&99!"
MNDLUKW4"]RP'OW7AT-'66?J\UC\=1M4(<>\#Y&D6?RN*9YRD=7!3A&<^.=XP
MP ;1J4LI]9+>ZT>C'83*092KI:.>''UE30)'19+'3Q$IF-ONLWDF2EU.C5U#
M%&?*7#!ET,MG!U^ZUT6OY$]+4>S-TU&.I:REJ*#+J^2QHIGF2''FH8O]J7=Y
M3-# A]+&0EEN#8CWKB.K ]$_EDK-MURI4AU:EJ-<;>1Y8'EC<:)HDD8K(C6X
M;3I8$\GW[JW0C[-BJ<Q5',50UA&9XF6,()9Y6?QAE"*I?2^H!1=2H)_6/?NM
M''0[JU+11PTT$R3NL2-4U$++)%+4. [K"P.EX80P4,.&(+#@CWOJO7?W8)//
MXM]?];^GOW7J=<Q5?G5^?]8?X?T^EO>^M==_<CBYN#;ZGDV/YYO[]U[J1#D9
MX&#0U$T+#Z&.5T-_Q8J0+@<>_=>Z>H-VYF"P%<TOXTSJLH/^NS+Y/]Y]^Z]T
M]0;\K%L*BGIY0+<QLT9/YOR7'_$>_=>Z=8M]4+A5EIJF/_@GCD%SP.=:L;D_
MT]^Z]TX1[HP\]@*KQGZZ94>/Z<VU%=(Y_/\ 3W[KW4Q:F&=/+$ZR1D?YR,ZU
M_(_4O%_?NO=8F<'D'Z<7)_Q_V/\ 7_6]^Z]U&=A_L+VM;\V_Q_P'OW7NHQ:Y
MOP/K_K?7@<7M?W[KW2SQD/CH(019I%,I))YUW*W_ ,"H'OW7NIA46-N2"!Q_
ML/\ #W[KW78%OIP2/]]Q^.??NO=<' /! (-PP/(L;W!'((-_?NO=%\[ VMFL
M-A\Z-NSF+#Y6*HD$:^5Q@:ZI\1ED^VC*QU6#K#3QI4P,&1HU4D!XH9$UUL=!
M1C>H<+1[9Q^;DKL8N9R4M-22XJJR%/05D58\#,:C 44E3*,Q@<A.S>"KB),,
MJ&GJ$AF&AM4_;U:O[.B*?)3=N0V#3MLN!6I<_FJ8SDAE,M%A)GFA\IF33>>M
M\;*&' 0-;^ONK&F.K+G/ET4WJ'K>;L+=M#25(E3;]#4T]5N"L0E6^S24&6EI
MI-#+]Y5QHRQW%EY<@A;>Z@5^SJY-.KFL%A:F2HP>,V?M]'VC3T'VU5ES+]A1
M[;^S1%I*6HA,506B: +8AKWXY8@%W_!TR?Y]*Z3;4WAJ*UJS'S1TKQPF"CED
MEJ9$=?()466&#]H!^6-K7_PX]UKI+YZKJUI5I7#?:0TSJ8IGNOCF\K*JB1],
M*&6I=FT74,3>YN??NM_;U"R-%6TNU=G8^-:6U=+E<TZ!J>:LIVER<V-^TJ#X
M354K(E G[18J6/-[+I]U[SZF[!:N?LC#TN.9XIOO(3-&\WBII(*9ON*DMJ1P
M4\,3'A=0(X_Q]Y];/#H3]F/D8NS^Q,K0TTN1JMO/C:K%$/ ]$M=1UE'3XQJ^
MI64- \4UUUNP='L&8:3[]UKR'31V]CZFEW1D%J_ L\2T]+)%!H$=.])049\!
M",0KP%S&5XTZ;#CW[KPZ"G&3_:Y"AG']BIB)MP"K,$;Z_2Z$^_=>/IT,.VZ1
M,[+NF6:1=&-V7N[)QQ,3>62+#U5-#86N%CEJ@]_ZI[]UKHM^XF"]3(IL2VZJ
M4@W:_$>Y-1L!S8<>]'AU;SZ,]MS>V0BVQMVFC6G1:? XB%6,;,S>+'TZ*S%W
M*ZCHYX^OO?53UFFW9DY3ZJQUN;VC6.,?D#](!_V_O?6NFV3-3RC]RHE:P/ZI
M6:_!OP6MQ[]U[HM64=)\/O@L.5R];(I+>HEMU0@GZW;@V_V'NO5^AYI*]?LJ
M4:KWIH+_ . \2#\_4'WOJO7?WRHJJEU55 55  55&E0 +   ?3W[KU.L1R;\
MC5_L?]ZYX_KS[]U[K ^3;B\EN/\ $_\ &[>_=>IU%?)'Z%SQ]>0#_3^EQ[]U
M[J(^27_CI?\ Y"^G'%^;<>_=;QU&?*1@GUC_ 'NYM_B+W]^Z]U&_BZQR)(DL
MB21,)(WC9HY8G0@K)'(I5XY%;Z$$&X]^Z]T_5&9H]S4ICGJ8<5N-7)CSQ@/V
M=>LCHSC<E)21-*7(#7K*>-Y#J_=B>VKW[KW#[.F22*KB9*'*P-3U_P"X\$JZ
M9,?DT1-0FQ57!J2LIWN;.M[&VH W'OW7NLN%$LOD,TBH8Q(]+5U!CBB\\-F^
MRJ6"L89I -0(%FL?H+E?=>/0=Y=V@R6FGJ%@(E5YHG5HH6EOJ42HA&@7YU(S
M+=K@C](UUL=.<J7*R^C]Q%=Q$X>-7*@R('6U]+&W(!!_I[WUX=1Y(E>,JP]+
M*RL#]-+7!'YM[]UZO0/;RI*RGQ67@HIUIYA$UIR)F98&93)X5@BFF,[0$A+*
M?41]/K[J>'6^@DVUM>EAK8$F/GR<3(\-,Z,8\<)T;]V9P&@;(")"'"LY@!T_
MG4= ?MZWT.5&&H4*TQ"NR@23%5,C\?[4&TJ#^/\ ;^[=:Z!'O>C?(8/%UDK&
M2:CKRJ%@+Z)XB746_LWB!^GNK=;'7#HR&5-KUJ$MX?XK.8A<Z00J+)<< ?3Z
M^_+PZ\>AI,0YXY(_(Y(YN0;?T]VZUUUXP#^F]["Y^E_]XY_XCW[KW7O%>WI_
MK_M[_P!";?GWZO7NN!AXXTCC_$6)]^Z]UC,=Q>WU^OX!_'^W/OW7NL?B^GT-
M_K_3\6Y^@'/^\>_=>ZZ,1%[@'_;GZ\?G@WX_K[]U[JQ#QC_AIC38_P#;Q*]O
MS_V37;^G].?=/]$_VO\ EZM^'\^BB93_ (NN2O< U]9_4_\ *1+Q_2UC[<ZI
MU ^O^Q(N#S:Y/'(X]ZZWUX ?CBW^W/XY_P!C[]U[KE;G\?[R?Z?0BQ'O?6NL
M@_Q_I_K_ .\V!^H]^ZUUS''^M_C_ (6_Q'OW7NLB\#_6/-B.?Z?X6]^ZWUS_
M " +'_>>;CGZ_4CW[K?7("_TY^G^V_P/Y_WGW[K761>/Q]?R.?R../Q[]U[K
MD!QS_P 3_P 3<6]^Z]UR _P-_J;VM_A]/?NO=<Q_OOK_ *_^L+W]^ZUUD'UX
M^O\ QLVXMS[]UOK)8'CG\_\ %?Q]??NO=9 +6Y/XOQ_K?[U:]_?NO=<Q;_BA
M_IQ_O /OW6NN8 -K_P"]W_P'^]>_=>\Z=<P.+_7\?Z_%N/I]![]UKKG^!<?\
M:!'-C^>/?NMGKD+WN?Z7_P!;_ #Z^_=>Z[_Q-_I_K?[?_6M[]UH]=#_;<?U_
MUA^./Q_O/OW6^N0_XI_QL_3Z^_=>_P '78'//^V_K]./]?W[KW7*U_P;W(!O
M^1P3_L1[]U[KO3?\\7_I^/\ #D\'W[K9Z[*V'U_Q-OI:_/\ L;>_=>ZZL?H"
M?ZWY_-_Q;D$?[S[]U[KLJ?K]>/P./I]2/Z^_=>ZXZ>1]0/I<_P"\7''Y'OW7
MNO$6_K_K_P"-^0+_ $Y]^ZUUT+_[[_B"/I[]U[KIXUD5HW171U9'1E#*RLMF
M5@;A@RD@@_4>_=;Z)C,^1^._84M28I9^LMWUBF=E1Y%Q-Y"4E33>U1B1(0RV
M)FIK$>H<4^$_+JW$?/HYV*J:3(T4-?05$-71UB155-54\BR05$$L:&*:*1"5
M9'0"Q%Q[OTWGJ?F:I:+'TDKO9%96$0^D\YTF)&_HBN2Y_H5]^ZV.DUEJO^\>
M\L/24:E*'"8_&P'6R*UZ&F22KD=DC6)CYM:AP%OP38W/OWGUO@.AMZ?V)6=L
MYW==1')(\5/"8PE#2/5@4\<BK3""IK*E8\>LT<(TVDD(&JZZ-1'J]:..'07]
MAY.?)[LRE/45DM3!05G\*@<_8QKX<2B8Y&A2EDFI=++2"Q1W!%O6WU]^Z\.'
M0R;-R31;5K,1#DZNCI<C2*DVF<J'D,2K)!*(9XA]M+ 2KK;5I8@$V][ZUTE-
MY86MS\&27*/4Q56;JAD)*TKXWF:HJ!.\RW!4JUV!'(-ROT/O77ATV8;"TFUL
M+%BZ)JB6&F$[B2I<2U4KRRR3,7=40/9GLHMZ5 7Z#W[KWGU7'GOF=NN#=-72
M8O:^&@Q5'D9:8Q9-J^3*2PP3F-S)+!4P04DSJI]/BD$9/):WNFH].:,=62;8
M2NW;14,M#1FH%=0TU=IT^2&.FJ(HI1-*YNBPJ''J/U]WZ;Z&NFQ>*P.)\=)4
MSOE062:IA-((/*L:,BEJB*0T]*@?2!97);5>Q*C?6N@_7<61QF4I\M25*-6T
MLZ5"&2%6&I&U$,#>-T:UB"I!!_P]^Z]U"[>W;D]SU=+D:B1:JF>GBFHFC==<
M&J(">DE59&"/'*K"P)XM_6WO75AT ^2VY%O*>BDK'DI*DKYO)J'J@B9E>)Z0
M(TG@$C*_W);679ENQ= NJ5ZW]G01?(OLBNZTV=AMF[99QD=Q056-.6)T345!
M"D,=;/ $/[=?5_<JD9!/A3Z$D*1IC0=;45-3T838N.WG6[>V]!C<7FLK*F$Q
M<31T>+J\@Q=*&G5@!!3RN2&7_'W;[>J]#/B.HOD!FM)Q?3_8F01CQ*FQ-SI$
M;V_W>U'' !_B3;WJH]>O4Z%'$?%+Y097QZ.F\]2ZR/7E,IM[ @<7.I,]E\;H
MT_T)X]ZUKU[2>A3Q7P,^1]<D<E9@]J8))7\8;*;YVW.OETN_CO@J[,ZG"1L=
M(!-E)MP??M:];TGH0<=_+E[>F"OE-^]5XP$W:-<GNO(U"C\^FGVBE.QY_P".
MH'O7B#T/7M)Z7.._ENSD*<WW7BJ,BQ=<1LBNS -CSI>MW)@!_L2O^/O7B?+K
MVGI<X[^7?UK3,#E^U-X91!;4N,V]A,$6/YLU5D=PZ>/\#[]XA].O:1TJ(?@=
M\>:8J9<_VQ5NH]2R;EVE# U_K^W#L,3 $C_CK[UXC?+K>D=+#"?$GXW[?JJ*
MNBVQF<Q54%3!5P-G-T92HA:>ED2:,U-)CFQ=)4Q:T&N-T,;CTD$$CW[4QZ]0
M=,GR,-92;,K8\=5-1)'3R+$E-71TBQ@(P4*$GA5% 'XM;WM./7FX=4X9/)U<
M.3K!]U.LHF)D9:ACJ<V+,65V$A<F]^;W_/MSIOK''N.N3_=^NW_'14;Z6X)L
M&_WGWOK=.IL6ZI5_SD,4@-^4+1M_3^T7 N/\/?NO4\NE6O9:*J(N*TA%55 K
M;@!1I L:8<V]^ZU3KQ[+/]G%I_KFK/TM_3[<#_D7OW7NN'^DIQ]<9&?K>U8U
M_P# ?Y@_3W[K=.N+=CN23_#8OK]?N6-_S_QP7Z^_=>H>L+=A-(C1OC(&2161
MT><LC(W!1E,-F1E)N#^/?NM4Z"W/5M/38S*K!MM,_BO!69.EVN:]Z6II,U%"
M)Z:KVSETB,^$KI:FFA76HD6Z(6#&./1H]6&>J7ZFL[*^5/>-70&D<]E;UW*F
M#EQ&1E3%8K;>,I?%0T>,$F6GMA\/M[&4GB#2RCQT\ #%F8DM<>G1@=6_X#XI
M;>ZAPE%MBFKZF;*4Z4TF:6JH9Z.NFKOMM=96SQFZ"&>8#2H++3TP3ULQ)]N
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M2WOW7NL;"_U'X _I>W^V/OW7NN.@6M;Z#G@_C\V'O?7NN!4$VY_K]?ZD?T_
MM[]U[JP_2/\ AIVW_@Q#^O\ X#;_ -&^Z?Z)_M?\O5OP_GT3W*K_ +D\C]+_
M ']9<_U_RB7ZV_(M[<ZITWZ+_P!?J?\ >_\ "X]^Z]UZW^]_X?\ &OI?W[KW
M7=@3_P B_!_WBU_?NO=<U'Y_'^^_/'OW6NL@!XM]/]<?3BX_%O?NM]<@/P?Z
M_P"(_I]!;W[K?7/3?\?C\?2W^%O]]Q[]UKKG:WXYX_K]"/I<V/(]^Z]US -O
M\;?X_GZ?["P]^Z]USMQ]/]M_0>_=;X=<EMQ^!_O-OQ>_'OW6NN8O_K<?4?\
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MZR"!"?I;^EO]OQ]3?W[KU>LHIU/TOS^/K8_GZ\_2UO?NO=<Q3CZ7//\ @/\
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M>_=;Z9YJ'2?T_P"V ^O]3P/?NO=/'74/BW]5QD?YS96>6QX_Y0<I8<WYNO\
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MXL[401"B:IIJ2IJ#+2Q:/(PLRKSQ[L>O#AT"[XO>X;QR=?5V//T)SNXMC88
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M^'\^BRY%?]R>0^O_  .J_P#>9Y+^W.J=02MB?]8G^E_H?^)]^Z]7KDHO^/\
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M>/5APZ-+@*2^"PS$6U8G&GFUK-1P_7_&_NXZJ>E9#CPU,&(^BTY^EN-$P/\
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MT.)SN6QM(U1CLB\[4U#73TT+2R1Y>)&D,<8N0B@GZ >Z:CTY0>=>FF/YA=B
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M!1V+3P#>>?$JV+3PO^YME<@NC^'4DA/WJ9&F:95!Y.@:?I]!?WKK?^#H.W.
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M/T_=>/P:O)S]OI\W]JVGVW_HO^U_R]6_!^?12,D/]R.1_P :ZKO;Z?Y^2_\
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M^O!Y!_WCW[KW7,*?^)^MOJ/I8#Z>_=>ZXNI]7'^Q_'^/U]^Z]UP^GXM]>/\
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M0AM.J/5Q<,O^!]MCIP].TM.%14>HK)F55#225E06D8  NZQR)%J<\D*H7G@
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M<#_7-A_L+$>_=>ZQ5U?%BZ?[V2.2:&.>D6:&-@DCQ2U44,@CD9757T2'22&
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M \:I8E@$$D_CL2J<$<_1?K>PY'OW7NE@I_QM;G_7X%@/]>_^'OW7NLMQ_L+
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MGI+M[<.?W9_"=US)B_N<'%D*1L(NF>22K2*OI:*9J>HJ6CDDH(Y)"'T % &
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M][ZUT4KY$;7I]R[>?'UD25"U%5!)XI5612L<H+%E8,I#QL1;G@GWH\.K+QZ
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MY-2G5:X-[CW6NGELYB:&FHUGRN$CIXH!%45,V8I(UB>.-%B5%;T2K*U[DNA
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M /\ 6!'OW7NN5K#ZVL>2;_UN3P.1S[]U[KP L+CZCZ\7XM>WY]^Z]UQ87/\
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MT%O?NO=25_%N+CZ\$*/P20"#^??NO=9%/UTV_/\ KW_WO\^_=>ZSJ?\ 8?\
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M#K_0"Q/]E%+&_P#K*"??NM=*'!;9S62KZ)H<?4)3_<P/)531-%!'&LB,SEW
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M _/OW7NH,GYL2>?]?Z_C_>??NO=1W^AO^?\ 6^IY'Y]^Z]U$D:X/XX]7YO\
M3Z\_7W[KW3?+^/\ "_YL>>/I;GZ?7Z#W[KW0';X _OMA&-SX\?0/IN""4RU8
MWT_' _V/O1ZL.'18]Z.R0TTP0$++EDY_ZB&-A;DW^GNIZMT=;&97'Y:GJ),?
M50U*T==78JJ$1L:;(XZH>EK*69&LT4L4J< CU(5=;JRDVZIFOSZG$?ZYM^0>
M/SS_ %M_O?OW7NF_L;?T'7FSZ7)K''59G+UV'VQM;'2!O'D]SYUA3XNEF*,K
M+2P /45)!#+302%?4 #XFG7@*GHHVZ9JB;-5TM9*9JJH9IY)715EE::FEE\K
MJFF-6<."0H YL !Q[J>K]'AV_P ;:P/&DK@\2+$?C["  &UOI_K>[]4/'J--
MD8,74TM75")J>&KH/.)D4P^&7[N&3R!P1XPKW-^+>_=:Z%BFW+G:*2IIL534
M^*H1KF@J,9F'HVJ'XCB?[>EIZ4P5!I]5WU$I<*"1[UUOI+[KVUM[>-/546Z,
M=3[IQTTL%34T.X&DS%%5SQN'CFJ:7(//#-*E0RR*Q6X=%-[CW[KU3TF]R[%V
M7N_"4>V=R[;QV9PF.A^VQ=!6B:1,5 0JB/$R"99\8I6-5M T=U 4\6'OU!UZ
MIX])S;7Q&ZZHJFBJMN]3[=A^RJXY159T05)$X0-'+'5[IK9Y7$'W2/IC8J&*
M, &"GWJ@ZWJ)Z$7'_'^? YG(Y_&]7[ DS%>:RHGS%-3;$&6JY:QC55$<U?\
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M/V']X_\ 0=XOX9_%/MM7VW\.]?@^X^G_ "E6X]M?Z)_M?\O5\:/SZUZ<;O\
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M?*92>/PH_K[]U[H)NQJ'?YRE$NSA3Q4YC/GDJX<M/  $:WBBQ*.&F,I&KS6
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M_M[>_=>ZB2$?U(_I8@?G\W/XM[]U[J X%SR?H#].>;?7G\>_=>ZBR6 /^O\
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MX?&UE3A\I35Z5E6M8XEH9L%CZ7(XR5(*>==+8YIUAT-',9Z@."?$"NLUZ]U
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MV/\ C[]U[J#)(/P?K^"1_3\6%A_K'^GOW7NF^1QSR"1?G_BO']??NO=0I'Y
MX_WC_>OZ#W[KW4*1^+FW^\&W^P]^Z]T#.ZK2;UHA>UL/"PY _P W49*0 %N!
M9E_Q]U/'JPX=%_W\=-+C?38%\NXN+?6LJ!?C^H-_>CU;HTE!5#^&8\WY^PI#
M]?R8$/(^EN?=NJ_9TAL/.:7L#?%#J].0QFS=R7_K-51YS;DP'^"0[5@!^OU'
MOWGU[%.I/PXJ2_2F"Q=QYH3O7&LO-]=-O/+5A32+6.F,'_#_ 'CWI>'7FX]
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M;\V]^Z]UPN/Q]1^;<?G_ %[>_=>ZYK>WX_U_Q_K?X\^_=>ZY@\VXX/\ L/\
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M37CWON].O8]>HK=G=!T!U2;ZRE0PN;14N/13]..:N:PX^OOU&ZW4=,E1W?\
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M ^GT_P"*^_=>ZC,?^-_[$BW^)'^M[]U[J)*3SSQQP;CZ?[QS[]U[J')^+_\
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M'<?3W[KV.CX_8Y+_ (;#\/\ D?W'^SX^7]<WB\/^R^Z/KXM>O7^+6M^?=/\
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M-P/]4NDFWO?5>GQ<+$A4Q35D!7Z>*JF 7G\!F87_ -A?W[KW65L=D #HR,S
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M!N1[]U[KH_GZ?[ <\<<W/ /^'OW7NH\H_)_!_P >/Z7]^Z]U"D6W)_!-R/\
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MCUDW?N#)[+GR^[9ZE\CCJG^#X;&X*HJHZ.AI)E%=-6UH<4TCM45+,BDDDE4
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M_P"%[?D7O<VL;_[[_8>_=>ZBR$DGZ 6N?];^OT^I(_U_?NO=+;$C_<?37/\
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MK\70J=&M!+TYU@]. L7]QMLH O #1XFFCE'/Y$RG_8^]KP'56XGH4=(_P/\
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MNEOB6/\ #Z;\V1^?^GC_ )_I[]U[ITO?DDD_D?G\6_(_XGW[KW7-2%M?\?\
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M18?X>_:CUZ@Z8Y>F-I*28:O.4W)8+#D8RHX^FF>EFXN/I[]J/7M(Z;9^H,,
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M>J8M41*:ZILLQT1W>W)](^ONPZJ>->E&WTO_ $O>_P#C86]^ZU_@ZXVM]?\
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M/]2?>M Z]K/2*JOY6_QER&O^']R=M8)B#H_B6%VGG8D>YMK%+08&71_K&_\
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M,T%3)#CJRGHCCS0_Q"774U4-/KEBJL=$54*>)&^E_?J@G'6]) J>A5%OZ_\
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M&8W?450M87:P+:1]23874 >_=>Z3U;G<%0W^\SN%IG%]44N5H!..0.8!4-4
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MK($ED$$A0ZHW**P4M9B/I]![T?4=>Z;CO/*R4\=0Y2:!P [:0SQRC]2DWNC
M\@D_ZWOU>O=>CS\M>H/EM]#]?J/Z$7MR?][]^KU[H$^R?DOW1U=N<8K#;N@;
M 28S'UN,QV6PF!R<<%-XFHF@2JK,:^1\0J:)[ 3>D&P^@]Z+$'K853TG:/\
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MO\'7O]C]!QQ_Q4_T]^Z]UQN#_K6O]1>]C_4?X^_=>ZX_C\"W_&O?NM]<@?\
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M.T#)HZ]VU63I^F7+T SLHL?[,F<?(LOJ'T'O5!UNIZ%C"X3!X*$4V&Q&.P\
M728,;04^.A"@ :?#1QTZ*.!] />^M$]**"&GE(7Q(POR6)<?7D?JO]+_ ./O
M?6NE'#%24X0*D:$_DZ/&?ZV)Y'^^_P /?NO=*:@DA1U8^,#CZ7-@>!:Q8#_7
M]^Z]TM:/,T>.0O,Z.#P RK<$\ *?3<@_CZ^_=>Z$/;.X<4TJ5=3<E6&BS*4
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M6Z]2[C^H_P!N/?NO==@@\@W']1S[]U[KWOW7NO>_=>Z][]U[K#-'"XM+I%^
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M"I*@^_=:Z1.5[YIL%'_!JW=)EJ<<BTU33T,5142121H!*KLH%/&!*"+,X/\
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M_L/?NO=3J<#TDDW# C\DCD&Y/TX'^/OPZ]TH,K'&9HG+!?-2QM8GZVXN!?U
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MU<?6_O1)KUN@Z674+SUE7F<EEZJ6JJJBIADDJ:N1Y)IV$"HYDF?5>R*@Y/
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M?Q^+^_=>Z[]0'T_'^ _%_P"GX]^ZUUV/I;_'^G] 3^?H+CW[K?#KWX_Q(O\
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MIG",;?VRK-]/KZN3[WUKIT:.FD0O'3P$VOZD !/Y!-^/]M[]UKJ(M6:26_\
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M 6LY-KC^GOW7J=-\VXV'^9I01?\ 5J,G^PL@2Q!/]??NMTZ@/GYF!#/%&P_
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M]^Z]U&%%BV_W4W(Y*E%XX/\ :CM<_P"O[]UX=9XZ&FC*FGF:.Q_2]G!%[_@
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MRZM;]3%XE%[@_EOS[]GTZ]TST^[]M):"HI*[',#S]S3R"QU$D/)&[NP^HY/
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MAQ86%C_7WKK?4!ZZ1KH&9SP!I'Y!O?\ WWT][SUKKP$S".61[A9%*JQ'-O\
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M\D\W_P!A[]U[K%)CE _S?))%K7M>_JL-1OQ]#[]U[J V.0W.C\,;6^EOJ20
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M)M_R" >+&Q'OV>M==ZV-K"]^2"W^M^18 _[#Z>_=>Z\' O=A<DD*H+M_A?\
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M@DFX-_?NO=1G1?T\W/Y))N+'D_4D #\C_8^_=>Z;YGCC!UR1VN2!J)N/4-7
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M#@-^#8_0,/Z<^_=>ZQ,64@$@?4_6U_H!:QM]?]8^_=>ZP2RQPJSSNJ( 22[
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M)#&7I@\@$C(GB/ D8$JFJ]A>P-Q^?=M77J=&=V3W/19B*(TF5B=P#//$)P9
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MZ/(ZF8.Y^MA<\BYO;Z\_[Q[]7KW6*>:-QJ7EAP>1].;?3_#W[KW4$59X^O\
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M&:6&1:><W1D(*$\6!YTW_P"##WL'K73WE<:M5"TL UII+@A1^/5;4!?42/\
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MQ$CZ"Q8G@7-OH>/]A[]U[K@T%/%]0\QN/[84$\?@#^@]^Z]7KWD1+%:=%/\
MB"[?6UR6N2??NO=2$F9[EF*6'"@Z;$?ZW!^G/]/?NO=94*F_J_P/)^H_I?\
MP/OW7NLBZ@Q/-K&W/UL/IS<<#_>??NO=9/*" +7_ ,>#_MS^!?\ WOW[KW7F
MNHU$VYYN?J 20+<B_OW7NLT;HS+J/T/!_P"*<@V_WC_>??NO=3K1,0..01<#
MCG\_X'WOKW6+[<.#I/T!(_/^Q'']??J=>ZCM"0/2+6-R?K_7C^EQ[UU[KT=T
M8'D"]OSR#_9MQ]??NO=."L[_ $4BY])8@ ?B_P#L1]?>\GKW7I*<.8VDD6X+
M#2G .H _4^H\@^_4]>O=9%CC7Z 6L#P+\_C_ !/O=!UKJ0B*0"4MIX^@_I]
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M^EC^K_'^GM7IUO3Z] 9N'=6^]U2O5;YWKDWCE_<^QJ<A, T9/,<.-C<!T%@
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M4@\\?0F_O5.MUZ9*G$%1ZZ<'_:BH!%^=-R 1:_XO?W[K=>F&;$17X2Q!^C*
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M4%5J#+54OA1K"_IEB\02523<@V/]"/S[KW00YGK/<&+9I*2)<M2J.&I1:I5
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M^(4 #_8$GWKKW31/F@\BP8V"7(/?]%(CRLI'X>-+Z1_K\#W[KU.N4^WMV9"
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M&.-T)(++P/7];&]O]:Y]^Z]U&,:+;39E!T<'Z6_LWYY4<$W_ !_L/>NO=8W
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M)]W6#5SRL3+"A-_]6;'\>]TZ]T]0=>XN,K)7U%9DW%R14RA*?\7(B@6($?\
M!BW!]^IUZO2HI*;'8Z(0TD$,:+;2D$:*EN!_84#G_8^]TZ]T!?R#SFY</M*E
MBVQ/#3S9*NDHZQW"%S0FDF=X*>1@!%)(RCU"QL"+B_O1K3K:BO1$:',5]5.N
M+R./J:6>62./[R.)7IX_-*(U>2.86T:C<E2W'T!(]TKU?H5LYU%N#!1K/D<
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M'Z7_ #[]U[J. M[G2OJOP 2Q:R@+<FQU?FQ%OSS[]U[K@RW#W%@5])-[D@@
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M;_'Z?[$GGZ_U_'OW5>N9<@ <\?X?T_(O87Y]^Z]U'+$?DBUO\+?7\?X>_=;
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M5D+@Z8B/K8N57B_X5=9)_P #;WKK?7DNY8.2>;V6Z\?BY!)/^W]^Z]US,:V
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MZWOW7NN7F92;D-R=-RM^6/I(X;5QQ]/?NO=8'O(2+6 YN=1(X+'2E^+W//\
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M%[#_ %O\/?NO=8#^X"/U#4'4AS<#46%P6O9CQ];6X_P]^Z]UR2-5N0S#Z<@
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MH-S_ !?S%+O_ *UJJM]NU%;1QS0U57/-'C26E,NW\[ 1HR>W<LI"02N1/35
M6SAB&?1%.'#KP-?MZ-GOG)[>[7Z]POR3ZZB^QW'AL8:K>6(B*^7.8/& MN3;
MN26/T5.7PB122T$[#4P4 >B0 ;^8ZU\CU&Q]9297'T>2H)HYZ2NHX*REF0Z?
M+3U4:3Q.#^"8W'^M_3W;JO4IK+=KG4XU!";L+<!KV U$KQ;_ 'CW[KW7$"R
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M111Z>-3S_P"[%'^TW!M]??L>77NDU45YJ#Y,OD%>Y)%)$XBHXE'( CU .?\
M:FN;>Z]>ZR1YA?#IQ..JJSDJ&HZ<^(M;Z-4!/&O^W]^Z]3KR8?=V5L96IL5
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M;7OQ^+6%A[]UJIZ4%+MG+3!2E!->]@2AY6Y! -K@F_O?6NE11]?;BJ&4K2E
M?KJ##BW'X^G'^\>_4/7NEC0]0Y^J*WTKJ_"*S<CG^E@+GW[2>O5Z$K!] UD^
MEJB.1OH27&A;<WOQ<<>[:>M:NA>PG0U!2LK3B <#^R7<&^D_BU[_ %XMS[V!
MU75T+6*ZZP6/0:*99'6UV< )8<+P .>/Q]/\/>Z=:KTM*7'0Q$1T\<( Y/C
M4@*PXN++P#8#^M_>^M=.<N(H:V T]52TU5$P:-HZB-9-2GAAI* $'G@@<'W[
MKW0%[H^-?6&X*IZI]L8^@JIO4:C'1)1N[WN&>* +$S#^T3S[KI'5M1Z>MF]'
M;'VC)%-C\+$\D-G2>J=J@B1'],L0<F-'!YX'X^OY][  Z\6/0X0HBA?HIU!
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M*Z3HJ!]FEC:YCC3W8 #JNH]#+3Q4L$<<5.BQ1(B1Q+$BQQK&JD1JD:<: HL
M !^/>^M=2HV4_@,PYY8*-0N>2"#<DWL3[]U[IAS.WL!G5\>6QU+5E5"K(X*R
MF-+G2)U9)@H)/%[<GW[KW4S%XW&XJ!:/&45/04L<=A'30(BA4"J)#I"F1P+7
M8ZC]?K[]U[IU!8^HZK$:=+:N5_4=.H , 3;Z'\^_=>ZSW?BY8W++ZQ9K,#IT
MK9?0&_)(X]^Z]UG'ZC=00  ;"]RWU4#T@A0.1^;6]^Z]UR)TDJ-5D]0NO!6X
M])]=N%^MA[]U[KRJPD()5 RZ25-D#-R=9-E1K_0W/T]^Z]UF^I((&D'D7O=3
M8"PTC4?\;\<^_=>ZS+:-+HH"O92AN#>^HFVH\$?X"Y_VWOW7NNC/I0#2"=3!
M06T_0&Y<CTD%OQ?^O^'OW7NO><!&4FRA06O8$6X"AP-2CFUQ_M_?NO=8FJ!?
M5;3<CZ%[$@:1IU&X)N+CDW;\6M[]U[HBGR&V^N*W?'G14O,-S1-/) T00TDF
M-@HJ)@'61_(DJ:6N0"#?_#W4XZNO#H ]0_P/U^G_ !3_  ]ZZWUS$UK<@\W_
M !_@/]A]?>^O=<C)?F_^]6 M_@/R??NO==0M'H;5R=;@6L+!I&)YOS]??NO=
M.<:A(V9"+?4WM;\FY_I<^]=>ZY*&*V3@$ E1R3];V/UXO;GWOKW4.QUD<CU7
M-SQ90?H3Q^??NO=.F%J7^_5&)*O'(O\ 7Z*UB.>?S[]U[J>E5$UW(55#$+J/
MJ(N2&()^G]#[]U[J'-DHPS ,/I_@3^?P+_7W[KW3!5YNUPH'!^I-Q_MN+?3_
M %O>J]>Z99LG+(;ACS];$@?D?0'_ !]ZJ>O=2::L\@(D(+?UO8?6Q_%[^]@]
M>Z[FK0NK1R0I/]?ZWL/]Y]^QU[IJFJ6D2Y:P(-N3>UA8<6_)]ZK7KW3;][!!
M9GD%_P##DFQ^EAS^/?NO=&<Z=Q44&(&Z35$_QJ&6!*8Q*JP14=?/ 79]3M+)
M(].2. %7CD_2PX5ZJ?3H5*K.T]*#=P2"2+ 7+"_'U'T_Q][Z]3TZ164WFT8;
M2RH.>+\\?BY;Z^_=> Z0E7NNJJ&;Q!@+_K<ZK\VN!S[U7JU.F:6OGG.J21F;
MC]7]D6/^/T^G^V]^Z]UB2JJ!9O(;?X?CZ\W-Q]/Z^_=>ZE#-20*QUW9 6L;D
MBU[\!O\ #W[KW5>G8=92X#(YVOFI:FAH(YY\G-%(\=3-)]Y7B SJ8XH#(CRL
M"->IQSZCQ[;/5AT_]*YNIS&:2?;]950XJ+';@R.0G6H?'XYXL?AZF=J6N0RT
MR2/7U*QP1QD/]Q+(D>E@UCX=>/1KNH:Z4[QJEEJF>=\14O4H78Z@*BET!_JI
M8,;J#;@&WNZ\>JGAT:3[A6 N01^#_7ZGG_8^[=5ZPO,D9\@D:,H0ZN#I9"O(
M8,"-+7_Q]^Z]T_8SM#=.&T+#7IDZ<<"#*AJE5 XO'4+)'6#2O ];+_A[]UZ@
M\^A/QO=V%FC49?'5E/4"RN:1HZNG-RNIP99*:9./HNDV_KSQ[K5#T(6%WKMW
M<0$>*R$$M3H+_9RW@J4%@'TPRE7<1K?45U*/P?>^M4Z4'E6Q8D:B"K,I'U%K
M*P!!*!A];_CW[KW4)ZA/TFY<Z19^ 2K$)Z3ZE'/'('/OW7NHTC JQ U?1C8D
MZ P;7]0]N;VM^;6]^Z]U"<K^KU<,!=F(((YXMQ;2WX^OOW7NL+R^,E@2=2DK
M=P2H)O<$G5?FY_-O?NO=8C46 /*V;1I7D$M<'5<#3<G_  M^/?NO==-+K?TV
MX&O3ZM( )X4V ]0MQ<$?T]^Z]UQ9?(02-*V-D"K];L0/P22/Z&_/OW7NN)B5
MKEOVPIU:5U*A1F"D7)DL23>[6X'OW7NNTB'Z=+$^G26%R22RD:6!# \$\7)(
M]^Z]UWXHT/J'^>/I(5-+6L=-P/U'_&UOI[]U[KDR 6'Y8E54W_I]+BXX%K7-
M[_CW[KW0?]E7CZ_WC*%)$>V,PQ/H*D_P^<ER>;7O]/J;GWH\.MCCT3WI^!6P
M.");U&*F-@/K=V/%CSR?>EX=6/1^(XE8C6>=-K-<!E-@/J RDCZ7M8G\>[=4
MZY%(N672I+,MBJM8DE 1KN UQ^+^_=>ZAS444^JR$@FP-N0%TMI  ' U7''O
MW7NFJHP,<B@! 3P]OJS)P2 .=/H(M>P^GOW7NDED]@05L;QO&2IYLX0DDW4
M7/U-^>/>NMUZ!G=71-/D8F,"RP2$G3)$H87O8:E9%.EF('-C[T1UL-Z]$O['
M^/?9.V\LNY-CU==BLM3)-%)D,/+)15M13. 6@D3F*>-](+JZL&(!_ ]U*D<.
MK@@\>'05=:;@[1ZJWE!F1M[,5V6#5%/4K_"ZVI3*T]4P^Z@JXZ*(->5@&#(
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M^/?NO=8U8NX&NY9=)!( +'FZ@G\@D?@6%O?NO=<'(U,& 4 2+P-*CDCZ, "
M1^+GCW[KW7F%WN'T^F^E1Z]17TA2QTD\W_K^>??NO=%,^3:*)-G2*26*YU2G
MIX"-B"#=2;DES_L/=3U9>BIR(I%[<V-B+@_ZPMR+^]=6Z@M.8B 3K%S8?1B
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M=?I[T.'5CU8(T2@$*+V",#:W-[?CZ'2+#Z<>[=4ZCF!V-F4,A(N%5K@D7+V
M)MS];@CW[KW4[[4J=4:Z2XLGH8A)"MVTGDWY^G]"/\/?NO=9H:286C99/%<$
M7MI=N%O<K^O4Q_5]5'U/OW7NIJ4H9M!0^FQTD'FRG2H%@58_D_2XM]#[]U[K
MD,>I)U1A;!B%"BUK,K1FZ\:@1_OOI[KW6&?!4,T;&>DC>X0*"(G!)N+\C3<W
MN;?0^_=>Z8,ALFBJH)8H*.GB=KLEH(HRQ5@RJ) /07^A_/)]^Z]UU2;>QE-3
M0TKT(@<  JP5$CEOZHY"RC2[7] )LPY'Y ]U[KA+LZC)8JC4QX*NMRPM868
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MW[N^77NWY]9$_P! -C;_ $PZK<ZO[EZM5S?Z\WO[]W_+KW;\^I2_[+_<Z?\
M2YKO%JM_<F_^;].JW/TM].+?['W[N^77NWY]<_\ G'^[7_TO7_VK^YNFV@Z?
M\;ZK6]^[_EU[M^?6%_\ 0#<ZO]+>GG3;^Y%K?['B^J_UYO\ 3W[N^77NWY]<
MU_T"62_^EZVH?\\9_A_J?]KM?\7_ ,/?N[Y=>[?GUW#_ *!_)_S5ZVIOU?W-
M\7U.B]O1HO\ 3^S?Z\7]^[_EU[M^?77_ !@:Y_YG#]1HM_<K]-^+?\A7O?\
M'O7?\NO=OSZQ2_Z!=!O_ *8K66^G^YFJUS;3H]-[WO\ GWOO^77NWY]=1_Z
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M^S*Z+<:?]%^GZ<:K<W_U^/>LU\NO8ZPQ_P"R>W'_ &4G:WY_T7:;?X_BU_\
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MO)Q[H=7RZ]CIFV3_ +(3IF\7^S&_Q30]_P"/_P!Q/LM7_-C^ ^J_T_SOHO\
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M>[?GUTO^@C4-'^EK39K:O[FV^HTVOSKU?["U[^_=_P NO=OSZ<$_T%:9-?\
MI6MJ-M7]R_TV.N_YT?7_  O?W[N^77NWY]8D_P! ]Q_S-:VD6_X\[]%VTZOQ
M:]_K^??N[Y=>[?GUCK?]E\\3?Q#_ $HZK-?R?W4^Y\>A/T^/]WQ6^OXO?5Q[
M]W?+KW;\^F6N_P! _@IO#_IO\.@^+[+_ $>?HTC3?[G]WPZ;:;\?T]^[_EU[
MM^?3=0_[+OY6_P"9U?<^)O\ BY?W5\OC\T7E^WU?L>/7H\GAXOIU?CW[O^77
MNWY]3I/] .L_\S;M=K:/[F?73Q?_ !^M[_XW]^[OEU[M^?7";_0!XTT_Z6OU
M>GQ_W-U_K'ZK<?ZW^\<^_=_RZ]V_/J+)_H!_'^E_1SH_X\FVB_.C\ZO)?]/.
MK_8^_=WRZ]V_/J$_^R^W%O\ 3'^D?I_N3IM=?U7]7^WYM]/?N_Y=>[?GUS/^
MR]:#_P S>T6?]/\ <W3JOQ?1SKO;Z^FWUX]^[OEU[M^?6%O]E[L+?Z8/JVK3
M_<J^KU6\EN/K_L/?N[Y=>[?GUQ;_ &7WF_\ IBOK-[_W*T?0WU7YOI_WG_'W
MKO\ EU[M^?49_P#9?KK_ ,SE_4=-O[E6MIXTZO\ :OZ\W^OO?=\NO=OSZR1_
M[+W?C_3'>_&G^Y.J]Q^FW-K7_P!A[UW_ "Z]V_/K)+_LOV@?\SCT6-_^/(_3
M=K:]?-OZ?BWO??\ +KW;\^N*_P"R_6X_TQZ;\6_N7].+7_XC\^_=_P NO=OS
MZP+_ ++S>6W^F:^KU:_[G:-7H_3?]O\ I^G_ &/OW=\NO=OSZY#_ &7OG3_I
MBTZ^-/\ <?\ IZK_ (TZOK^/?N[Y=>[?GUB/^R_67_F<>C2M_P#CROIZ=&K5
M^;?[Z_OW?\NO=OSZQG_9?.?^9SZ-(^O]ROK<Z=.KCZ?[Q[]W?+KW;\^C9_\
M&&_]D9_YJ5_=3_9L/^S5_C_]XO\ 0_\ ^>[^"?P[_JH\W^T^Z=WB>5=/^7JV
&-'RKU__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2325130d1hqhar25130d2i003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2325130d1hqhar25130d2i003.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ /P!! P$1  (1 0,1 ?_$ :(    & @,!
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2325130d1hqhar25130d2i004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2325130d1hqhar25130d2i004.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ )P"Z P$1  (1 0,1 ?_$ :(    & @,!
M      <(!@4$"0,* @$ "P$   8# 0$!            !@4$ P<"" $)  H+
M$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R( "#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL? F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M  (! P($! ,%! 0$!@8%;0$" Q$$(1(%,08 (A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M  P# 0 "$0,1 #\ W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=(/M
M+LS9'2W6G8';_9F?H]J]=]6[+W-V#OK<N08K18':6S\-69_<&6J-(9WCH<70
M2R:5!=].E06('OW7NJ$=A9;Y ;G^<O\ +8^3/:F].Z.M^UOFSNCY"[AG^(]=
MO?<L'5'0WP3ZZ^)^_<I@NL]R=;4@@VMG.Z\WW/N?K3=V[]PY2&++X[<=2V%H
MBF-QXBG]U[K8J]^Z]U[W[KW7O?NO=>]^Z]T'?:_;G5W1/7^YNU^Y^P=G]6]:
M[-Q\F4W1OG?>X,;MG;.$HD(425V6RM134D<D\K+'#$&,L\SK'&K.RJ?=>Z#W
MXP?*WX^_,[JB@[R^,?9.-[8ZHRF:SFWL=O3$8K<6(QU;E]M5AQ^<I:6#<^&P
M>1F6@K08FE6 PNX(1VL;>Z]T8;W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW12/F9\XOC?\  3K#!=P_)_>>0V1L+<6_,1UWCLGBMJ;FWE5G.Y3$9_<M
M34SX;:6+S&7BP>W=I;3RN7RE;X3#18W'SRN?2JM[KW1I_P"+8K_G9X__ (M_
M\6_X&TW_ !:O^=G_ )S_ (M__-[_ #?^/OW7NJ6OYC=/\R_C%LC>7R@Z1^=7
M85;V1O;Y!?%CICH[XR]@]7?'[*?%JDI>\ODUU)U#)MG.;>P?45)\C-X9+%[;
MWSF,I49'&;]QN6J(Z:P*P4T<:>Z]T?;XK_)/=?;4>YNK^]^N?]!WRHZJ\,79
M_5O\2_C.V=QX"JJZFBVUW;TENAEC_OYTAV']F[T-7I6OPN0CJ<-EHJ?)44R-
M[KW1O_?NO=>]^Z]T'?;>U][[UZSWQM/K7LBHZ?[ W!MO)8S9W:-+MC$;UGV'
MN&I@9<9N>/:.?E@PNY/X54Z9#153K!4*"CD W]^Z]TKL#!FZ7!86FW-DL;FM
MQT^)QT&X,QAL/4;>Q&6S<-'#'E<EBL!5YG<=7@\;75ZR2P4<N0KY*:)UC:HG
M*F5O=>Z=O?NO=4[_ ,V>I?N?+?!O^7=2HM;C_G-\H<5)W=B'C(3)_$;XLX>7
MY"]^XQZ^*LIZK%P[ORVV]J[6J)%4K+2;CFIPRRS0K)[KW2AV1/4]Y?SF.Z=U
MPPQU6R?@7\.-G?'ZEJW4VIN^/F%N_;_?79./B\B>NLP?2G5'7DVN,@10[A92
MSF8K%[KW5L_OW7NJFNOODQ\U?F?N_MW.?#J7XM=3?%?K?M;?'3^Q?D/WILKM
M+O[<O?NZ>JI)=E]I978W3O7?:WQYQ6WNM=K]SXK+[>H]PU6\JV7-?P>HJ*?&
MK2O354_NO=#A_+I^5^Z_E[T3N;>N^*/9-3NOK7N[MKH'/[_ZGH]R4/2G<.:Z
M>W%_=G,]H=+4^[Z[+;D@Z^S&86>B2&JK\DU)D\?64RUM9'"E3+[KW1L>W.U^
MONB.K>Q.ZNV-RT>SNLNJ-E[D[!W[NFOCJIZ7 [3VGB:K-YS)-2T,%5D*Z2FQ
M]&YCIZ:*:IJ)-,4,;R.J'W7NJI?C'\:<A\\=U[&_F*?.?:F4RT==41[W^$7P
M[WU-09?JOXQ=85.BJZU[=WIL 0U&!W3\N]^X61,]D,QDVKGV:M=38K%K2U&/
MDJI?=>Z.#U+\Y-@]K_-[Y;?!6EVUFL'V3\3]H]%[\R>=K:_%U&#WYM;N_:LN
MX*6LP%)#)'EJ&JVA71+1Y".:)HC]U321RDRM'%[KW1N=W[JQFQ]LYG=F:I=R
M5N+P5&U=6TNT-F[O["W-/"KHA3#;+V#@]R[QW%6$N+4^/H*JH(N0A )'NO=$
M"[3_ )J?Q>ZCJL/0;BVG\Q<GD,NLTC8[;'P!^;>8R.&@B6D=)]PX_P#T"4U9
MAEJXZQ6@29!+,BLR*0I/OW7N@JKOYRG2\E#0Y397P_\ YJ7:.,R&/JJJ#);$
M_EE_+I\;]]1Y/)XN?!'(;KZWVK1/E(Y\;=WCD>AB$R))4)*D\</NO=5G=4?S
M?OF=\A/G)V;VW\>?Y;7\PGL?XF[$ZZS/Q&JNGLY#T=UQ)B?E_P!<]A[IW#V?
MO'?4^Z>XFVALK+;3@DPVT9H%K:F58YZV:IE2>AAQT_NO=;%'QA[HW;W]TUMS
MLO?G0O:GQFWGD,AN?"[FZ8[DI\(F]=IY?:FY<KMJID.0VSE,SMS<6V\Z<6,A
MA\I0U,E-D<94P3KIUE%]U[H?_?NO=>]^Z]UJW?SR*JI[E[;[3V#AL?49X_%_
M^61\C,'B,!1S%#N;Y2?S;<M2_ ;XL[45);Q'.+1XW=DM$B)-+4MD/"H5I%DC
M]U[K9!_T0;-_XX9#_F5_^B#_ ('R?\>;_P </T_\7#_F_P#J_P /?NO=5W_S
M'))-X_(O^4=T,N8AQ%'V'_,!E[3S7[4L]7DL9\5/C!\A/D'CL3#%'-3!*6NW
MOL_#+-+KO&=%TD0NC>Z]UF_F-YB7J'O/^5_\D<7/)15F%^<>V?BUO)TE98\O
MU7\TMC[MZFEP%72QRPR9",]YT6P,E$I++3RXT3E2L;>_=>Z$_P"9GS0WKTWO
M#87QE^+74U'\C/FYW1M_-[LV!U9E]R2;+ZVZVZRV[5Q8O<??WR'[ BQ^4DV-
MU1@\Q4QT%#3T]//F]UYIQC<5"S)655%[KW2-_EA?-KM'Y@[8^46T^^=O=,X/
MO3X>_*W?OQ9[,K_CWN?=VZNG=XY7:.V=F;H7=.SI]\8;%;FPBTU5NVIP=;C:
MR2LGBK\)-.TD2U*4M/[KW1BNF?G!\:.^\A\HJ3K?LK#Y/'_#GLC,=6=\[GK*
MBDQVTMJ[HVWM+';QW0Z;@J*H4-3@]KT-=+35]<3'3T]=05D18_;NWOW7NI7P
MO^971_SX^/NV/DW\=LMFLUU5N_/;\V_@\AN#"R[?RM14]?;XW!L/*U4F+FFG
MDAH<CD-O/543,VN6AGA>1(I&>*/W7N@7IOYI/P_W!F/AMA^M]X[B[:D^=W:W
M:W5?Q\K-A[1RHH\__H-Q6[\CVUV55?WO7:59-U#LJHV>]++G\=#D:>LDKJ2H
MHEJ:!Y*R+W7NB:?+7O[8O37\X#J_?W;^'R1V#\8OY0_S&[VV[EHI/NJC*;YW
M]\HOB5UE+M'KW#5%11TF2[-W+08:EP5!11R&IR]9N.AHT4RO#?W7NK ?@+T7
MN3IKHR?<O:-)H^0WR.WQN?Y+?)"LG,,V0C[4[5DIJZ+8L]=3TM!#7XOI#8-%
MA-A8F5*>G63$;8IG,2.[W]U[J#_,V^1VX/B3_+_^6OR%V;6TN,WYUWTKNV;K
M?*5Z4DF/Q?9^Y*=-G]9Y3))D:6MQCXW';]W#CIZ@54?VAAC;SLD6MU]U[JM[
MH3;&].RNE^I_Y:'P1SN4V'\0_B1C]M_''YD?-R#^*[3SW:.2Z]Q)Q/<W37PZ
MK:&!,AE.T-[;TIJVGWSV+')CJ#9\N2JA@:BMSJ%L7[KW5Y'4_5'7'176FQNG
M.H=GX7K_ *QZUVSBMG[&V9MZG--B-O;=PM*E)C\?2H[RSS,L::I9YGEJ*F9G
MEFDDE=W;W7NJO?YU^V%[#^-7Q[ZCW/1+D.D>Y?YBO\OSK#Y'T345+4I6=0[C
M^3>Q)*;'3UE5?^"T.7[7H-KT=75H-:TE1+'PLC,/=>ZN"1$C18XU5$151$10
MJ(B@*JJJ@!54"P X ]^Z]UK[?RL>Y^J?D[_-)_G5]Z;"@H9I:#/?#KI7;>:I
M::+3NCKGJ7:G=&Q7W_2U_P"[+6TN]NV=J[HI:>HC=*>LPNW\5+'%:U14^Z]T
M)?Q#^:_8GRU_FB_-C^&;HJMH?#7XC_&+I[:NU]KYK*XZFQO8^^.VNT^XLM5?
M)R:%:&%\=M7,[2Z+J(-N3U=;+3UFTIZ'.4FFGSC:?=>Z"'X:?SMQ\D.V_P"8
M5N_<6UJ.@^+/4W9GQ5Z0^ N.P&)J8.X_E=V)W1LS?&ZEI]OT&?RU#_&<AV]C
MI]KYS;D,E)B*/";5R'W^6FAIZ;(UM/[KW1U/@)\R^X>WNB/EYV3\L,=UIM3=
M?Q<^3?R'ZLW3C^LY,A'M;;6V^GMM;5W;E<%4;@W)DW;<U9L>JSM?B'W"\&&I
M\W38Z+(_P^@%0T*>Z]T5'X1=^8+^7E_).Z0^5_R%Q.[M][][QAH?DEN;:'7>
M.H\WVSW)WW_,&[HG[-VAL3:VW\I5[:I\SV%F,YW3CL;- AI8J:*CGF*)!3N1
M[KW5SW;7>G4?Q]ZRRO<'R [%V3TEUWM^AIZO<>Z^RMU8+;.!PL]1%JCQ<^8K
MZZ/'UF6J*@&"FIJ:2::LGM'3K*[*#[KW01?#KYV_$_Y_; W3VA\1.XL/W+L;
M9>_,KUIN;-XK"[KV\<7O##X[%9BIQ[XW>6!VYEJBCGQ.<I*BFKH8)*&KCE_9
MF=DE5/=>Z#'M[^9;\=>K?DEC_AW@,/W5WW\HIEV'D-Q]._'KI[=W8U=UIM;L
M6O\ M-O[X[=WZ]-A.H>J]JI2@U]1)G=Q4-5'CM%0('2: R^Z]U3GU=L_<'SD
M_GL?..MV=4[7RGQ'^*G:'P'S7=6YGJL)E:W?7R2^*74_>F>ZLZIVI#"*^J3%
M]>]P]X1;BSE9-]M)B]P; AI( WW\SK[KW6TC[]U[JG?^8CD<1M'YZ?R2^P-P
MYS"X3"X[Y<_)#84DV<R=+AZ63+]I?!+Y$;>V[&F0KGCI/NJK,TT5)3TY/EK*
MRJA@BN[@>_=>Z3/\Q7L3:_R'^3'\O_X.=0U\?9':^U?F_P!'_+?Y XS862H<
MS4_'CHWXJU];VK%NWM^IHGK:3KV/L/LFBV_M[#T>8^TJ=P1UE='CQ)/3DI[K
MW29WMU)_,3QO\P[YJ5G3G6N)V_UQ\O\ 8/Q'V+L3YP9S>'763Q/QIZKZ5VMV
M'!W!@L5U,F>I^T]T=Q3[K[&RE;LFFGQQVJN7RZY'(UDM+13XV?W7N@YZ7_EC
M?,[XI]I_(CH;XG=D=.=._!CY-[\V1V+NSO2+/[]S7S5ZYQF Z/ZTZ?W=LGK3
M#93 5NPJCM3?=5UQ)D)NQLUEZZHI:C/5.2&-ER=/$LONO=0>@OY-_:?57;/R
MP^.T.[>G>M_Y2_;O?.T?D9B>ENIMM9RB[W[DJI^K>LMC[D^.'<&^,ODJG%[7
M^.6$R_4U)59"GQ,%1N3>\>0JHJ_+4]+79&BF]U[H-8_B_P#S0-Y?%SY#?RN]
MH=>T?QWV=D^U/GKN?=7SI_O_ +-J-N=S=2_)?M7N?O\ ZQZWZ(VC15&ZNQ=B
M;TWWN;NB';>]\KG,.:;9^W\3D9,7/E<G6T1I/=>Z+9\1_B!_-R^"7R@Z.[Y[
M;^&77_S(VEU#_+DV3\)?CSUW\3>_.J]D8_XTQ;<W#L5\R=]U/R9W%U=6;OWI
MV7_=MJ[.;JPL>5"FHFIU2*BCBB]^Z]T.7<?4_P @ML?S1OY:/\P[^97MKX^C
M96\MQ;J^&/6/3'56.S6]]N_$/N?MLU&_/C1O+?7;&\JRCE[C[%WAO'$5>UI\
MMC=J[>P6W<\,744)DDECJO?NO=;2?OW7NJC/YW_6.ZN]/@'G.A-M['[$WOC>
M[_D7\,>M^Q1U=_$?[V;5ZFR7RVZ9RG96[HCAX*K*P8O';4P]1!6U,44B4--5
M/55 %+!.Z^Z]TB.I/Y;?S@^).T-B=&_"_P#F98?9GQ=ZLHZ#'=;]3?)?X2;!
M^0^\MNX2&K;(5VSZOMWK?M[XOY#.[/DK)IA2?<8K^.TM/,T<F5J&6*2/W7NA
M>WW6_P [+!Y^3&]9;;_E9]H;6IZ6F6+>N^][?+3HC/YBMTM]Y+)UAM_K_P"1
MN.VY2AP/%&-W95R"=3BW/NO='C[FZ3V?\ENA]\=&=U8=:O;':NQ:G:N]*/!5
M\M-6XBLR5%&PS>S<^T'WN%W-M+.QQ9'!9:)$K,=DJ.FK(2D\*,ONO=$%_P!E
M@_F6=E8ZOZ/[Z^9_1_\ LMJUD^V]P[RZ=Z%WAM+Y=]^]05>,?%9#:6^NQ:CM
M=.L>CMX;EQM7-39O<>R-M??S-_E>#.VZAD\'NO=!ID_Y.M%COE'N[?\ T[\A
M]R?'KX@=N?'OHOX_]Y?$3IK9F*V?-OK:7QM3<>.ZNVMMWN2ARJ[DZUV/6[;W
M=7XO/1X6CIL[6XV>>FI\I2?=22Q^Z]T)O8O\I/J3?/R'SG:N$[3[&ZNZ0[+Z
MRZ%ZK^0GQ"ZSQ'7>V.FN_MI_&!=\4?2&UMXYBEVA_I$P?7.#P&_ZW$9C;&&R
MM!A]RX:&GQ^0BEHHWIY/=>Z'SI7^7/\ %'H+Y,=Y?+CK_8=<O=W?>:.;W)G]
MP;BRVXL5L^6KVYMC;6X*3JO;F2GEP_7=+N^CV?CVR[4$25->*2GIWE^RI:2E
MI_=>Z(94?!/Y5]*=5_S@8J?M;9/8G4_RAI?F_P!S]']![$ZVK8M_;@[)^175
M=*AINT-]9_*99ZVJP&7P/\%P.(VY18^GGBJY*ROJ:N6:"CH?=>Z))MGX_?S(
M?D]U3_+!^1NP.B\;LSJ;^7[#TUG.I/@1\L]Z1='=J=]9?:'QTR?6,G??:V\=
MH[5[IQ?6N[ML[GSU+-LC;=;CJ.IH<?C\E69/15Y>CHL7[KW1B_G]\'?YC_S9
M[>^&6_J_JK^7]5T/1?6/<>?R'7_<W9O;W;O0O6'RBWKO;9^(VCVR=D+TELZL
M^2]5L+I?$U:[:H,SCML4%!N7)5M5/,8::FAR/NO=/'\G_P"$W\S_ * ZTW-0
M_,CMWJK8VX=^_)'L#Y!=PUW6L47:?<GR"W)FGV_M_!TV[]\YFAQO6/3?6U#L
MG8F'PT& VI@ZRO\ [OT\$5%DMNS1^"/W7NE5\5/Y*>^.B^J(N@>U/YA_R$[=
MZ.R&Z-Z[U[,V7L#:NUOCIO#Y$[JW]DZC)[ES7R.^0NSLGN3Y-=C5F66K:BK'
MI=Y8>2NQ5/24%0TE)3F&7W7NA,^-'4>SOA?_ #2OD#U+M;;FU^N>G/EO\3/C
M'NOXW;:P>-BP>"I,W\,,?N[I7M?JS:=)2+'CXO[F]=[NV1F5I"JSRTV2GFB\
MJ4U6:?W7NKFO?NO=$L^;^'_E]9CK[:<7\Q2;XJ0]6TV[,I+LL_+;.=98/8S;
MVJ^O]YX?)# R]IY#'X.JW(G7>3S;Z(F>H@HUFJ5"&G$L?NO=![_+TVO_ "K]
MH[>[+Q?\L"I^%U7@9,U@\AW!+\0MW]4;V89>N7/3;1C[$S'6V;S]=$J0_P 3
M&%I<C.(:>'[I:.-$\H]^Z]U8K[]U[KWOW7NO>_=>Z][]U[KWOW7NBY?+7:OQ
MJWU\?>PME?+O(]>X?H+=U+AMM;ORW9FZ\3L7;N,RF<W'B,;L;(8[>N7R6&7:
M.^J/?M3C)-LY.DJZ;*T.XEHIL?+'7)3L/=>Z)1*W\UOXH[9V_P!?=?=?],_S
M,]IXN%<1M[LGM+OVJ^('R$PV"QT?BQ5/W#,O47=O77<^XOLECBGW-BQM6IKY
MD,M3B3*\E2_NO='MZ#RGR4S^VZ_/_)C9O3G66YLI44,N#ZRZ>WSN[MJEV?C5
MH(S60[F[<W5LOJJ/>><K:^1B8Z#:>*I,<L?C6IR(<3K[KW0[^_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@:[@@
M^/\ 45'4\?>[=2K7+V]M.?HX]HU&TZ6O_P!.U+#DZG9:]5R[GEAJV[2:BAKA
70QXDG*34AJHT5H6F4^Z]T,OOW7NO_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tm2325130d1hqhar25130d2i005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2325130d1hqhar25130d2i005.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ H@!T P$1  (1 0,1 ?_$ :(    & @,!
M      <(!@4$"0,* @$ "P$   8# 0$!            !@4$ P<"" $)  H+
M$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R( "#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL? F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M  (! P($! ,%! 0$!@8%;0$" Q$$(1(%,08 (A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M  P# 0 "$0,1 #\ VT(,>M^0>+"Y^@_J;6L?;WV]-=/,.- M8<?X?ZW]3[]U
M[J;%0$FRH3;\VO\ \5]^Z]U,6@<'E2#_ +'_ (W8^]=>Z<(\6Y4G3_AS^?\
M>OZ^_5ZW0]2(\<."P!M_4?[P?Z^_5Z]0]9I:2G0ZW:.)+6O<)<\_2Y O;WZI
MZ]2G3;)+C%T_[D:(7("@U4 )_%O5(+G_  ]^Z]U/CI[J.;AA<,+$$?7_ &(L
M?K[]7KW4>6G&HG1R/Z#_ &P]^ZUU@\-K\7L?^-GCW[KW7 P*?[)'_&^.+C_'
MWOKW7!Z=2+#CC\CZ?C_;>_5Z]U#:E^IM<7_Q_P!Y^OY]^QU[I6?;C^X.G3Q_
M?#5^G_JRV_WOWKS_ "ZWY=)J"A/UT6'/!!Y^I/\ O/O?6NG>"A)(X) XTKR#
MQ]#8_47]ZKUOI_IL?H4,4M]?K]+7_K;\^_=>X<.IGVD5BQ4'C@6'U^O']??J
M=>KUS6G!%E7GZ'@BW^\?\:]^Z]7IKR5128V)I)W1G 5EI493/)<MZ@G]B(!&
M+2-9$168FRGW[KU3T73LG=-7'A<J^-SM!,ZQ5.L4TE,*&GJE,B4U&*^IG6ED
MF3ZE LKNWTY*CW91UHG'5#?<V2W?F]P92KQVZ,K-54U15?9S4F*R AADCE9X
MYH\@*>CG2>.RV;[:X%]/!Y?Z;Z&WX?\ SC[,ZVS<>RN^LM7YG8\KBCHL]DV>
MOR&,JI9E2E<5DP\IHO&%#QE]$0/I1-)+49*_;U<-3[.KP=@]H=?]G"H3:.X\
M9DZRFC6HFHH*NG>J:BD5&BR$$22.:C'S"5=,T>I/4 2"?;14CCU8$'H16H!^
M%O\ 4'ZGZ?[Q^/>NMXZCFBTWNFJU_J.?>L]>H.NWH4(_S?T%K$&]OK]??L]>
MQU!DH K747%_\?S^/I>WOU>M4Z5?VJ_W+TZ.?[SZK6'U_A5OI:WTX]^_%UNA
MITWP8\GEE Y/''^\ <^_4Z]4>73Q3XZP^@YY^GX_/X]^J!UKIQ6B"VL+_P!1
M<G\>]5/7NLGV0-KQB]P;GZ#C_;W]ZJ>O=(;L_?.WNK-G9+=N?ETQTRK3X^BB
M*-6YC,5%TQV)Q\,CQ_<5E;/956X %V)"@D64$FG7C@5/55F4[FKLWN>6FW-N
M&<Y2.I:MS]-B'B_A6+6?P,:"GD)2:IK:)=,/D*H@D4&-FC0>WPN,=-UKQZ8=
MZ]BR[DI1B,.DF-PT$)IU$,J+-/'<AA)='4-,&&HKRP%B;#WL"F3UXFO0>TV*
MQ0I$A,0 1"OI1(]1=0&#:65KL%MS[MUKH'>Q.NZ"NHYY::FIR9E=7143U K)
MJ60$:9!(&^C<&_U]^ZUT2[;O9/8WQ4[1VMN/:%?5PX_^+-+CXJN5WH(I) 6K
MMLU].S"2KQ>2BN80I+ .W *#54C%/+JX-?MZVR^FNS-M]X]7;,[4VB^K"[QP
ML&2BIW=&FQ]8K24N5Q%64)3[W$92GFII;<>2(VX]IS530]6Z$&6E-CZ/I_7_
M 'D<?ZWOU>M]1Q3GGC_?7Y_%[^]]:ZX?:$WN!]3:W]/Q]?S[]UOI0?;_ ._4
MT:>?X_>W-_\ BW6O[U^+\NO>7Y]=P4E@+B_T^MR?Z?TYO[T37KW3FE*0 Q 4
M?4$_G_6'Y_WOWZG5J>O7?C>]@I)_WGW[[.O<.'4J%!<+(C:B0 0">2> 0 3[
M]Y=;ZJM^<&XLB_8RO62&/;?4^VX,Q14!=$BJ]UY:!JM*BJ]+L7>*6BAA TO$
M0SDZ6LST?#[>FG.?D.JV>NZM\@:W(.YFJ<E635M1/(SN\TK.68DR,[%0SD_X
M,Q]O=-]#A18]ZAE,UUU $BU]7%@#]/Z^]<.'7NE&V( B0K92UU)XN2+<VN1P
M>![]UNG46JP:5-.P8!F (/U((*FUP#<D?7^OOU>O4Z)+W_UO%N3#9;$Q 1UG
MACK\54II66ERU#*TU!+'(5+Q+)->-R.0CM8CZ^_$5'7@:'JS'^4!OU:G8.\.
MI:K5$M&:#M/;=+QX\=2;O H-VX"%!Z::'$;JQYG\?J.O(.P(0HH8D7@>G%H3
M3JXR:ET?6Q'XXN#_ (<^VJ=6(Z;'@"O:R$6#?6WU)^GUX-O?NM=<UIP?]B 3
M<#_'\V]^KU[I\^V']WM%A_Q>=7YM_P  K>_9KUNF.G""D ](4,>3<@&W^N?J
M/>B?3J_6;[1G(!4B]P20+ ?Z]O\ >/>]77NI<6+'!+-Q?](L.?Z_6_OU>JUZ
M>J>@5/4$%^>;<_C\VU>]<./7LGCUKJ?S+MWR87??8.(BF)J,EN3%05+%Q<QT
M>V:66D165@Q2)*F- OT#Q?3T^U4?P@]--\5.BG=/5318"CJ))02D3O(2XTZ;
MZY"?[7'Y_''N_5.C,8;-4F2*+#74Q922Z1R)J%B/PNHKR?\ 7]^X=;Z7].JS
M1H;KI!%GU6"@V)-A_C_L1[J>MXZ;,MEL#@8C-D<YCZ)0Y!^ZK8(1J+: C"24
M,&U<6^M_H/>^/7L=%S[0JXTJ2Z,KI.J^*2,JRO'(&L5T\,&_Q%N/>^J]#W_+
MMQT6 [_ZP?$%BN\-E=M4&4BB\:I#BJ7*25E,T\8.K1%7;4HQJ55NTZGZ$CVW
M)\'3B<:]7^5%(Z%M7*D\$@D?X6-K?CVP#T[TTS489M2VN !8\?ZX!%OH??J=
M:(ZS0TPXUW((_I:W^\#WZG7@.G[[6/\ @VC4;?Q'7]1?_@-:W^VY_K[U7/5N
MGF.FX %@/R+7/]?^)]ZIU2I/4^&CU?V>+BYL;7_PXY]^P.MT]>G6"B6UV XX
M'U_V]O?J]6ZG+"@_'_%/>NO=:FG\U3;NY=K=[]DPRR4^2QU1E\!N:E:"J<5M
M-2;OEK,MCY:FED5;BEG.0H1I+#PTRL.3I56AJ@Z984;H@\F[]Q;:P^&:MH,I
M7X>N$3)C\) DF6R,DDH@AI(#4-'211%SJ>61EA0"Y:^GW?/5: ],.T-Z=N[T
MK]PYW96W-_[(Q.SLM#MR3&=@T6+:3)2M#453YW;F6Q%/15.4QM*\"05$H\L"
M>:,ZV +1ZSUN@ZL2V1OG-;RZ=>N@G-)N'(8EHEJG:4K099U:'2_@;R@15(NQ
M7U6_3S;WOJO#'5;V>V;\G,+V+B8ABI=^X?<"Y&7*YZMW'-08[!3T]? ]/#D(
M==5E 9:6)FAJ*$S!698S&I>317-<<.K56G1QZ/&[OJ-N0Y;<U%58J0".1\55
MSQ5WVDPIY%005]-XXIJ8,+ F..2]KJ+GW;JG5I/\K?K''U_9O878U0:AI=E]
M=;%V_M:B3R/C::'L.7-9C,UWD8E9:]EVY$!HX'W4U[^@AJ4T '3L8ZNWFI 5
M_3:_U#<@\_['VQ@]7I3(Z8SCE#$@L/5<@BX(O>P(^GOU3UNO7):!%/T)!OPU
M[C_6L!>WO53UJHZ<OMD_A^C3Q]YJ^G-_#:_OW7JXKTHX:  7<G_6_P!Z-_J;
M^_5ZW2G3@L:*  .![UUOKG[]U[KWOW7NM5'^<M!N';OS4P,](U4=J;PZ#VQG
MLS"BL],V9P>]LW@:65_3I66#&TK:3>PUG_56*B+X>FGX]%NZMR&T=T8&@QN<
MH[S,(I::>-BU7%XA: !WLX14&OZD:C8\>WNFSQZ%/?TNU.N.O,EDYZ^D@GRB
M'%X>"J\*Y+)Y"M5Q#34D,KB-#%&"[S.2B(&8V ]^Z\.D'T5E;]35]098E^RJ
M*O(O)YXWHXTBJS4S4[U:L%)C>X+?4<&WOPZ\>/1L.OMR[:WGAIV@*P9>B5Z;
M(8ZJ6 544Z $6>(?Y1#,DBNLGTEC<."5Y]^X=>Z"ON3*M2[;K:>"-(&@CG+K
MJ]3$ A&^H(4D@CCZ?U_'AUKJU/\ E"X7-0]5=B[ARD3K19;,;*Q..E+2.DCX
M/:WWE28Y9&<O^QN"G9U%ECD=D &GVGFX@=/1^9ZMOE@##Z"P^G^Q_K[9Z<Z:
MY*-E;@7'X(%[?Z_]/>Z]:H.L;4Y6^H'CD'^G']"+_GWZO7J==^-OMK7_ .4F
M_P!?QX_]Z]^QUJG2A]ZZMU[W[KW7O?NO=>]^Z]U2U_.5Z*W9OKK#:7;.S\+6
M9>+K:EW-3;[CQ<,$E33[9JTQV5Q^X,HK.E1/@]KU&,K/+XUE,!R!E*K$)G5Z
M)J5!\^J,//K7 Z/S&;BJ\<T0EF6J%5%&I5K%\?ZIX-9)%V1 VFUR+^WQTTW0
MG=L;XZ\W3D<=U_V7EL=0YB:@;*/39>H@IZK'XV:5J.*>CCGE1X8)7611*%(D
M8&YX &S3@>O"O$="IT_TU\>-E[1JW3LZCR.V,CBY?N-M5FY</'M2&I_;D=I<
M:E8E)*T]@NB96N22?[5] 4^SKW'CQZ?Z?=^U<[FJRFZ?S^VJS<6U8*6DJJ?;
M=;CZBB;&A!+#@\E%C:C12"&%PU(2NJ#D >.1@=_9UKI.U#;U[=[!VEU?@8O+
MN+?VY,+M>@B9IVIX*C)URX]ZFK,23.E)1^1I)W ;QPQLYX7WXF@KUM14];</
MQ_Z?QO1'4>R^L<=4)7R[>Q4*9C+)$8?XSGIU$N7R0C<O)'3S59*4\;,S0TJ1
MQW(0>T;-J:O3X%!3H9/=>M]=:1_3\W]^Z]UC:($?U_P-C_MOZ>_=>ZP_;C3I
MMQKU6X^NFWU^GOW7NI?OW7NO>_=>Z][]U[KWOW7NM=[^>C_-OZQ^(/56X_C1
MM"JI-T]X=LX7^ZVZZ>/P5>$ZWV%NNG:DSB[DD24S#=.ZMO5$M/0442F:FIZK
M[Z5HP*5*FZC\1X=:/IU0-U3O2+&4_P!JQC;+;4WK&V0:EE2H@J,;5"HQL]52
MR(1]Q1N]0DBR*;,@!Y!/M2#TR1T9/L?:6U>VLQC<OE-NX"MS. K9:6GJZK&T
ME1,*.)M:>&I:%YZ:PFTAD8?7_"WNQ /502.A?VWU5L&/&OBH]C8Z.E?&+3"%
M*[)TN.,$JLT0;'1E*&6*.34!#)$T0L0%L??J#KU3TKZ+&[=Z[PKRXO$XZDEH
MYJVHEEIJ2*F5CEF,U8R:%"M-4U,2O(S>IV /ZK>]]:Z/I_*=Z!7?&_<_\H=P
M0H^'V/)D]F=?T\J'R5&\LK0I-N;/V>-+083;F:6B@9=:235\_*O3<L3-C2.G
M47SZV!?:?IWKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z:\UG,)MK%UN<W'F,7@,)
MC86J<CF,UD*3%8N@IU_5/6Y"NF@I*6%;\L[JH_K[]U[JK_Y,_P Y3X+_ !PP
M.0J8NU<5W)NV!94H-F=0UE)NDU-2B/I.0W;!+_<[$4*2J!*[5DM0%-XX)2"O
MNX0GC@=:KUJO?+'_ (4D_*SN#)5NRNGGVWT#LG,5]/BHY=DK69/L4T5;6PP-
M%4]AY*WVE6$8Z:G#T>)E7FS?UL%4=>SUJ[?*_LG>F_-T9G<&XL]7YFNK<A59
M.NK\C6U&1R&1KJN=JBHR>0K:N>HJJNLJIB6:5W+EKW)/OS?RZ\.K*?A-\CY]
M]=5X3<U2D.2W'US14'5O9>,L#+DMOT%##2[0W)X5>-]53MJEAI9)F;]VMH9G
M/+.1=&QU0C/5A_5OR,QU-G,EC<Y7^.C?*328NMJ62-I,94F/0DDA"@30:.0+
M7O?BQ]N!NJ%:_;U9GM+NK9D.$>JK<C0!9:,212+41.H00J6)*R@@I_CP#S;\
M^[=5H>B?]K_(2OW'D)]J[*I),C'6S""LRR)))1PTS*(O"DL)M6U$E[*J,S$@
M#5>Y&B?(=6 \ST9[XC_\*0>B_B?09'XD_(GX_;GP<?16^M[=9S]B=+5.,SD>
M?DP6Z\K1R;JW#LK=>5PM7'F,[,KUV1J*3*5"35$TG@I(D58@F<58FO3J\!U>
M!UG_ #W?Y4G:46+&)^76SML5^36#5B^Q=N[YZ_DQL\Y4?;9/+;GVQC]LP-$S
M6>1*^2G'U$A7GW72>K=6:]<=L]6=Q8%=T]2=E;![1VR[*B[AZ\WAM_>F%+NI
M=8SE-N9#)40D*B^DOJX^GNO7NA ]^Z]U[W[KW7O?NO=:_P#\YOY[?4_1U?D>
MOOC'0[=[PWS1K)!DNP*K)2R=1;>K0'_R;'5>)G@J^P:R(("YH:JFQRAUT5<S
MB2)' GF>JEO3K4Q^7O\ ,>[]^2V6J\CW7VSG-S425$M3B=H4M5_!]BX"0ZUC
M7![/QII\)2SQP-XONGB>NE11Y9I6NWMP4'#K5">/54N_NV_XN6@7(S"%QK<Z
MG<-^WPI9'N@'^L;?[;WHGJW1?ZC(4C3P5E-67ECK*64#4R&T4ZN-(=_4%'U^
MEA^?Z5KU[K#N]H]Q4+DHDE0T'[CNK,SB-"+:];FX4W'UX_I[\<CKW2P^#6^!
MT_\ (3$4N8D$.S^S:5]@[A%3*8\9#69"H27;64K(VM3N]+F$%())#IAIZ^=B
M;$^_(:-G@>M,*CJ][L#X[9B@H6WCA\763[98C[QX()9H\3,_#&7QHWAIF#<$
MW"GT\@@*\5\^J:O+SZ577/5% B4M1E\6,[0D0S4KO*U;C&AF75&PIY'>&.JB
M/$D++<$7"E3?WL#K1/1U.C]CXS/]J8N@-!$N/V[3U.\ZVF2!1$\."EI8:)'&
M@(JG*5].@4V+J7L/2]M]:)QUJ.?-K%;FVK\KOD(^:2>&IRG<O8FX8FD1XQ58
MK<.[LQG<)5K]-:28W((M[VNIM[3,.X_;TZOPCH#<-GEJBL4DS*S +&Q;_.$$
M@@M=1J(^AMR#R;^] ^1ZMT9OHWY%=Y?'#=]-V!T+VUV!U-N^FC2!LYL+=>8V
MY55=&D\,[8O*#&U4,.7Q$\T"F:BJTGI)@MI(V%P;=:ZV[?Y?'_"JJ>ACP_6_
M\P[9T^50/!1T_P B.K<-2Q5Z0E(HQ5]B=8T2TM+5E)-<D]=M_P +B,!$Q<CW
M=JE1Y=>ZW"^C/D+T=\F=AX[L[H#M39/;>Q<DD/BS^R<[19B&BJ9J:*K_ (5F
MZ2&3^([<SU-#.OW&.R$--74K'3-$C @4X=;Z&3W[KW7Q[MX?(>6L$T%%334L
MHX"RB,/&'U%75!(=:.MBK"X(-P2+7?)\NM4\^BT9K>-=E:B26:ID:^MCJDO^
MH$7 8L0S V( M[K7KW22J*KS6UZKLP"ED!X_('YYMQ^>/\?>NO=,]=4?;KZ5
MLSD@V72-)4!SI+6(]8_V_P#MO=>Z<J?)S"G5I!Y(W) 6P!"RD\:VO< _0'CW
M[KW7H8A4R+*H=5634LH)$JRQ\H8V50RLC '4IO<6'Y]^Z]UN?_RY^]Z?MKI'
M9.Z,Y'399LICAM?>U'5T]/+3U&Y<,!B<VU32L'B\64$25*JP]4,ZD\'VH4ZE
M^?3#"C='!W[\0^BL7M/?'96$R&\-B46/VOG-Q5>*VQG<=3X8345!4Y"-*6DS
ME!D(:622H0".**:"/40%TBWO7G0=;X]$C^*/R<V-MC<V9ZGW/M08;<7:U974
MW5W9$6Y?[TQ;LJMO[;J<M#U]NZ*?";;J=I;EIJ:+*5F.$%//BL@\59&M1]P(
M&KO YZ\1BO5*/\[[J_%[:^4>U<_34JPTN^^LXX*@QQN!/E]I9JMI:JH62RQ-
M-]GEJ4-P6L!JX(]TD'=^75XSCJC<038]G0JVF)PR2@']R._%C:X8%N03]?\
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M>]@.6+ &Y!_UC^/?NO=)*7_<;E-14BASLL<+L>%ILV D-'.;*=,>4B1:=O\
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K_F]_3_:O?AU[JSO_ +IN_P#=N=_V6G_Y:G_S(S_W_P#_ /*[[W^+KW7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm2325130d1hqhar25130d2i006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2325130d1hqhar25130d2i006.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ K@#A P$1  (1 0,1 ?_$ :(    & @,!
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M/6^$/=V%V3N;L_=-+U9NG(Y7*8.EQ^%R^V>P9-Z=V]=[@P\6R\[!64>?S:X
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tm2325130d1hqhar25130d2i007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2325130d1hqhar25130d2i007.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ UP#A P$1  (1 0,1 ?_$ :(    & @,!
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MN0P\F"V/O&NR6?KA14%1',F/\$HC>OCA]U[I!=?=O?([JGN?:W77<N1S7;F
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M9"CK\'C7S>3IZ):F=%IGJYXXTD9I(]7NO=*S:V^MD;Y3+R;*WCM7>"8#+5&
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M[,[?F"1L*#+]-]T35;,\0D:-7P.P<W0ZXF.AKS!2WZ25]7NNANMZAT#/9/\
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M\%M?.5?;VS< ^[L#M3/8? [AS-#C-T2#>>W<;NC"8,X%IY:Z?=3XG,T338R
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M;<V$WKMG;^\-M5C9';NZL+C-Q8'(-25M :_#9FBAR&,K11Y*FHZ^F6KHJA)
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2W7NO>_=>Z][]U[KWOW7NO__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tm2325130d1hqhar25130d2i008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2325130d1hqhar25130d2i008.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ D@'+ P$1  (1 0,1 ?_$ :(    & @,!
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M6TZK?=!O/;=349CNO;ZE-RXW!+)'5.\+2B)[>Z]T^GYB=>1X',;HJMJ]@T.
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M)("%E415M/2U TEAR4 -^+^ZD%30\>M@@BHX= EM+XN[,Z\[5W+VQU_N7?\
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MB*W&UDM#]]''4*KZH9KHW(/O84G@.M$@<>A._P"'<OBK_P \[\E/_2:.W/\
M['/=M#^AZUJ7UZ7VR/YD'2W9*9>38O67RHW,F 6B;,G&?&7M>3^'KD16FA:<
M28&,@5(QT^FU_P#-G_#W4J1Q'6P0>'77_#D/2W_/LOE3_P"DR]K_ /UA][TM
MZ=>J.NF_F1]**K.W6?RH545F9F^,O:X554%F8DX&P  O[]I;TZ]4=%U^5/\
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M=@M5=O\ QP^5TN_(LDR'&8/XS;^BAJ<=/D*>&*:":FQ\F,4T5#4-+())4=Q
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MJD^_=>Z"S9??/7^_MTR[,P%-V72[B@Q39NHI-W=']V=>TM/C1*D$<]1E]_\
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MS5$U%BLG5QP(YBI9F 0^Z]T2;XKU>7VQVRFS^O\ MK9GR8V%NNAWCO;>^_\
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/WOW7NO>_=>Z][]U[K__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tm2325130d1hqhar25130d2i009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2325130d1hqhar25130d2i009.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ D@'$ P$1  (1 0,1 ?_$ :(    & @,!
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M#_\ U7[]U[/7OXKF_P#GEJS_ ,^F'_\ JOW[KV>O?Q7-_P#/+5G_ )],/_\
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M&:'-2I]_)?WZAZWTT[V^+?8.6V+)1;/[;W?MW>\V_?F1N3&3#<FY*3;>R_\
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M>3$#"PMH"V' L/?JGKU.E734M-1PI34=/!2T\2Z8H*:&."&-1]%2*)51%']
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M+24-35TT_NO=)'<W06X<UG\#NQ>Y-WYK,[>QNW-LT&-WOM?J?*[3AVS59S8
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M #FVG_\ 8O[]4>G7NO?P3)?\]?N+_P YMI__ &+^_5'IU[KW\$R7_/7[B_\
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MQK%?XAEGIX<+AXV$V1K*2G#2K[KW1#NQ.X^]NU\/E\KVGO;'?#'H*6HBQO\
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MN_\ G=D__K?[]CKV>O:]V_\ *MMW_P [LG_];_?L=>SU[7NW_E6V[_YW9/\
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M #SFXO\ SFH/_KE[]3KU>O?Q^;_GG-Q?^<U!_P#7+WZG7J]>_C\W_/.;B_\
M.:@_^N7OU.O5Z]_'YO\ GG-Q?^<U!_\ 7+WZG7J]>_C\W_/.;B_\YJ#_ .N7
MOU.O5Z]_'YO^><W%_P"<U!_]<O?J=>KU[^/S?\\YN+_SFH/_ *Y>_4Z]7KW\
M?F_YYS<7_G-0?_7+WZG7J]>_C\W_ #SFXO\ SFH/_KE[]3KU>O?Q^;_GG-Q?
M^<U!_P#7+WZG7J]>_C\W_/.;B_\ .:@_^N7OU.O5Z]_'YO\ GG-Q?^<U!_\
M7+WZG7J]>_C\W_/.;B_\YJ#_ .N7OU.O5Z]_'YO^><W%_P"<U!_]<O?J=>KU
M[^/S?\\YN+_SFH/_ *Y>_4Z]7KW\?F_YYS<7_G-0?_7+WZG7J]>_C\W_ #SF
MXO\ SFH/_KE[]3KU>O?Q^;_GG-Q?^<U!_P#7+WZG7J]>_C\W_/.;B_\ .:@_
M^N7OU.O5Z]_'YO\ GG-Q?^<U!_\ 7+WZG7J]>_C\W_/.;B_\YJ#_ .N7OU.O
M5Z]_'YO^><W%_P"<U!_]<O?J=>KU[^/S?\\YN+_SFH/_ *Y>_4Z]7KW\?F_Y
MYS<7_G-0?_7+WZG7J]>_C\W_ #SFXO\ SFH/_KE[]3KU>O?Q^;_GG-Q?^<U!
M_P#7+WZG7J]>_C\W_/.;B_\ .:@_^N7OU.O5Z]_'YO\ GG-Q?^<U!_\ 7+WZ
MG7J]>_C\W_/.;B_\YJ#_ .N7OU.O5Z]_'YO^><W%_P"<U!_]<O?J=>KU[^/S
M?\\YN+_SFH/_ *Y>_4Z]7HBN]^Q*["?S#.E<;%UGV5GH]Q_&;LK#SY3!8O;U
M1B]L15G;W5"MF]SRUNYZ"II,)0^$&>2GBJIE#KIB:YMKK?1D_E'F]Z;8^./>
M&Z^N]UMLG>NT.L-Y;PV_N=,)A]Q28VLVGA*O<3"+$9^GK,+4S5U-C'ID:I@J
M(8&F$K0RZ/&WNO=%_P ?W+V+2=EC)2[U?<C9?L_OGK:L^/,E'LK%TVS-N]6;
M:K\ILW?=)N&GP$>^_P"+;PGQFV9JC^(5M5CO'V70K#3Q^&E:?W7NBJ9/Y)]X
M8ZHK\=C?DA)N/'8SX,Y?YETN[H=F]14ZYSM"BH\/4T?3#T\6S9*"FZ?JL974
M^2_AL87? I\G$?[Q&-HF/NO=.G^S#=R_PW^\G^S0_P"_C_V3?_9M?]$']Q^I
M/)_I*_C'\-_T._?_ -T_X_\ Z*/[S?[]O^$Z_P"_7\0]/]X?/^U[]U[JY#W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1/<U_V7QU
MY_XJ7VQ_[]SJ+W[KW1NJNDI:^EJ:&NIJ>MH:VGFI*RCJX8ZFEJZ6IC:&HIJF
MGF5X9Z>>%RCHX*LI(((/OW7ND1N+JOKC==9/D\_LK;M?EJK(;$R=7FOX;!2Y
MVMJNL=XXOL#8 K<W1+39:MI-J[RPU-7TE-+,].DT9NA5W5O=>ZSCK'K98H:=
M>O=CK!3;T;LBGA&T\"(H.Q'GEJ7W[#&*#1%O1JF>20Y10*XN[-Y;DGW[KW7O
M]&76WWG\0_T>['^__OA_I"^^_NG@?O/[_?8_PS^_'W/V'F_OA_#?\G_B>K[W
MP?M^33Q[]U[IYDW5M>&22&;<F BEB=XY8I,QCDDCD1BKQR(U0&1T8$$$ @CW
MNA].O=</[W[3_P">HV[_ .?O&_\ U3[]0^AZ]U[^]^T_^>HV[_Y^\;_]4^_4
M/H>O=>_O?M/_ )ZC;O\ Y^\;_P#5/OU#Z'KW7O[W[3_YZC;O_G[QO_U3[]0^
MAZ]U[^]^T_\ GJ-N_P#G[QO_ -4^_4/H>O=>_O?M/_GJ-N_^?O&__5/OU#Z'
MKW7O[W[3_P">HV[_ .?O&_\ U3[]0^AZ]U[^]^T_^>HV[_Y^\;_]4^_4/H>O
M=>_O?M/_ )ZC;O\ Y^\;_P#5/OU#Z'KW7O[W[3_YZC;O_G[QO_U3[]0^AZ]U
M[^]^T_\ GJ-N_P#G[QO_ -4^_4/H>O=>_O?M/_GJ-N_^?O&__5/OU#Z'KW7O
M[W[3_P">HV[_ .?O&_\ U3[]0^AZ]U[^]^T_^>HV[_Y^\;_]4^_4/H>O=>_O
M?M/_ )ZC;O\ Y^\;_P#5/OU#Z'KW7O[W[3_YZC;O_G[QO_U3[]0^AZ]U[^]^
MT_\ GJ-N_P#G[QO_ -4^_4/H>O=>_O?M/_GJ-N_^?O&__5/OU#Z'KW7O[W[3
M_P">HV[_ .?O&_\ U3[]0^AZ]U[^]^T_^>HV[_Y^\;_]4^_4/H>O=>_O?M/_
M )ZC;O\ Y^\;_P#5/OU#Z'KW7O[W[3_YZC;O_G[QO_U3[]0^AZ]U[^]^T_\
MGJ-N_P#G[QO_ -4^_4/H>O=>_O?M/_GJ-N_^?O&__5/OU#Z'KW7O[W[3_P">
MHV[_ .?O&_\ U3[]0^AZ]U[^]^T_^>HV[_Y^\;_]4^_4/H>O=>_O?M/_ )ZC
M;O\ Y^\;_P#5/OU#Z'KW7O[W[3_YZC;O_G[QO_U3[]0^AZ]U[^]^T_\ GJ-N
M_P#G[QO_ -4^_4/H>O=>_O?M/_GJ-N_^?O&__5/OU#Z'KW7O[W[3_P">HV[_
M .?O&_\ U3[]0^AZ]U[^]^T_^>HV[_Y^\;_]4^_4/H>O=>_O?M/_ )ZC;O\
MY^\;_P#5/OU#Z'KW7O[W[3_YZC;O_G[QO_U3[]0^AZ]U[^]^T_\ GJ-N_P#G
M[QO_ -4^_4/H>O=>_O?M/_GJ-N_^?O&__5/OU#Z'KW7O[W[3_P">HV[_ .?O
M&_\ U3[]0^AZ]U[^]^T_^>HV[_Y^\;_]4^_4/H>O=>_O?M/_ )ZC;O\ Y^\;
M_P#5/OU#Z'KW7O[W[3_YZC;O_G[QO_U3[]0^AZ]U[^]^T_\ GJ-N_P#G[QO_
M -4^_4/H>O=>_O?M/_GJ-N_^?O&__5/OU#Z'KW7O[W[3_P">HV[_ .?O&_\
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M;([:W#M_:N$B6A^1M*CT^'P]'% CN&E=4N[LQ)/NO=&M_P!D>Z8_Y[7Y?_\
MIPGY]?\ W2WOW7NO?[(]TQ_SVOR__P#3A/SZ_P#NEO?NO=>_V1[IC_GM?E__
M .G"?GU_]TM[]U[HOGRW^)_7G7GQ3^3F_P#9G9/S$P>[]C_'KNG=^U<W!_,#
M^>%1/A]R;:ZWW+F<'E88*[Y'U5'--C\G113(LL<D99 &4BX]^Z]T+^S?A9U%
MDMH;5R-=OKY@5%;7[;P=;63M_,'^>ZM/556+I9ZB9EC^2B(K22N6(  YX'OW
M7NE)_LCW3'_/:_+_ /\ 3A/SZ_\ NEO?NO=>_P!D>Z8_Y[7Y?_\ IPGY]?\
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;>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tm2325130d1hqhar25130d2i010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2325130d1hqhar25130d2i010.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ & !G P$1  (1 0,1 ?_$ :(    & @,!
M      <(!@4$"0,* @$ "P$   8# 0$!            !@4$ P<"" $)  H+
M$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R( "#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL? F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M  (! P($! ,%! 0$!@8%;0$" Q$$(1(%,08 (A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M  P# 0 "$0,1 #\ WD*/Y#],9#Y YOXKT6_<75=_[<ZGPO>.=ZVAI<J^4Q?5
MNX=TY+96&W55Y$8_^ 1QUNY<3/3BD^[^_10DSP+!+%(_NO=$H_F?_P V7XJ_
MRL.F\COKNW=^'RW:V<P>1GZ7^/F+SN/I>Q>VMPHLU)BXX*:3[B3:NPX\P$BR
MVYJV'^&XR'7;[BJ\-)/[KW1.O@W_ #S?AEGNC]M-\S_YE'P.G^2.=JL[NO>6
M%ZSW)5;!ZOZ]Q^X,W-6;=ZPP&=W]6+)O";8>'JH*"HRKSB2NEB>2TJ)]S-[K
MW5WW5O</4G>6U(=^=*=I=<]P[&J:J6AI]Y]6[WVSV!M2>M@AIZB>CAW%M/)Y
M?$2U4-/5Q.\:S%U25&(LP)]U[H1O?NO=!_4=J];4O:>)Z/GWOMM.W\YU_N'M
M7%]<?Q2F;=]5UMM7<>V-HY[>_P#!4=JN#;=!N?>6-H/NI%2.6JJ?'&7:.71[
MKW0@>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZTD/G3_,'^7'Q__FR_
MS%.T_B;\7>PMW;?V3TS\2_AAVK\MQU;NOM;KSX@8NBI]U=\;][FW9TUUWB,Y
MNWMA<%M7LY*['RR9+!8JB_AMJ^FR$<D$4GNO=; 7\OGX-_"6GZJH/DKM_=VW
M?Y@/:'R1VK!G>POG1W-3[>[5[ [JQ><6EJJO!X:LR]-DZ+J[JG'U=''346PL
M.E#BL%'114DU.U32M)[]U[JK+^87FMP8O^>[\+-C]?\ PF[+^4&V.@_@QWQW
M\G1W4LG0VV-K[TS_ &WO = S[UW;0=D[YV-M3)[?V/!604L[9EI9J2OKJ2>A
MI6435 ]U[HG'S%V)\L_A5T[\\/YNV3^//6_\IVGQGQ,JOBCTK\-_B[V+L:NW
M9V!V]WOV7B^N,=\J._=[=#8O"=45V^.L<7O"');9I:$9.OIIL5#(]=2FDTUO
MNO=/G\O;Y[?,+X5]\?)'(_S-,OW)WS\N_FC\8_Y>V]_Y?/Q'ZTI>U-TGL"+-
M; [PCSG66V<3FH*S9O6^X.N\M08N#LG<V<JJ>&DR+5N3JZVMDJB]3[KW2X^/
MW:7=GPQ^67\[?^9!\^-P9CN_Y+_$7X0?$K%R=>;,@RG^C;K:7Y)X[=?>65^-
MO453+3Y+[/J?9N^-N;4QLN;BFJB^C(YBO$DKL3[KW1O=K]1_S!_E'T=M?Y__
M #4_G-XGX&]'[WV#MKL_!]7?#JGZFV-T3U!UIOR"DR6U)=\?)WN>;.IOO<V0
MI,WBXJVOJH%Q=/D?+!CY989XV'NO='2ZA_G,_P K+9^)ZN^/='_,6V_\F.S-
MO[/VQM2HWKB,9N?MW>W85=A<5B,75[UWEENE.N:_:$68S51.E1D*E(Z6F2HE
MD+Z2DFGW7NKGO?NO=4[?S*-R9?._,#^37\>\/E]U8R/L'YN[U[LW/2[=JLGC
MZ'-;1^+GQM[5WJ^,W358RH0UN!&]-S8*H-!412TE3-!'+)H-,C#W7ND-_,(V
MO@N\?YI7\H+X][IJ<AD-E4&+^?'R!WWLT5#P8+<=)M3H?;_3NVDRR1PRR35
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BV=S>5S^6S&,VY#2Q35U34?:T\DB1!05T>Z]T='W[KW7_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
